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ABSTRACT  
Exposure to air pollutants is a well known issue both in indoor and outdoor environments. 
However, the scientific community has only recently started to focus on indoor exposure. 
People spend a large portion of the day in indoor microenvironments, and although the 
exposure levels found indoors are often lower than outdoors, indoor exposure has a relevant 
contribution towards the total exposure.  
With this work, the main biomarkers of exposure to VOCs and PAHs were analysed in different 
populations groups, focusing mainly on general population, with an aim to evaluate the 
exposure in everyday life by analysing biomarkers of exposure and effect.  
We also tried to build and validate a physiologically relevant model for toxicological studies, 
in order to advance the knowledge on biomarkers and biomarker discovery. 
We analysed airborne personal exposure to VOCs and PAHs and urinary BTEX, cigarette 
smoke exposure and oxidative stress biomarkers of a population of non-smoker volunteers 
from Birmingham, UK. The three main categories were: a control group that lived and worked 
in buildings that were refurbished or built more than one year before the study; a group of 
volunteers that lived or worked in buildings that were refurbished or built less than one year 
before the sampling and a group of occupationally exposed subjects that were working in traffic 
or using tools powered by petrol engines. The second group underwent a second sampling after 
one year, in order to measure differences between the first and second sampling. The third 
group was sampled at the end of the working week and again after the weekend, in order to 
measure differences between the end of the working week and the beginning of the new one.  
In addition to this group of subjects, a subset of a previous study with high exposures to 
environmental tobacco smoke (ETS) was added (Harrison et al., 2009), together with a subset 
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of samples from schoolchildren in Saudi Arabia, living next to a high-traffic ring road and to 
an oil refinery (Trasande et al., 2015).  
Results showed a significant correlation between urinary cotinine (ETS biomarker) and urinary 
VOCs, suggesting a contribution of ETS towards exposure even at low concentration, and a 
generalized variance of exposure biomarkers even in general population. Urinary VOCs were 
found suitable for exposure assessment in general population, although the correlations with 
oxidative stress biomarkers were weak.  
Analyses of PAH (both airborne and urinary) in schoolchildren from Saudi Arabia did not 
reveal significant correlation between urinary PAHs and oxidative stress.  
The results from this last study suggested that oxidative stress in that population might be 
related to some other compound or behaviour that was not measured.  
In addition to these studies, we designed a custom exposure system to expose cells to controlled 
atmospheres, to evaluate the immediate effects of exposure to low concentrations of benzene. 
This system was designed to develop a physiologically relevant model of exposure that could 
be applied in future toxicological studies. The results obtained with this system proved the 
validity of the model for benzene exposure, where we observed ROS generation and DNA 
damage in the cells after benzene exposure.  
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I. Introduction 
This chapter presents an overview on exposure, metabolism, measurement and effects of VOC 
and exposure. 
I.1 Exposure to VOCs and PAHs 
Exposure to volatile organic compounds (VOCs) and polycyclic aromatic hydrocarbons 
(PAHs) is a well-known issue, and there is an increasing interest from the scientific world 
towards the estimation of the exposure in houses and workplaces for general population 
(Wolkoff, 1995).  
Typically the exposure to VOCs is studied in populations or categories that are exposed 
to occupational levels, therefore high ambient concentrations. However, as mentioned above, 
exposures linked to indoor microenvironments are gaining importance towards the overall 
exposure of general population, and not only certain categories of occupational exposure. 
The microenvironments that mostly contribute to exposure in everyday life are the 
home or the workplace (Delgado-Saborit et al., 2011). People spend the largest part of the day 
indoors (e.g. working, cooking, eating, sleeping) while outdoor activities are mostly limited to 
commuting, with some exceptions in general population. It has been reported in several 
international studies that people spend 80-93% of their time indoors, 1-7% in enclosed transit, 
and 2-7% of the time outdoors (Jenkins et al., 1992; Thatcher and Layton, 1995).  Furthermore, 
it has been reported that within the time spent indoors, the large majority of it (60-70%) is spent 
in the house (Thatcher and Layton, 1995; Hinwood et al., 2003), making it one of the most 
influential microenvironments for exposure evaluation.  
In addition to the home microenvironment, the workplace has also been reported to be an 
important microenvironment for exposure evaluation (Harrison et al., 2002). 
Most of the measurements conducted in the field of PAHs and VOCs exposure have 
been performed by air sampling, at fixed site or in the breathing zone with personal or passive 
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samplers (Manini et al., 2006; Harrison et al., 2009; Scheepers et al., 2010). While this 
methodology gives a good global idea of the exposure, it does not take in account all the 
possible variables that can contribute to differences in exposure patterns, metabolism and 
absorption in a person (e.g. level of activity, age, fitness). 
Air sampling itself gives an idea on the level of pollution in the microenvironment, and 
it is possible to calculate the exposure from this. Unfortunately, it does not take in account the 
ratio of absorption and the metabolization of the pollutants. 
A good way to assess the exposure and the interaction with the environment is to analyse the 
metabolites of the pollutants that the subjects can get in contact with in their everyday life or 
in the workplace (Hu et al., 2006; Manini et al., 2006; Campo et al., 2011). In such 
investigations, the main subject of analysis is the human urine, which contains most of the 
metabolites that are excreted after being processed in the body. All of the analysed metabolites 
are relevant trackers of exposure to various pollutants, and their analysis and quantification 
allows making a more accurate estimation of the exposure of the subject. Moreover, due to the 
relatively easy recovery of the metabolites and the non-invasivene nature of sampling, urine 
analysis has been used widely for biomarker studies. Nowadays, there are a reasonable number 
of studies on the high level exposures and environmental exposures to PAHs and to VOCs 
using urine sampling (Qu et al., 2003; Fustinoni et al., 2010). 
I.2 VOC and PAH sources 
VOCs and PAHs are ubiquitous compounds that are found in both outdoor and indoor 
air. The most common sources of both VOCs and PAHs are related to combustion, including 
traffic, environmental tobacco smoke (ETS) and wood/incense burning. The contribution of 
outdoor air towards the overall exposure to both VOCs and PAHs is always present, and it 
represents one of the primary sources of pollutants since outdoor air can infiltrate indoor 
environments through ventilation (de Blas et al., 2012). However, household items, consumer 
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products, building materials and even furniture, or activities such as DIY are known sources of 
VOCs. Use of printers and photocopiers is also a source of PAHs. All of these sources can 
contribute towards an increase in the concentration of the pollutants in indoor 
microenvironments, creating in some cases significant changes in the concentration of certain 
airborne pollutants (Delgado-Saborit et al., 2011; Delgado Saborit et al., 2009; Edwards et al., 
2001).  
Building materials and furniture, including carpets, wall papers, linoleum and glues are 
known sources of VOCs such as formaldehyde, toluene, xylenes (Missia et al., 2010; Shin and 
Jo, 2014; Bolden et al., 2015). Together with the contribution of the outdoor air towards the 
indoor concentration, indoor sources can contribute significantly towards the overall exposure 
to VOCs. In some cases, the indoor concentrations can reach significantly high levels, causing 
serious adverse reactions, known as “sick building syndrome”. Typically the sick building 
syndrome is associated to high indoor VOC levels, and the symptoms are dizziness, nausea, 
headaches or asthma (Wolkoff, 1995). These episodes, however, are generally related to spot 
exposures or poor building design, which in some cases can cause a significant increase in 
indoors VOCs concentrations causing adverse effects on the building’s occupants (Missia et 
al., 2010).  
I.3 Biomarkers, biomonitoring and metabolism 
Biomarker discovery and the consequent biomarker monitoring are gaining importance 
in the exposure field as these methods represent a way to estimate and establish an early 
assessment on the level of exposure.  
Biomarkers like proteins adducts (Qu et al., 2003; Rappaport et al., 2005) have been 
used for high level exposures, as the pollutants tend to conjugate with transport proteins like 
albumin in the bloodstream once absorbed by lungs. These methodologies have a good 
reliability for high level exposures and allow analysing the pollutants in a form which is similar 
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to the original as they are sampled before they get completely processed in the body, making 
it easier and more immediate to track a certain pollutant.   
On the other hand, they require blood samples (invasive sampling) and have a low 
sensitivity; furthermore the half-life of the pollutants in the bloodstream could negatively affect 
the final result and the estimation. A more effective way to analyse the exposure is to track the 
exposure from the results of the metabolization, i.e. after excretion in urine. In this case, typical 
metabolites arising from different pollutants, known as biomarkers, can be found.  
One of the most diffused pollutants in the VOC mixture is benzene which is known to 
generate not only albumin adducts when present in high amounts, but also trans-trans-muconic 
acid (TTMA), S-phenylmercapturic acid (SPMA), phenol (PH), quinones such as 
benzoquinone (BQ) and hydroquinone (HQ), and catechol (CA) via its metabolism (Melikian 
et al., 1999; Kim et al., 2006; Manini et al., 2010). 
Some authors (Kerzic et al., 2010; Lim et al., 2011; Lin et al., 2007) have focussed on 
quinones, which showed a good reliability and a good metabolite to track the exposure. 
Quinones are one of the principal metabolites of benzene, arising from the metabolization in 
the liver, which consists in the addition of two oxygen atoms to two of the carbons of the 
benzene ring.  
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Figure 1: Schematics of benzene metabolism, Snyder and Hedli (1996). 
 
As explained in Figure 1, benzene is metabolized in the mitochondria by Cytochrome 
P 450, which acts by adding one oxygen atom, which tends to rearrange as phenol or benzene 
dihydrodiol. Then, both of these metabolites can undergo to an enzymatic reaction (benzene 
dihydrodiol) or a chemical reaction with OH ending in catechol which rearranges in 1,2-
benzoquinone. Another pathway of metabolization is from phenol, reacting with OH and 
forming hydroquinone, which rearranges in 1,4-Benzoquinone. Both benzoquinone species 
have a dynamic equilibrium between the reduced form (hydroquinone) and the oxidised form 
(benzoquinone), which is pH dependent. At the cellular pH (7.5) the prevalence is for the 
reduced form, because of the nicotinamide adenine dinucleotide phosphate (NADPH) 
contribution to the reduction of the benzoquinone in hydroquinone, although in an acidic pH 
the reduction does not occur (Boersma et al., 1994; Snyder and Hedli, 1996). 
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Figure 2: Main metabolites of benzene, Snyder and Hedli (1996). 
 
These biomarkers can be monitored and quantified to evaluate the exposure to benzene 
in humans from urine samples, coupling the non-invasive sampling with the accuracy of the 
measurement of the metabolites. 
Many studies have been performed on every metabolite, showing a good reproducibility 
for  hydroquinones, which have been used as biomarkers in several cases (Qu et al., 2003; 
Waidyanatha et al., 2004; Kim et al., 2006). In general, all the studies on the metabolites, have 
been performed on subjects that were exposed to high levels of VOCs. There is a lack of 
knowledge about the low exposures of the general population and none of the previous studies 
has taken in account the exposure arising from the contribution of sources such as consumer 
products and building materials in indoor air.  
A study on this kind of exposure, coupled with personal air sampling will help to better 
understand and evaluate the exposure to VOCs and PAHs in general population. Furthermore, 
such a study would help finding suitable biomarkers to analyse and evaluate low level 
exposures. 
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I.4 VOC exposure, DNA damage and toxicological models 
In light of the contribution of indoor air towards the total exposure, this kind of 
exposure should be studied extensively. Indoor exposure to VOCs has been reported to cause 
a number of symptoms ranging from irritation of the respiratory system to sick building 
syndrome (Brinke et al., 2004; Wang et al., 2013). In addition, VOCs are also reported to 
contribute to oxidative stress induction via production of reactive metabolites and hence have 
the potential to damage DNA (Knaapen et al., 2006; Lu et al., 2007; Saint-Georges et al., 2008; 
Snyder and Hedli, 1996; Sørensen et al., 2003a; Wang et al., 2013). Exposure to VOCs can 
also lead to an inflammatory response in the lungs that can then result in oxidative stress. Some 
compounds, for example styrene, have been reported to be directly responsible of leading to 
oxidative stress by induction of inflammatory response (Bönisch et al., 2012; Röder-Stolinski 
et al., 2008). Inflammatory response has been suggested to be an important source of oxidative 
stress in a review by Knaapen et al. (2006a). An association between chronic inflammation and 
the development of cancer has been observed in many cases. In fact, chronic inflammatory 
bowel diseases are associated to the development of colon carcinoma (Collins et al., 1987), as 
well as chronic lung inflammatory diseases (i.e. sarcoidosis and fibrosis) are associated with a 
higher risk of cancer development (Schottenfeld and Beebe-Dimmer, 2006). In the review, the 
author suggests that the inflammatory process, involving interleukin production, which triggers 
the neutrophils response with production of reactive oxygen species (ROS), could trigger DNA 
damage. The author, however, specifies that this has been observed in rat, and while it still 
needs to be proven in humans, the proposed process represents a possible pathway of lung 
localized carcinogenicity in case of chronic exposure. The inflammatory response can be 
triggered by bacteria or foreign particles that enter the lung, as well as VOCs, PAHs and 
particulate matter, as mentioned previously. Indoor concentrations of the pollutants have the 
potential to trigger inflammatory response (Pariselli et al., 2009; Bönisch et al., 2012), making 
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indoor air crucial in terms of pollution-induced diseases and studies. The pathway described in 
the review starts with a non-specific response of lung cells through expression of cytokines. 
Resident macrophages in the lungs produce chemokines and cytokines (interleukin 8 is one of 
them, generally considered a marker for inflammatory response), together with the lung 
epithelial cells. This cytokine and chemokine production triggers the process of adherence, 
extravasation and migration of neutrophils that will reach the lung epithelium and produce a 
broad spectrum of oxidants, mainly resulting in production of H2O2 and its conversion in HOCl 
in order to eliminate the inflammation trigger (Klebanoff, 2005). In case of PAHs, it has been 
observed that the presence of ROS can activate the compounds by transforming them in their 
chemically active form of hydroxides. ROS generation arising from inflammatory response has 
been linked to DNA damage and higher levels of 8-oxo-dG. However, H2O2 is not directly 
responsible for DNA damage, but one of the ions deriving from HOCl formation, OH is 
thought to be the responsible for DNA lesions, due to its high reactivity (Pryor, 1988).  
For benzene related DNA damage, together with the inflammatory response, another 
mechanism of action has been proposed through the known reactive benzene metabolite p-
benzoquinone. One of p-benzoquinone cellular targets is topoisomerase-II, which is inhibited, 
generating DNA double strand breaks (DSB) which are then repaired by homologous 
recombination (HR) or non-homologous end-joining (NHEJ). NHEJ is thought to be more error 
prone than HR, however, generally, DSB damage can lead to DNA aberrations by base 
deletions or translocations due to genome instability. Furthermore, the metabolism of benzene 
through redox cycling and generation of ROS is proposed as another main source of DNA 
damage. When hydroquinone or catechol are oxidised in presence of oxygen, superoxide (O2-) 
is formed, which is then transformed in H2O2 by superoxide dismutase. H2O2 is not responsible 
for DNA damage directly, but it increases the oxidative potential of the cell, and in presence 
of transition metals ion or copper, hydroxyl radical (OH) is formed, which reacts with lipids, 
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proteins and DNA. OH is responsible for the formation of 8-oxo-dG and other nucleobase 
alterations due to oxidation (Halliwell and Aruoma, 1991). H2O2 production is also linked to 
inflammatory response of which, as stated above, VOC exposure has been reported to be a 
trigger.  
Therefore, low level VOCs, PAHs and their metabolites have a potential role in DNA 
damage due to their inflammation triggering effect, and their metabolization in the cells via 
redox reactions (Moller, Folkmann et al. 2008). VOCs and PAHs can also react directly with 
the DNA forming adducts with the nucleobases. 
In the case of nucleobases adducts the nucleobases are modified by the reactive species 
that are produced during the metabolization of the exogenous compounds. In both cases the 
nucleobases are not anymore coupling with the complementary one on the other strand of DNA, 
perturbing the double helix. This perturbation is sensed by the cell which activates the DNA 
repair systems which will cut out the non-pairing nucleobases and substitute them with new 
ones (Loft, Danielsen et al. 2008). The increase of the ratio of damage with the consequent 
repair can generate mutations in the DNA, that can lead to irreversible DNA damage and either 
apoptosis or carcinogenicity as the repair system is anyway error-prone. The nucleobase that 
is more prone to modifications is Guanine, which is often modified in 8-oxo-dG, but also the 
other nucleobases are modified by reactive species like ·OH or ·O. Other common markers for 
guanine are 8-hydroxyguanine (8OHGua), 8-oxo-dihydroguanine (8oxoGua). The other 
nucleobases have also their typical modifications, such as 8-oxo-dihydroadenine (8oxoAde), 
8-oxo-2’-deoxyadenine (8oxoDA), 5-hydroxyuracil (5OHU), 5-hydroxycitosine (5OHC) 
(Cooke, Evans et al. 2003; Cooke, Henderson et al. 2009; Ziech, Franco et al. 2010). The 
nucleobases that are excised from the DNA are then excreted from the cells in the bloodstream 
and then in the urine. 
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Measurement of these biomarker of oxidative stress is a field of study that in the last 
decade started to have an important role in understanding and evaluating the level of DNA 
damage generated by various agents (pathogenic, inflammatory, cancers, diabetes, 
degenerative diseases, environmental exposure) (Cooke, Evans et al. 2003). 
Exposure to benzene and its correlation with the DNA damage has been extensively 
studied, especially for occupational exposures, proving that benzene and its metabolites are 
involved in DNA damage through reactive metabolic intermediates (Snyder and Hedli, 1996; 
Hartwig, 2010) and ROS generation (Barreto et al., 2009). Because of the detailed knowledge 
about its metabolism, benzene can serve as an ideal positive control test compound for the 
development of new toxicological assays and tests on environmental exposure. Furthermore, 
in several studies of human exposure to benzene at medium and low concentrations (0.001 ppm 
– 0.03 ppm), a correlation was found between levels of urinary benzene and benzene 
metabolites and urinary 8-oxo-2’-deoxyguanosine (8-oxo-dG) a biomarker that is widely 
considered to be associated with ROS related DNA damage and repair (Andreoli et al., 2012; 
Manini et al., 2010; Bagryantseva et al., 2010).  
A recent review (Hartwig, 2010) summarised the possible mechanisms through which 
benzene and its metabolites can cause DNA damage.  In vivo, after absorption, benzene is 
metabolized by cytochrome P450 2E1 (CYP2E1) in the liver to produce metabolites including: 
phenol, catechol, hydroquinone and 1,2,4 trihydroxybenzene. Then these closed ring 
metabolites undergo further metabolism in the bone marrow to form o- and p-benzoquinone. 
P-benzoquinone is thought to be the toxic metabolite responsible for myelotoxicity due to its 
high reactivity, and in fact the metabolite is known to form adducts with proteins and DNA 
(Rappaport et al., 2005; Linhart et al., 2011). Bone marrow, due to the high rate of cell mitosis 
and a lower DNA repair capacity (Buschfort-Papewalis et al., 2002) is a sensitive tissue for 
DNA damage, resulting in possible health effects sooner than other tissues.  
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However, all of the phenolic benzene metabolites are chemically active in the cells, 
increasing the oxidative DNA damage, directly or through further metabolization. Therefore, 
although the main target tissues and the metabolism of benzene have been studied and 
understood, it is important to develop models to assess the toxicity caused by VOC exposure 
to other metabolically competent tissues including the lung epithelium, which is the principal 
route of exposure to benzene and other VOCs. Even more, such models could be useful to study 
other VOCs, as currently there is still little evidence of any linkage between exposure and DNA 
damage for other VOC species, although it has been suggested from studies in animal models 
and in-vitro studies (Sarma et al., 2011; Singh et al., 2009). 
Currently there are only few detailed studies on the development of in vitro models to 
examine the effects of such pollutants on the lung. Pariselli et al. (2009) developed a method 
to expose lung cells to various concentrations of benzene and toluene, evaluating some of the 
effects caused by the pollutants on lung cells growing on permeable supports that allow 
exposure of cells to gas mixtures, modelling a real life situation of exposure.  
The CULTEX system to expose cells to controlled atmospheres has been developed 
and used mostly for studies on cigarette smoke, nanoparticles and gases such as NOx and O3 
(Ritter et al., 2001). Similar in-vitro methods were developed, although none of them used an 
active exposure to the pollutants. Sarma et al. (2011) exposed cells to VOCs by adding the 
compounds to the growth media, which is not a physiologically accurate model. In another 
case, the cells were exposed to controlled atmospheres containing VOCs, where the VOCs 
were injected in liquid form and the exposure was performed by evaporation of the compounds 
(Mögel et al., 2011). In this case, the exposure was more physiologically accurate, however the 
methodology is limited for future applications due to the pollutants that have to be added to the 
exposure chamber via injection. An exposure system using gaseous exposure such as the 
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CULTEX system, allows the possibility to expose cells to different pollutants and complex 
mixtures of pollutants.  
Although interesting results on inflammatory response triggering by VOC exposure and 
cell viability were reported from Pariselli et al. (2009), no further studies on DNA damage or 
ROS production were reported on the effect of VOCs on lung epithelium models. 
I.5 Half-life and excretion of unchanged VOCs 
Airborne VOCs are absorbed through the lungs in different percentages and depending 
on the compound the lung retained dose changes, as Janasik et al. (2008) confirmed from 
previous studies (Kostrzewski, 1993; Gromiec and Piotrowski, 1984), and they are then 
transported in the bloodstream. Once the compounds are in the body they are metabolized at 
different ratios, depending on the mitochondrial genetic subgroup, level of exercise, amount of 
body fat (Fustinoni et al., 2005; Verdina et al., 2001; Rappaport et al., 2013), while a small 
fraction is excreted unchanged in the urine. The urinary VOCs pass in the urine by permeation 
by passive diffusion through the kidney glomerular tuft, and therefore are to be considered 
equilibrated with the blood concentration, which is regulated by their coefficient of solubility 
in water (Janasik et al., 2008; Fustinoni et al., 2000). 
The excreted unchanged VOCs represent a very small fraction of the total VOC uptake, 
with calculated values ranging from 0.0011% to 0.0032% (Janasik et al., 2008; Ikeda, 1999; 
Fustinoni et al., 2007). Only a few studies on excretion and metabolization kinetics and half-
lives (T1/2) of VOCs have been performed, however, the results are consistent with each other.  
As Fustinoni et al. (2009) reported, the uptake (and therefore the urinary excretion) of 
toluene is very rapid, and the urinary concentration rises quickly during the exposure. Right 
after the exposure (where the highest concentration C0 is recorded) the urinary concentration 
of the VOC (toluene in the specific case) starts to drop quickly within 1-2 hours after the 
exposure reaching a C1 which is approximately the 20-30% of C0. After this step (T’1/2) a 
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second, slower decrease in urinary concentration is observed, for the following 20-22 hours 
(T’’1/2) until the urinary VOC concentration reaches the baseline level (Fustinoni et al., 2009; 
Bois et al., 1996; Janasik et al., 2008). 
A common procedure used for biomonitoring of the VOC exposure is the analysis of 
the metabolites (the most common are s-phenyl-mercapturic acid, trans-trans muconic acid for 
benzene, but also quinones have been used as biomarkers of exposure, o-creosol and hippuric 
acid for toluene) (Rappaport et al., 2010; Fustinoni et al., 2007; Janasik et al., 2008; 
Waidyanatha et al., 2001).  
As reported by Waidyanatha et al. (2001) together with other authors, low level 
exposure raised a concern regarding the validity of these biomarkers due to their natural 
occurrence from other metabolic pathways during normal biological processes. For example 
protein catabolism or metabolism of benzoic acid (which occurs naturally in some fruit), 
produce hippuric acid, that can invalidate the evaluation of the exposure to toluene in low 
ambient concentrations. Generally, when analysed for low concentrations, the levels of the 
naturally occurring metabolites can represent a major problem for the correct evaluation of the 
exposure, due to the high and variable baseline level (Fustinoni et al., 2000; Waidyanatha et 
al., 2001).  
A univocal way of determining the exposure is to measure the levels of the unchanged 
VOCs in the urine, using SPME-GCMS, which allows high sensitivity and specificity, which 
recently has been adopted by a growing number of researchers (Waidyanatha et al., 2001; 
Fustinoni et al., 1999; Janasik et al., 2008). 
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Table 1: Summary of previous works on excretion kinetics of VOCs, all of the studies are 
focused on occupational or voluntary exposures to high air concentrations in spot exposures. 
Author and 
year Paper title Topics covered 
Airborne VOC 
concentration 
Bois et al. 1996 Population toxicokinetics of benzene 
Benzene metabolization, 
benzene in exhaled air and 
blood with excretion kinetics 
1.7 and 
10ppm 
Fustinoni et al. 
2009 
Self-collected urine sampling to 
study the kinetics of urinary 
toluene (and o-cresol) and 
define the best sampling time for 
biomonitoring. 
Comparison between o-cresol 
and urinary toluene with 
excretion kinetics 
16ppm (mean) 
Janasik et al. 
2008 
Excretion of unchanged volatile 
organic compounds (toluene, 
ethylbenzene, xylene and 
mesitylene) in urine as result of 
experimental human volunteer 
exposure 
Kinetics of urinary excretion of 
toluene, ethylbenzene, xylenes 
and mesitylene 
26ppm 
(toluene) 
100mg/m3 for 
each 
compound 
Pierce et al. 
2004 
Exponential modeling, washout 
curve reconstruction, and 
estimation of half-life of toluene 
and its metabolites 
Excretion and washout curve 
modelling from different 
databases 
Various, 
ranging from 
low level (not 
declared), to 
50ppm and 
80ppm 
 
All of the previous works on the kinetics of the excretion of the unchanged VOCs have 
been performed with spot exposures to high airborne concentrations for obvious reasons of 
simplicity of calculation and estimation of the excretion rate. The airborne concentrations and 
the kind of measurements performed for the excretion curve calculation are summarised in 
Table 1.   
All the excretion kinetics graphics and data are coherent in identifying two phases of 
excretion, a fast and a slow phase (T’1/2 and T’’1/2) with the first one lasting between 2 and 4 
hours, and the second one lasting up to 20-24 hours. 
15 
 
 
Figure 3: Time-course study on benzene excretion levels in blood and exhaled air, Bois et al. 
(1996). 
Bois et al. (1996) (Figure 3) reported concentrations of benzene in blood and exhaled 
air in a time span of 50 hours after a single controlled exposure event. A and B graphics show 
the blood concentration of benzene, A is related to an exposure of 10ppm, while B is related to 
an exposure of 1.7 ppm, both exposures were of 4 hours.  C and D refer to the concentration of 
benzene measured in the exhaled air, which is a measure of the evaporation of benzene from 
the bloodstream, and one of the excretion systems suggested by the author. The two phase 
pattern is evident, since the urinary excretion and the blood concentration are very strongly 
correlated, we can extrapolate that also the urinary concentrations will follow the same pattern. 
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I.6 Metabolites extraction methodologies 
To analyse urinary biomarkers it is very important to have an extraction methodology 
suitable for the compounds of interest. There are several different extraction methodologies 
that have been used to extract metabolites from human urine. The factor that most influences 
the choice of one method or another, is the target compound or group of compounds. 
The principal extraction methods can be divided in two main kinds based on the 
approach, liquid phase extraction and solid phase extraction, plus some exceptions on 
headspace extraction. Headspace extraction is a relatively limited method of extraction, as it 
allows extracting only the substances with a high vapour pressure (i.e. benzene). Liquid phase 
extraction methodologies rely on the higher affinity of the metabolites for non-polar than for 
polar solvents. The extraction efficiency can be enhanced by acidification of the solution and 
addition of salts. The limitation of this methodology is that it is not very reproducible, as the 
extraction efficiency can vary between different samples. Also in most cases there is the need 
of concentrating the organic phase, as the extraction is often performed in excess of solvent, 
and the evaporation step can lead to sample losses and inter-sample variability.  
Solid phase extraction is performed using columns that are packed with a stationary 
phase that has a high affinity for the compounds that have to be extracted. Different stationary 
phases have different properties, and therefore, different affinities for different families of 
compounds. The extraction in this case is generally more reproducible and it shows a better 
recovery of the single compounds. Moreover, it allows the cleaning of the sample as once the 
compounds are adsorbed to the stationary phase they can be washed with different stringency, 
without eluting them. In this kind extraction, the recovery is dependent on the stationary phase 
that is used and it can be changed for different target compounds. 
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The liquid phase extraction is a less refined kind of extraction, with a generally smaller 
recovery ratio and it does not allow a sample cleaning, but it is faster and cheaper than the solid 
phase extraction. This methodology tends to be more consistent with hydrophobic compounds. 
In Table 2 are reported some examples of extractions of different compounds from urine 
or synthetic urine samples. 
Table 2: Summary of the urine metabolites and extraction methods. 
Reference Extracted compounds Extraction method 
Leinonen et al., 2006 
 
Metabolites of: 
fluoxymesterone, 4-chloro-
dehydromthyltestosterone, 
stanozolol, danazol and 
methyltestosterone 
Liquid-Liquid: dihexylether 
or 1-octanol, polypropilene 
fiber helped, salting out 
method 
Rodila et al., 2006 
 
Drug and metabolite: drug 
ABT-869, metabolite A-
849529 
Liquid-Liquid: 1:11 
hexanes/ethyl acetate 
solution, introduction of little 
salts and acid 
Hu et al., 2006 Pyrene metabolite (OHP) Liquid-Liquid: DMSO 
Sabatini et al., 2008 
 
Benzyl mercapturic acid 
(BMA), phenylmercapturic 
acid (PMA), o-
methylbenzyl-mercapturic 
acid (MBMA) 
Solid Phase Extraction: 
Evolute ABN cartridges 
(Argonaut technologies Ltd.) 
Gaikwad et al., 2009 
 
Estrogen metabolites, 
conjugates and DNA 
adducts 
Solid Phase Extraction: 
Phenyl Solid phase 
extraction cartridges 
(Varian) 
De Alwis et al., 2009. Dialkil phosphate metabolites 
Solid Phase Extraction: Elut 
PPL SPE cartridges (Varian) 
Paci et al., 2007 SPMA (s-phenylmercapturic acid) 
Solid Phase Extraction: Sep-
Pak plus cartridges (C-18) 
(Waters) 
Jacob et al., 2007 
Naphtholes, 
hydroxyphenantrenes, 
hydroxyfluorenes, 
hydroxypyrenes 
Liquid-Liquid extraction: 
90:10 pentane/ethyl acetate 
Kim et al., 2006 
Muconic acid, s-
phenylmercapturic acid, 
phenol, catechol, 
hydroquinone. 
Liquid-Liquid extraction: 
Ethyl acetate, two 
consecutive extractions. 
Waidyanatha et al., 2004 
Muconic acid, s-
phenylmercapturic acid, 
phenol, catechol, 
hydroquinone. 
Liquid-Liquid extraction: 
Ethyl acetate, two 
consecutive extractions. 
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I.7 Metabolites analysis and related issues 
Using urine analysis takes in account all the routes of exposure, including also the food 
pathway. Depending on how the food is cooked and its provenience, the levels of pollutants, 
and therefore their metabolites can vary (Falco, Bocio et al. 2005; Ibanez, Agudo et al. 2005; 
Marti-Cid, Llobet et al. 2008; Cirillo, Montuori et al. 2010; Xia, Duan et al. 2010). Hence it 
becomes important to keep track of food consumption and cooking method. It is also important 
to keep track of the lifestyle of subjects, as medicines, and cigarette smoke can also influence 
the excretion of benzene metabolites (Lovreglio, Barbieri et al. 2011). Monitoring these 
variables, the evaluation of the total exposure to the pollutants becomes more significant.  
The most used techniques to analyse the majority of the metabolites are HPLC/MS, 
GCMS, HS-GCMS, due to the various physiochemical properties of the compounds. In fact, 
there is a large use of GCMS and HS-GCMS for volatile metabolites and HPLC/MS for the 
less volatile compounds. The headspace GCMS is used mostly for unmetabolized benzene and 
other compounds that have a high vapour pressure. This methodology reduces the extraction 
times and improves the reproducibility but it is strictly connected to the volatility of the 
compounds to analyse (Fustinoni, Giampiccolo et al. 1999).  
Benzene, due to its known carcinogenicity, is one of the most extensively studied and 
monitored pollutants. As previously mentioned, all of the metabolites of benzene have been 
measured in previous studies, but most of them have given good results only for high levels of 
exposure. It has been reported that the levels of hydroquinone can vary from 0.066 µg/ml for 
people not exposed to benzene, up to 50.6 µg/ml for people exposed to high levels of benzene 
(>31 ppm) (Waidyanatha, Rothman et al. 2004; Kim, Vermeulen et al. 2006).  
Also phenol and SPMA have shown to be good biomarker candidates for quantification 
as they show a good reliability and response in case of low VOCs concentration (Qu, Melikian 
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et al. 2000). All these compounds are generated from the benzene metabolism, which involves 
a passage through phenol for almost all of the final metabolites.  
The best and most used metabolites of assess the exposure to low concentrations of 
benzene are the phenol and S-phenylmercapturic acid (SPMA). All of the metabolites, 
however, have some limitations for low level exposures, due to the fact that they can arise from 
other metabolic pathways that are not related to benzene exposure. The baseline levels of the 
metabolites represent a confounding factor that makes the exposure evaluation of general 
population difficult. Another way of assessing low level exposures is to measure urinary 
benzene which has not been metabolized, in order to avoid contamination of the metabolites 
arising from unrelated metabolic pathways (Weisel, 2010). Urinary benzene (together with 
urinary toluene, ethylbenzene, o- m- p-xylene and naphthalene) are analysed by headspace 
solid phase microextraction (HS-SPME), which allows very low detection limits (in the order 
of 10-20 ng/L), but it requires a specialized equipment to perform the extractions. On the other 
hand, the monitoring of the metabolites doesn’t require special instrument, although the limits 
of detection are higher, due to the contribution to the production of the same compounds arising 
from other unrelated metabolic pathways of different substances. 
 
I.8 Oxidative stress and DNA damage biomarker analysis 
There are three main ways to measure the level of DNA damage caused by oxidative 
stress biomarkers in urine. The most commonly measured biomarker is 8-oxo-dG, as 
previously mentioned in Section I.4. A commonly used techniques is HPLC/ECD (Electro 
Chemical Detection) (Sørensen et al., 2003c), but also other methodologies are used, like the 
ELISA (Enzyme-Linked Immunosorbent Assay) that provides faster measurements and is 
produced as a kit for the measurements (Cooke, Lunec et al. 2002; Wu, Chiou et al. 2004). 
Other analytical methods have been developed using GC-MS, derivatizing the biomarkers after 
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extraction from urine (Lin, Jenner et al. 2004), enhancing the sensitivity and the throughput of 
the analysis. Each methodology has different pros and cons, the HPLC methods are often 
requiring an extensive clean-up of the sample, as urine is a very complex and variable matrix, 
and the methodology can result long and time consuming. Immunoassay or ELISA are quick 
methodologies and have a comparable sensitivity as the HPLC methods. However, these assays 
they can react with non specific molecules that present the same epitopes as oligomers of 8-
OH-dGMP (8-hydroxy-2’-deoxyguanosine mono phosphate) in the case of 8-oxo-dG. 
Furthermore, the discovery of new biomarkers using these techniques is not possible due to the 
kind of sample analysis that are used. GC-MS analysis allows to obtain separation together 
with the possibility of identifying the compounds. Methods were developed to have an efficient 
extraction of the excreted nucleobases from urine and subsequent analysis in GC-MS, this 
methodology is reported to be efficient and sensitive, and it also gives qualitative information 
on the analysed compounds. The weak point of this method is the derivatization procedure that 
the markers have to undergo. A derivatization step is always critical for reactive molecules 
such as 8-oxo-dG. Furthermore, the addition of a derivatization step in the sample preparation 
increases the uncertainty of the measurement, especially for low concentrations. 
Trimethylsilylation is the typical derivatization that is used with GC-MS samples, but the 
normal procedure is performed at high temperatures and in contact with air. These conditions 
have demonstrated to create artifactual 8-oxo-dG due to the reactivity of the analytes. An ad-
hoc methodology was then developed to prevent artifacts and therefore higher readings in DNA 
damage levels using GCMS technique (Jenner, England et al. 1998). The latest technique used 
for 8-oxo-dG measurement is LC-MS, which allows to analyse the molecule without the need 
of a derivatization step, simplifying the sample preparation procedure, and allowing to have 
reliable measurement in a broad range of concentrations (Lam et al., 2012). The main problem 
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of this methodology is that it requires a specific instrument that is not always available in 
laboratories that do not perform biological or liquid analyses on a regular basis.  
 
I.9 Aim of the study 
The aim of this study was to evaluate the impact and contribution of different behaviours and 
microenvironments towards the total exposure of general population. We concentrated not only 
on the markers of personal exposure, but also on the biomarkers of early effect, such as 
oxidative stress. 
The thesis was oriented towards measuring and identifying as many biomarkers as possible, in 
order to identify a fingerprint of exposure to air toxics from urine samples. We tried to evaluate 
the best methods of metabolites and biomarkers extraction from urine. Due to the extremely 
low level of exposure and high inter-individual variations of general population, the task of 
identification and measurement of most metabolites and biomarkers proved to be difficult. As 
a result, the focus was shifted to analysis of VOCs and the association with the marker for 
oxidative stress. Specific objectives included:  
- Assessment of the differences in urinary VOC concentrations between low-exposure 
and high-exposure (occupationally exposed and exposed to high levels of ETS) 
populations. 
- Assessment of the correlation between personal exposure and a widely accepted 
oxidative stress biomarker (8-oxo-dG) 
- Identification of typical behaviours and microenvironments that potentially contribute 
to the total exposure 
Since analysis of urinary PAH metabolites for low exposure populations was found to be 
difficult to quantify, additional analyses were undertaken to characterize the impact of high 
level exposure on urinary PAH metabolites. This study was conducted in collaboration with 
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the King Abdulaziz University in Saudi Arabia. The objective of this study was to identify the 
contribution of high levels of exposure towards the biomarkers of oxidative stress.  
 While analysis of biomarkers provides important information about exposure, it is 
difficult to quantify and properly evaluate the biological effect of exposure to different 
concentrations of air studies without a metabolically comparable model. With this in mind, a 
cell exposure chamber was designed in order to reproduce a model of a metabolically 
competent tissue (lung epithelium A549 cells) for toxicological studies. The objectives of this 
study were to:  
- Test the feasibility of the methodology in order to reproduce in-vitro a response 
comparable to the one observed in-vivo.  
- Test the early effects of exposure to VOCs on cellular metabolism 
- Establish a new methodology to study singular pollutants and mixtures on a 
physiologically accurate model 
- Establish a methodology for future in-depth studies on the metabolism of pollutants 
 
  
23 
 
The thesis chapters are organized as follows: 
 
Chapter 2 discusses method development for analysis of urinary PAH, VOCs metabolites and 
oxidative stress biomarkers.  
Chapter 3 details the methodology for collection and analysis of personal exposure and urine 
samples analysed in the current study.  
Chapter 4 discusses urinary VOC and oxidative stress marker concentrations in different 
subject groups, and underlying causes and confounders.  
Chapter 5 presents results on chemical characterization and oxidative stress biomarker for a 
population of children in a highly polluted city in Saudi Arabia.   
Chapter 6 describes a cell exposure study focused on effects of VOC exposure.  
Chapter 7 and 8 describe the conclusions from the current study and future directions, 
respectively.  
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II. Method development 
This chapter describes in detail the different approaches tested to extract and analyse the 
various metabolites in the urine samples.  
II.1 Benzoquinone and hydroquinone stability in aqueous solutions 
Due to our instrument availability we focussed mostly on quinones for benzene 
exposure assessment. Our initial goal was to analyse benzoquinone, if possible, as this 
metabolite has better chromatographic properties. Hydroquinone was considered as a 
secondary target because of the difficulties to separate and quantify it by GC-MS.  
Tests were performed to assess the stability of benzoquinone in urine. Benzoquinone is 
reported to be one of the main compounds responsible of DNA toxicity arising from benzene 
exposure (Hartwig, 2010; Snyder and Hedli, 1996), therefore we investigated the possibility to 
measure the compound in the urine. This would have given us the possibility of determining 
how much of the benzene is actually metabolised by using as a biomarker the compound 
responsible of the effects. Benzoquinone has been analysed in other works as a protein 
(albumin) adduct in blood (Lin et al., 2007; Rappaport et al., 2005), we explored the possibility 
of analysing the compound in urine. 
Benzoquinone was dissolved in ethanol and spiked in different concentrations in 
synthetic urine. Extractions were performed with various methodologies (liquid extraction and 
SPE) to assess the best way to extract the compound. Results suggested that under any 
conditions the benzoquinone had poor stability, converting in hydroquinone. To confirm this 
hypothesis, 0.1 mg of benzoquinone were dissolved in various solvents with different grades 
of polarity and available hydrogens, then the relative amount of hydroquinone formed from 
benzoquinone was measured (Table 3). When dissolved in ethanol, more than 26% of 
benzoquinone rearranged in hydroquinone, due to the available hydrogen atom of the ethanol 
molecule, a similar behaviour was observed in water, but could not be measured directly by 
GC-MS. This behaviour has been described in the literature (Cheng et al., 2009; Boersma et 
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al., 1994), our tests confirmed that under physiological conditions there is little to no 
occurrence of benzoquinone, which converts to hydroquinone.  
 
Table 3: Summary of benzoquinone (BQ) solubility in different solvents and amount of 
hydroquinone (HQ) measured by GC-MS analysis. (+ is an arbitrary measurement of solubility 
of benzoquinone in the solvent, +++ indicates the highest solubility and + indicates the lowest) 
Solvent Boiling point BQ solubility HQ amount 
Dichloromethane 39.6 C +++ 5.12% 
Ethyl acetate 77.1 C +++ 7.45% 
Pentane 36.1 C + 7.02% 
Ethanol 78.0 C ++ 26.73% 
  
II.2 Hydroquinone/benzoquinone liquid extraction 
Hydroquinone and benzoquinone (together with other metabolites) were extracted from 
synthetic urine using different liquid extraction approaches to evaluate and maximise the 
extraction efficiency. All of the method development was performed using synthetic urine, 
described in annex X.1 
Liquid extraction was performed adding 5 volumes of ethyl acetate to 1 ml of urine 
previously spiked with 10 µl of internal standards (final concentration 1ng/µl) and 100 µl HCl 
0.1M, sample was shaken for 2 min and then the organic layer was collected for analysis.  
 
This main procedure for extraction was tested also with some modifications:  
- Extraction performed in native conditions (no acid addition) 
- 0.5g of NaCl was added to the urine to maximise the recovery of hydrophobic 
compounds in the organic phase 
- Extraction performed with dichloromethane 
- Extraction performed with smaller amounts of organic solvent (1ml) 
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II.3 Hydroquinone/benzoquinone solid phase extraction 
Metabolites were extracted also using solid phase extraction columns. Two different 
columns were used: Bond Elut C-18 and Bond Elut Plexa (Agilent Technologies, USA).  
The sample preparation was performed by diluting 1ml of urine with 2ml of 1% formic 
acid prior loading it on the column, which was previously conditioned with 1ml methanol. The 
column was mounted on a vacuum manifold that allowed to have the sample flowing through 
the SPE column via aspiration. The diluted sample was then loaded on the column and the flow 
was regulated to be approximately 1ml/min. The loaded column was then washed with 5% 
methanol and the extraction was performed with 2 washes of 500 µl of methanol.  
The same procedure was used with both columns.  
Different elution solvents were tested to maximise the recovery of the desired compounds:  
- Elution with acetonitrile 
- Elution with ethyl acetate 
- Elution with pentane 
- Elution with CH2Cl2 
 
The best overall results however were obtained using the manufacturer’s recommendations for 
acid loading to extract hydrophobic compounds, briefly:   
- From each vial 0.3 ml of synthetic or real urine, containing the standards, were diluted 
in 0.9ml of 1% formic acid  
- The SPE columns were preconditioned with 0.5 ml Methanol followed by 0.5 ml of 
water 
- The samples were loaded in the SPE columns with an approximate flow rate of 1 
ml/min and washed with 1 ml Methanol 5% 
- The elution was performed with 1 ml Methanol 100% 
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The Agilent Bond Elut PLEXA SPE columns showed the best overall recovery rate, while the 
C-18 columns were not able to retain some of the compounds. 
II.4 Benzoquinone and hydroquinone calibration curve and quantification 
Lim et al. (2011) published a study of quinones in human urine, where the reported 
concentrations were in the order of 3x10-8Mol/L with minimum standard values of 1x10-8.  
Based on the information reported on the paper, we estimated 6pg/µl as an average 
concentration value. To test the feasibility of an assay to measure benzoquinone and 
hydroquinone by GC-MS, we tried to set a calibration curve with the compounds directly 
injected in the GC-MS from an organic solvent and from an aqueous solution (synthetic urine) 
after liquid extraction. To perform the experiment, the solutions were prepared as follows: 
STOCK SOLUTIONS – NATURAL STANDARDS in water 
Hydroquinone 5.252 mg 
Benzoquinone 5.016 mg  
 
These Natural Standards were dissolved in 5ml of water, obtaining the stock solution of Natural 
STDS (Ns_Stock_Water approximated concentration: 1mg/ml). 
NATURAL STANDARDS in ethyl acetate 
Hydroquinone 5.095 mg 
Benzoquinone 5.118 mg  
These Natural Standards were dissolved in 5ml of ethyl acetate, obtaining the stock 
solution of Natural STDS (NS_Stock_EtAc approximated concentration: 1mg/ml). 
Table 4: standard stock solutions concentration. 
Name of Natural Stock BQ Concentration HQ concentration Solvent
NS_Stock_Water 1.00320 mg/mL 1.0504 mg/mL Water 
NS_Stock_EtAc 1.02360 mg/mL 1.0190 mg/mL Ethyl Acetate 
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INTERMEDIATE SOLUTIONS – NATURAL STANDARDS 
The two stock solutions were then diluted to obtain the following intermediate solutions: 
Table 5: Standard intermediate solutions with BQ and HQ concentrations. 
Name of 
Intermediate 
BQ Concentration
(approximated) 
HQ concentration
(approximated) 
Solvent
A_Water 10,000 pg/l 10,000 pg/l Water 
B_Water 100,000 pg/l 100,000 pg/l Water 
C_Water 1,000,000 pg/l 
(NS_Stock_Water) 
1,000,000 pg/l 
(NS_Stock_Water) 
Water 
A_EtAc 10,000 pg/l 10,000 pg/l Ethyl Acetate 
B_EtAc 100,000 pg/l 100,000 pg/l Ethyl Acetate 
C_EtAc 1,000,000 pg/l 
(NS_Stock_EtAc) 
1,000,000 pg/l 
(NS_Stock_EtAc) 
Ethyl Acetate 
 
STOCK SOLUTION – INTERNAL STANDARD 
IS Stock solution E_EtAc: The Internal STDS in ethyl acetate were prepared dissolving 
0.604mg of benzoquinone D4 in 5ml of ethyl acetate, obtaining a final concentration of 
0.1208mg/ml approximated to 0.1mg/ml.IS Stock solution E_Water: The Internal STDS in 
Water were prepared dissolving Benzoquinone D4 0.561mg in 5ml of water, obtaining a final 
concentration of 0.1122mg/mLapproximated to 0.1mg/ml. 
IS Stock Solution F: For a second set of liquid extractions a new internal standard has 
been made with a higher concentration in water as after preliminary analyses, it was almost 
impossible to detect the deuterated standards: 
Benzoquinone D4 5.069 mg  
In 5ml of water obtaining the stock solution of Internal STDS (1.0138 mg/mL, approximated 
to 1mg/ml). 
Table 6: internal standard stock solutions concentration. 
Name of IS Stock BQD4 Concentration pg/l Conc. (approximated) Solvent 
E_Water 0.1122 mg/mL 100,000 pg/l Water 
F_Water 1.0138 mg/mL 1,000,000 pg/l Water 
E_EtAc 0.1208 mg/mL 100,000 pg/l Ethyl Acetate 
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WORKING STANDARDS 
The Stock and Intermediate solutions have been left at room temperature for 2 hours to allow 
the compounds to reach equilibrium due to the reaction of self rearrangement of the BQ/HQ. 
All the standard solutions were prepared in triplicate. 
The dilutions used for the creation of the standard solutions for the calibration curve and for 
the extractions (1ml of final volume) are summarised in the following tables:  
Table 7: detail of the dilutions and volumes of the various standard solutions spiked in each 
solvent to produce the working solutions. 
Vial name Solvent Volume IS + 
intermediate name 
Volume Natural STD + 
intermediate name 
BLK_EtAc Ethyl acetate 0 0 
IS ONLY_EtAc Ethyl acetate 10l E_EtAc 0 
100 pg/l_EtAc Ethyl acetate 10l E_EtAc 10l A_EtAc 
1,000 pg/l_EtAc Ethyl acetate 10l E_EtAc 10l B_EtAc 
5,000 pg/l_EtAc Ethyl acetate 10l E_EtAc 5l C_EtAc 
10,000 pg/l_EtAc Ethyl acetate 10l E_EtAc 10l C_EtAc 
20,000 pg/l_EtAc Ethyl acetate 10l E_EtAc 20l C_EtAc 
BLK_Water Synthetic urine 0 0 
IS ONLY_Water Synthetic urine 10l E_Water 0 
100 pg/l_Water Synthetic urine 10l E_Water 10l A_Water 
1,000 pg/l_Water Synthetic urine 10l E_Water 10l B_ Water 
5,000 pg/l_Water Synthetic urine 10l E_Water 5l C_ Water 
10,000 pg/l_Water Synthetic urine 10l E_Water 10l C_ Water 
20,000 pg/l_Water Synthetic urine 10l E_Water 20l C_ Water 
 
Table 8: standard concentrations in ethyl acetate working solutions. 
Vial Name BQ 
Concentration 
HQ 
concentration 
IS (BQ d4) 
Concentration 
Solvent 
BLK_EtAc 0 0 1,000 pg/l Ethyl Acetate 
IS ONLY_EtAc 0 0 1,000 pg/l Ethyl Acetate 
100 pg/l_EtAc 100 pg/l 100 pg/l 1,000 pg/l Ethyl Acetate 
1,000 pg/l_EtAc  1,000 pg/l 1,000 pg/l 1,000 pg/l Ethyl Acetate 
5,000 pg/l_EtAc  5,000 pg/l 5,000 pg/l 1,000 pg/l Ethyl Acetate 
10,000 pg/l_EtAc  10,000 pg/l 10,000 pg/l 1,000 pg/l Ethyl Acetate 
20,000 pg/l_EtAc  20,000 pg/l 20,000 pg/l 1,000 pg/l Ethyl Acetate 
 
Table 9: standard concentrations in the synthetic urine working solutions. 
Vial Name BQ 
Concentration 
HQ 
concentration 
IS (BQ d4) 
Concentration 
Solvent
BLK_Water 0 0 1,000 pg/l Synthetic Urine 
IS ONLY_Water 0 0 1,000 pg/l Synthetic Urine 
100 pg/l_Water 100 pg/l 100 pg/l 1,000 pg/l Synthetic Urine 
1,000 pg/l_Water 1,000 pg/l 1,000 pg/l 1,000 pg/l Synthetic Urine 
5,000 pg/l_Water 5,000 pg/l 5,000 pg/l 1,000 pg/l Synthetic Urine 
10,000 pg/l_Water 10,000 pg/l 10,000 pg/l 1,000 pg/l Synthetic Urine 
20,000 pg/l_Water 20,000 pg/l 20,000 pg/l 1,000 pg/l Synthetic Urine 
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In the second slot of extractions, instead of the IS Stock solution  E, due to the 
impossibility of detecting the peak, the Internal Stock solution F was used (see Table 6 for 
information on concentrations), having a 10-fold increase in Internal STD concentration.  
The working solutions in ethyl acetate described in Table 7 were injected directly in the 
GCMS to evaluate the response and the linearity of the standards without the extraction 
process.   
The standard points for liquid extraction testing were processed as follows:  
After preparing the working solutions described in Table 9, the samples (i.e. working solutions) 
were left for 1 hour at room temperature to equilibrate prior analysis.  
Liquid extraction was performed in 2 times, adding each time 500 l of ethyl acetate, shaking 
for 1 minute and recovering the organic layer once it was settled.  Both extractions were 
combined in a vial (final volume expected to be 1 mL). 
For the GCMS analysis 50l of the extracted organic phase were transferred in a vial with a 
glass insert, containing 2.5l of P-Terphenyl D14 (20 000pg/l, obtaining a final concentration 
of 1000 pg/l). 
The direct injections of the standards gave good results in terms of accuracy of the curve 
for benzoquinone, which proved to be linear between 100 and 20,000 pg/µl. The calibration 
curve for hydroquinone proved to be problematic due to the poor peak shape of the compound. 
The benzoquinone peak was sharp and detectable in all the concentrations, also was the 
Benzoquinone D4 peak, as showed in the table below:  
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Table 10: GC-MS responses of directly injected BQ and HQ standards dissolved in ethyl 
acetate. 
Sample name Benzoquinone D4 (1,000 pg/µl) 
Hydroquinone 
D4 (naturally 
occurring) 
Benzoquinone Hydroquinone 
P-terphenyl 
D14 (1,000 
pg/µl) 
BLK - - - - 1,143,599 
IS ONLY 209,966 20,233 3,225 - 839,674 
100 pg/µl 220,503 12,627 39,374 - 1,224,327 
1,000 pg/µl 170,774 8,792 284,685 32,684 780,733 
5,000 pg/µl 196,405 37,011 1,734,266 692,035 1,054,394 
10,000 pg/µl 226,007 96,766 3,736,630 2,038,451 1,075,130 
20,000 pg/µl 227,530 135,592 8,359,599 4,971,429 1,152,567 
 
The internal standard benzoquinone D4 response was constant in all of the samples, while the 
hydroquinone D4 was less reproducible. The hydroquinone D4 in this case, was obtained from 
the self rearrangement of the benzoquinone in hydroquinone. Furthermore, the hydroquinone 
(both the Internal and the Natural STD) had a poor shaped peak in our system, making difficult 
the identification and the quantification of the peak in low quantities, as a precise retention 
time was impossible to determine for the hydroquinone peak. As showed in the figure below 
(Figure 4) in the maximum concentration (20,000pg/l) the hydroquinone peak at 13.00 min 
presented a considerable tailing, which carried over 15.00 min. In lower concentrations it was 
possible to find the presence of the identifying ions (110, 81 for HQ and 114, 85 for HQD4) in 
that timeframe but it was impossible to locate a univocal peak that would identify the 
compound. It was evident a problem of tailing in high concentrations (20,000pg/µl), due to the 
tailing, it was impossible to identify it and integrate consistently due to the bad peak shape, 
especially at low concentrations. On the other hand, benzoquinone, showed a better response 
pattern and chromatographic outcome, as showed in Figure 5. 
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Figure 4: overlay of the Total Ion Chromatograms for every concentration, showing the peak 
of Hydroquinone.  
-The black line represents a standard with a concentration of 20,000 pg/µl 
- The blue line represents an ethyl acetate blank injection 
- The red line represents a standard with a concentration of 100pg/µl 
- The dark green line represents a standard with a concentration of 10,000 pg/µl 
- The yellow line represents a standard with a concentration of 1,000 pg/µl 
- The bright green line represents a standard with a concentration of 5,000 pg/µl 
- The violet line represents an injection of only internal standard 
 
Below is showed the peak of Benzoquinone, which was well shaped and reliable instead. 
 
Figure 5: overlay of the Total Ion Chromatograms for every concentration of benzoquinone, 
showing the good trend of the standard points. 
- The yellow line represents a standard with a concentration of 20,000 pg/µl 
- The red line represents a standard with a concentration of 10,000 pg/µl 
- The bright green line represents a standard with a concentration of 5,000 pg/µl 
- The dark green line represents a standard with a concentration of 1,000 pg/µl 
- The black line represents a blank injection with only ethyl acetate 
- The violet line represents an injection of only internal standard 
 
BQ peaks overlaid in Total Ion 
Chromatograms 
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Each response was then normalized against the P-Terphenyl D14, dividing the response 
of the compound by the response of the P-Terphenyl, obtaining the results showed in the 
following table: 
Table 11: Normalized responses of the standard in each concentration. 
 Normalized response (Compound/P-ter) 
Sample name Benzoquinone D4 
Hydroquinone 
D4 Benzoquinone Hydroquinone 
BLK 0.00000 0.00000 0.00000 0.00000 
IS ONLY 0.25006 0.02410 0.00384 0.00000 
100 pg/µl 0.18010 0.01031 0.03216 0.00000 
1,000 pg/µl 0.21874 0.01126 0.36464 0.04186 
5,000 pg/µl 0.18627 0.03510 1.64480 0.65633 
10,000 pg/µl 0.21021 0.09000 3.47551 1.89600 
20,000 pg/µl 0.19741 0.11764 7.25303 4.31335 
 
After the normalization, it was possible to evaluate that the responses followed the trend 
of the standard points. The following table shows the ratio between the Natural Standard and 
the Internal Standard with the theoretical value that we should find, calculated by the ratio 
between the concentration of the Internal Standard by the concentration of the Natural 
Standard. The results were very reliable for benzoquinone, while the hydroquinone, due to the 
difficulties in the integration process, was giving problems of overestimation, when detectable. 
Table 12: Normalized BQ and HQ NS/IS ratios compared with the theoretical value. 
 (Natural STD/Internal STD) 
Sample name Theoretical value Conc NS/ Conc IS 
Benzoquinone 
Resp NS/Resp IS 
Hydroquinone 
Resp NS/Resp IS 
BLK 0 0.00 0.00 
IS ONLY 0 0.02 0.00 
100 pg/µl 0.1 0.18 0.00 
1,000 pg/µl 1 1.67 3.72 
5,000 pg/µl 5 8.83 18.70 
10,000 pg/µl 10 16.53 21.07 
20,000 pg/µl 20 36.74 36.66 
 
The calibration curves for each of the directly compounds are synthesised in the 
following graphics:  
34 
 
 
Figure 6: Response/concentration plot of benzoquinone, normalised against the recovery 
standard P-Terphenyl D14 in direct injection. 
 
 
Figure 7: Benzoquinone D4/Benzoquinone response plot, which shows a good linear 
calibration curve obtained from direct injection of the standards. 
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HIDROQUINONE D4 
 
Figure 8: Graphical plot of the response/concentration of hydroquinone D4, the response is 
not constant although the amount of standard in the solution is the same for every sample. 
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HIDROQUINONE 
 
Figure 9: Graphical plot of the response/concentration of hydroquinone normalized against 
P-terphenyl D14. 
 
Figure 10: Graphical plot of the response ratio/concentration of hydroquinone 
D4/hydroquinone. 
 
We used as internal standard the naturally occurring hydroquinone, arising from the self 
rearrangement of benzoquinone. The hydroquinone internal standard concentration proved to 
be affected by the natural standards concentration as it evident an increase of the response with 
the increase of the concentration of the natural standards.  
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To assess the reproducibility and the recovery ratio of the liquid extraction method, the 
same volumes and concentrations (Table 7) of standards of the ethyl acetate calibration curve 
(Table 8) were spiked in synthetic urine obtaining the concentrations listed in Table 9. Each 
standard point was prepared in triplicate and the average of the three values was used.  
Due to problems with the internal standard arising from the solubilisation in water and 
the extraction process, it was difficult to identify the peak and integrate it, as showed in the 
figure below: 
 
Figure 11: Benzoquinone D4 peak after liquid extraction (BQD4 concentration: 1,000pg/µl; 
Natural STD concentration: 100pg/µl). the peak can be hardly identified from the main ion 
(top) and the secondary ion (bottom), in some cases it is impossible to identify it (retention time 
of BQD4 is between 4.9 and 5 min, the peak at 5.15 was identified to be a contaminant peak). 
 
With the increase of the Natural Standards (10 000 and 20 000 pg/µl) the Benzoquinone D4 
response increases, showing that there is a concentration dependent cross contamination from 
the natural standards.  
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Figure 12: Benzoquinone D4 peak after liquid extraction with 20000 pg/µl of natural 
standards, showing a higher response than the same standard with lower concentration 
(Figure 11). 
The average responses are synthetized in the table below. Two samples of real urine 
were also analysed, they were spiked only with the internal standards:  
 
Table 13: Responses of standards and analytes after liquid extraction from synthetic and real 
urine. 
 Compound name  (responses) 
Sample name BQ D4 HQ D4 BQ HQ P-terphenyl D14 
BLK - - - - 1,400,421 
IS ONLY 149 13,995 - - 1,737,227 
100 pg/µl AVG 271 11,763 37 26,737 1,795,643 
1,000 pg/µl AVG 84 13,906 - 207,163 1,935,076 
5,000 pg/µl AVG 288 20,112 21,918 1,670,264 2,330,709 
10,000 pg/µl AVG 1,011 31,870 183,454 4,522,252 2,662,767 
20,000 pg/µl AVG 1,805 42,512 517,040 9,604,019 2,149,031 
URINE A01 236 113,431 570 124,386 2,613,857 
URINE B10 204 37,250 402 3,162 2,276,109 
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The responses, were then normalized against the recovery standard P-Terphenyl D14, 
obtaining the results showed in the following table:  
Table 14: Responses normalized against the recovery standard. 
 Normalized response (Compound/P-ter) 
Sample name Benzoquinone D4 
Hydroquinone 
D4 Benzoquinone Hydroquinone 
BLK 0.00000 0.00000 0.00000 0.00000 
IS ONLY 0.00009 0.00806 0.00000 0.00000 
100 pg/µl AVG 0.00015 0.00655 0.00002 0.01489 
1,000 pg/µl AVG 0.00004 0.00719 0.00000 0.10706 
5,000 pg/µl AVG 0.00012 0.00863 0.00940 0.71663 
10,000 pg/µl AVG 0.00038 0.01197 0.06890 1.69833 
20,000 pg/µl AVG 0.00084 0.01978 0.24059 4.46900 
URINE A01 0.00009 0.04340 0.00022 0.04759 
URINE B10 0.00009 0.01637 0.00018 0.00139 
 
The ratio between the natural standard and the internal standard was then calculated, 
and compared with the theoretical value of the ratio:  
Table 15: Natural standard/Internal standard ratio, compared with the theoretical value. 
 (Natural STD/Internal STD) 
Sample name Theoretical value Benzoquinone Hydroquinone 
BLK 0 N/A N/A 
IS ONLY 0 0.00 0.00 
100pg/µl AVG 0.1 0.14 2.27 
1,000pg/µl AVG 1 0.00 14.90 
5,000pg/µl AVG 5 76.10 83.05 
10,000pg/µl AVG 10 181.52 141.90 
20,000pg/µl AVG 20 286.50 225.91 
URINE A01 N/A 2.42 1.10 
URINE B10 N/A 1.97 0.08 
 
In previous experiments the urine sample B10 was found to have a higher concentration 
of hydroquinone and benzoquinone than the A01 sample, in contrast with what was obtained 
in this experiment. A graphical representation of the obtained data showed a definite increase 
of the internal standards with the increase of the concentration of the natural standards. In the 
following graphs are showed the standard curves after liquid extraction: 
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Figure 13: Plot of the response of internal standard benzoquinone D4 normalized against P-
terphenyl D14, the trend line has been added to underline the increasing trend despite the 
samples containing always the same amount of standard (the trend line is forced through zero). 
 
 
Figure 14: Plot of the response of natural standard benzoquinone normalized against the 
recovery standard P-terphenyl D14, the standard is almost not detectable until the 5000 pg/µl. 
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Figure 15: Graphical plot of benzoquinone natural standard/internal standard ratio. Despite 
a good fitting trend line (forced through zero), the behaviour of the internal standard prevented 
a reliable calibration. 
 
 
Figure 16: Graphical plot of internal standard hydroquinone D4 normalized against the 
recovery standard P-terphenyl D14, the trend line was added to underline the increasing trend 
with the increase of natural standard concentration. 
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Figure 17: Graphical plot of natural standard hydroquinone normalized against recovery 
standard P-terphenyl D14, the trend line is forced through zero. 
 
Figure 18: Calibration curve of hydroquinone, obtained with the ratio natural 
standard/internal standard. Despite the good R² value, the compound is almost not detectable 
the 5000 pg/µl. 
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Despite obtaining acceptable R² values, especially for hydroquinone, the problems 
arising from the standards being in a water solution prevented a reliable calibration curve. 
Furthermore, the standards are almost undetectable under 5000 pg/µl, while the urine samples 
of the study were taken from general population, low exposures, hence low levels of 
metabolites, were expected to be found in urine.   
 
Due to the weak signal of the internal standard after the extraction, a new batch of 
samples was prepared, with an internal standard concentration of 1 000 000 pg/µl (1ug/ul) 
(F_Water, Table 6) and the same dilution procedure was performed, resulting in having an 
internal standard which was 10 times more concentrated. Together with the standard samples, 
the same 2 real urine samples were added to have a second measurement of the metabolites in 
the urine. 
The results are synthesized in the tables below: 
Table 16: Responses of the compounds after liquid extraction in ethyl acetate. 
 Compound name (responses) 
Sample name 
Benzoquinone 
D4 
Hydroquinone 
D4 
Benzoquinone Hydroquinone 
P-
terphenyl 
D14 
BLK - - - - 1,012,791 
IS ONLY - 22,722 - 131,072 1,128,581 
100 pg/µl AVG - 25,141 - 16,624 724,703 
1,000 pg/µl AVG 111 27,339 - 202,612 677,441 
5,000 pg/µl AVG 131 46,425 2,626 1,285,983 873,480 
10,000 pg/µl AVG 171 52,990 18,712 3,591,054 893,129 
20,000 pg/µl AVG 585 56,352 223,729 9,725,341 917,353 
URINE A01 163 1,977,911 1,567 65,387 1,076,663 
URINE B10 274 704,405 213 44,093 1,104,647 
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Table 17: Responses normalized against p-terphenyl D14. 
 Normalized response (Compound/P-ter) 
Sample 
name Benzoquinone D4 Hydroquinone D4 Benzoquinone Hydroquinone 
BLK 0.00000 0.00000 0.00000 0.00000 
IS ONLY 0.00000 0.02013 0.00000 0.11614 
100pg/µl 
AVG 0.00000 0.03469 0.00000 0.02294 
1,000pg/µl 
AVG 0.00016 0.04036 0.00000 0.29908 
5,000pg/µl 
AVG 0.00015 0.05315 0.00301 1.47225 
10,000pg/µl 
AVG 0.00019 0.05933 0.02095 4.02076 
20,000pg/µl 
AVG 0.00064 0.06143 0.24389 10.60152 
URINE A01 0.00015 1.83708 0.00146 0.06073 
URINE B10 0.00025 0.63767 0.00019 0.03992 
 
Table 18: Response ratio natural standard/internal standard, compared with the theoretical 
value. 
 (Natural STD/Internal STD) 
Sample name Theoretical value Benzoquinone Hydroquinone 
BLK 0 n.d. n.d. 
IS ONLY 0 n.d. 5.77 
100pg/µl AVG 0.01 n.d. 0.66 
1,000pg/µl AVG 0.1 0.00 7.41 
5,000pg/µl AVG 0.5 19.99 27.70 
10,000pg/µl AVG 1 109.43 67.77 
20,000pg/µl AVG 2 382.44 172.58 
URINE A01 N/A 9.61 0.03 
URINE B10 N/A 0.78 0.06 
 
Although the concentration of the Benzoquinone D4 even if the concentration was 10 
times higher, no significant change was observed between the previous batch and the latest 
(Table 13 and Table 16), indicating that the measured concentration of the internal standard 
does not depend from the concentration in the sample. A similar behaviour was observed also 
for the hydroquinone D4, which showed an increased response, but did not reflect the 10 fold 
increase of the standard concentration. The responses of the natural standards changed even if 
the concentration of the standards was not changed. Furthermore, the real urine samples 
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showed a major difference of the internal standard response within the samples, together with 
natural standard/internal standard ratios that were not correlated between the two experiments 
(Table 19). A hypothesis that could be suggested is that some of the real urine components 
generate a matrix effect that is not linear or predictable in different samples. Moreover, the 
internal standard in the second batch of experiments was 10 times more concentrated, therefore, 
a drop of the natural standard/internal standard ratio would be expected, while instead the ratio 
for benzoquinone was found to be increased in the sample A01. 
Table 19: Comparison of the two batches of real urine, the same two samples were analysed 
twice, obtaining different results. The second batch contained an internal standard 
concentration 10 times higher than the first. 
 (Natural STD/Internal STD) 
Sample name Benzoquinone Hydroquinone 
URINE A01 1st batch 2.42 1.10 
URINE B10 1st batch 1.97 0.08 
URINE A01 2nd batch 9.61 0.03 
URINE B10 2nd batch 0.78 0.06 
 
Recoveries from the liquid extraction were calculated, dividing the response of every 
compound after extraction by the response of the corresponding concentration of the same 
compound in direct injection. The recoveries for the benzoquinone D4 were found to be not 
significant in most cases, while recoveries of hydroquinone D4 were found to be generally high 
and in some cases, over 100%. These findings suggested that there was a major contribution to 
hydroquinone concentration arising from the self rearrangement of benzoquinone, triggered by 
the aqueous solution, despite the acidification step and the equilibration time allowed.  
A variation of the recoveries was calculated using the responses from each compound, 
normalized against the recovery standard p-terphenyl D14. Recovery ratios for hydroquinone 
D4 were found to be generally under 65% for the standards containing 1,000 pg/µl of internal 
standard. In the samples with internal standard solution with a concentration of 10,000 pg/µl, 
all of the hydroquinone D4 recoveries were significantly higher, with most of them over 100%. 
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Since the responses of the second batch of analyses were compared with the responses of the 
directly injected standards, it is important to remember that in this case, the internal standard 
concentration was 10 times higher than in the directly injected standards, and it would be 
expectable to see high recoveries in the benzoquinone D4. No relevant differences were 
observed between the two sets of extractions for benzoquinone D4, while a major difference 
for hydroquinone D4 was observed, suggesting that the majority of the Benzoquinone in the 
urine rearranges in Hydroquinone. This self rearrangement is not happening with the ethyl 
acetate in the direct injections, which have proven to keep the compounds in the original form, 
lowering the rate of self rearrangement from a form to another. 
 
Table 20: Calculated recoveries for the first batch of standards (internal standard 
concentration 1000 pg/µl) calculated on the response of directly injected standards/extracted 
standards ratio and on normalized directly injected standards/normalized extracted standards 
ratio. 
Recoveries % 
Standard point 
(pg/µl) 
Extracted STD response / Directly 
Injected STD response 
Normalized response 
(Compound/P-ter) 
 BQD4 HQD4 BQ HQ BQD4 HQD4 BQ HQ 
BLK n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
IS ONLY 0% 69% 0% n.d. 0% 33% 0% n.d. 
100 0% 93% 0% n.d. 0% 64% 0% n.d. 
1,000 0% 158% 0% 634% 0% 64% 0% 256% 
5,000 0% 54% 1% 241% 0% 25% 1% 109% 
10,000 0% 33% 5% 222% 0% 13% 2% 90% 
20,000 1% 31% 6% 193% 0% 17% 3% 104% 
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Table 21: Calculated recoveries for the second batch of standards (internal standard 
concentration 10000 pg/µl) calculated on the response of directly injected standards/extracted 
standards ratio and on normalized directly injected standards/normalized extracted standards 
ratio. 
Recoveries %  Recoveries % 
Standard point 
(pg/µl) 
Extracted STD response / Directly 
Injected STD response  
Normalized response 
(Compound/P-ter) 
 BQD4 HQD4 BQ HQ  BQD4 HQD4 BQ HQ 
BLK n.d. n.d. n.d. n.d.  n.d. n.d. n.d. n.d. 
IS ONLY 0% 112% 0% n.d.  0% 84% 0% n.d. 
100 0% 199% 0% n.d.  0% 336% 0% n.d. 
1,000 0% 311% 0% 620%  0% 358% 0% 714% 
5,000 0% 125% 0% 186%  0% 151% 0% 224% 
10,000 0% 55% 1% 176%  0% 66% 1% 212% 
20,000 0% 42% 3% 196%  0% 52% 3% 246% 
 
The problems arising from the peak shape of hydroquinone represented a major issue 
as it was not possible to identify the peak at low concentrations and integrate it in a reliable 
way.  
The rearrangement of benzoquinone in hydroquinone affected the results, especially in 
the real urine samples using benzoquinone D4 as an internal standard. The outcome of the 
recoveries underlined a problem of reliability of the methodology, as the recoveries of the 
natural standards were not constant over the different concentrations, and more importantly the 
recoveries of the internal standard (hydroquinone D4) seemed to be affected by the 
concentration of the natural standard. Furthermore, the extractions performed in different 
batches showed a poor inter experimental reproducibility, this made the measurement of the 
compounds in urine impossible in a reliable assay. 
 
To investigate about a matrix effect in urine, another extraction experiment was 
performed, extracting the standards spiked in distilled water and not in synthetic urine, to check 
if the matrix where the hydroquinone and the benzoquinone affected the extraction and the 
results of the analyses. 
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The vials were prepared for liquid extraction using the same protocol described above, 
but spiking the standards in distilled water instead of synthetic urine.  
A single high concentration standard vial was added, containing an unknown 
concentration of benzoquinone (close to the benzoquinone saturation point in aqueous 
solution).  
All the vials were processed with liquid extraction using ethyl acetate with the same 
methodology described above in this section.   
A 500 µl aliquot was then transferred to a GC vial and analysed by GCMS to check the 
reproducibility and the hydroquinone/benzoquinone ratios. 
Since this was mostly a qualitative experiment, the recovery standard P-Terphenyl D-
14 was not added to the samples.  
 
Table 22: Responses of internal and natural standards extracted from water by liquid 
extraction. 
 Compound name (responses) 
Sample name and 
concentration 
(pg/µl) 
Benzoquinone D4 
Hydroquinone 
D4 
Benzoquinone Hydroquinone 
BLK 0 0 83821 226471 
100 505908 748266 124069 244709 
1,000 649195 888623 230492 527256 
5,000 608435 783617 459520 674265 
10,000 559937 635763 772526 878541 
20,000 673335 844569 1674894 1893525 
High CONC BQ STD 116384 5672 670357395 24755322 
 
 In Table 22 are reported the responses for each standard point extracted from water, it 
is possible to notice a difference in benzoquinone D4 and hydroquinone D4 which are almost 
constant at every concentration point, in opposition to the results obtained with the extractions 
from synthetic urine.  
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Since the P-terphenyl D14 was not added, the values could not be normalized. The 
natural standard/internal standard ratios for the standard points were then compared in the 
following table. 
Table 23: Natural standard/internal standard ratio comparisons with the theoretical value. 
 (Natural STD/Internal STD) 
Sample name and 
concentration (pg/µl) 
Theoretical 
value Benzoquinone Hydroquinone 
BLK 0 N/A N/A 
100 0,01 0,25 0,33 
1,000 0,1 0,36 0,59 
5,000 0,5 0,76 0,86 
10,000 1 1,38 1,38 
20,000 2 2,49 2,24 
High CONC BQ STD N/A 5759,88 4364,48 
 
In this case, the ratio didn’t seem to be affected by the different concentrations, and 
followed a good calibration curve, although there was an overestimation of the quantities, that 
became a considerable error at low concentrations.  
Benzoquinone D4 showed a stable response throughout all of the samples when 
extracted from water. The response at low concentrations of benzoquinone was higher than the 
previous experiments. 
The same pattern observed for benzoquinone was observed for hydroquinone, the 
internal standard was extracted consistently and the response did not increase with the increase 
of the concentration of the natural standard. Also in this case, the natural standards and the ratio 
between natural and internal standard gave an overestimation at low concentrations, mostly 
due to the poor peak shape and the difficulties in integration and localization of the peak.  
These results proved that urine generated a matrix effect, affecting negatively the liquid 
extraction protocol. Furthermore, the pH of urine converted most of the benzoquinone in 
hydroquinone, which is the specie giving most chromatographic problems. These findings and 
the impossibility of obtaining a reliable chromatogram and integration for low hydroquinone 
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concentrations evidenced methodological problems with the liquid extraction methodology for 
our study, which would have medium to low levels of exposure, and therefore low 
concentrations of metabolites would be expected.  
 
II.5 Quinones extraction by solid phase extraction (SPE) 
Taking in account the results obtained with liquid extraction, we investigated another 
methodology to extract metabolites from urine, using solid phase extraction (SPE).  
For the SPE extraction, Agilent Bond Elut PLEXA cartridges were used. The 
methodology used for the extraction was described in section II.3, briefly:   
- The standard vials were prepared with the same procedure of the previous extraction 
experiments, each point in triplicate, with an internal standard concentration of 10000 
pg/µl for Benzoquinone D4, but in this case 10000 pg/µl of hydroquinone D6 was 
added to the internal standard solution 
- From each vial 0.3 ml of synthetic or real urine were diluted in 0.9ml of 1% formic 
acid  
- The SPE columns were preconditioned with 0.5 ml Methanol followed by 0.5 ml of 
water 
- The samples were loaded in the SPE columns with an approximate flow rate of 1 
ml/min and washed with 1 ml Methanol 5% 
- The elution was performed with 1 ml Methanol 100% 
50 µl from the eluted solution were then transferred in a GC vial with a glass insert, and then 
spiked with 2.5 µl of P-terphenyl D14 solution. 
Each standard point was prepared in triplicate and analysed, then the three values were 
averaged. 
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In order to rule out a possible interference caused by phenol, another batch of synthetic 
urine not containing phenol was prepared. One of the three samples of each standard point was 
extracted from a version of the synthetic urine containing phenol, which did not seem to affect 
negatively the results. The average responses from the extractions are listed in the following 
table: 
Table 24: Responses of standards extracted using SPE, the average of each point is obtained 
including the synthetic urine containing phenol. 
 compound name (responses) 
Sample name and standard 
concentration (pg/µl) 
BQ 
D4 
HQ D4 BQ HQ 
P-terphenyl 
D14 
BLK n.d. 26344 n.d. 13858 374509 
IS ONLY n.d. 502089 n.d. 7309 513587 
100 n.d. 610941 n.d. 13992 549034 
1,000 n.d. 705405 n.d. 82914 593573 
5,000 n.d. 654035 n.d. 321661 558979 
10,000 n.d. 769472 n.d. 726560 601605 
20,000 n.d. 650121 9444 1223305 546976 
URINE A01 n.d. 452276 n.d. 78887 697060 
URINE B10 n.d. 398997 n.d. 28100 552757 
 
The responses were then normalized against the recovery standard P-terphenyl D14: 
Table 25: Normalized responses of natural and internal standards against the recovery 
standard P-terphenyl D14. 
 Normalized response (Compound/P-ter) 
Sample name and 
standard concentration 
(pg/µl) 
Benzoquinone 
D4 
Hydroquinone 
D4 Benzoquinone Hydroquinone 
BLK n.d. 0.07 n.d. 0.04 
IS ONLY n.d. 0.98 n.d. 0.01 
100 n.d. 1.11 n.d. 0.03 
1,000 n.d. 1.19 n.d. 0.14 
5,000 n.d. 1.17 n.d. 0.58 
10,000 n.d. 1.28 n.d. 1.21 
20,000 n.d. 1.19 0.02 2.24 
URINE A01 n.d. 0.65 n.d. 0.11 
URINE B10 n.d. 0.72 n.d. 0.05 
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The data was processed with the same procedure of previous experiments for 
comparison, obtaining the ratio between the normalized natural standard average and the 
normalized internal standard average: 
 
Table 26: Normalized natural standard/internal standard ratio, compared with the theoretical 
value. 
 (Natural STD/Internal STD) 
Sample name and standard 
concentration (pg/µl) theoretical value Benzoquinone Hydroquinone 
BLK 0 N/A 0,53 
IS ONLY 0 N/A 0,01 
100 0,01 N/A 0,02 
1,000 0,1 N/A 0,12 
5,000 0,5 N/A 0,49 
10,000 1 N/A 0,94 
20,000 2 N/A 1,88 
URINE A01 N/A N/A 0,17 
URINE B10 N/A N/A 0,07 
 
The recovery of benzoquinone is zero for the internal standard, while in the natural 
standards, benzoquinone was found only in the standard solution with a concentration of 20,000 
pg/µl.  
Although the calibration curve was found to have a good R² value, the chromatographic 
problems of hydroquinone were still present, making it difficult to integrate consistently 
hydroquinone at low concentrations.  
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Figure 19: Plot of natural standard/internal standard response ratio for hydroquinone after 
SPE. R² value is affected by one of the blanks where a hydroquinone peak was detected. 
 
In the graphic above is showed the fitting of the standard points obtained from the ratio 
between natural standard response and internal standard response. 
The fitting of the points is improved compared to the liquid extraction, and the R² is 
higher because of a hydroquinone peak was found in one of the blanks.  
Due to the results obtained with the SPE procedure, an extended assay with more real 
samples was performed, to validate the reliability and feasibility of the methodology.  
A calibration curve was prepared in triplicate with the same procedure described above, 
with standard points from 100 to 20,000 pg/µl in synthetic urine. The extractions were 
performed with the same procedure of SPE previously described, and the analyses were 
performed by GC-MS. In this batch of extractions, 5 samples of urine were analysed, including 
the urine sample B10 to have a replicate to evaluate. The samples of this batch were obtained 
from a pilot study performed in collaboration with the Arizona State University (ASU), with 
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subjects on different commuting routes and different means of commute, with an expected 
medium to low range exposure to VOCs mostly due to road traffic pollution.  
The outcome of the analyses underlined the chromatographic problems with the peak 
shape of hydroquinone, which presented an extended tailing, preventing the possibility of 
reproducible integration of the peak in the standard solutions. Furthermore, in the matrix 
complexity of the urine, generated a high background noise, which affected the correct 
quantification of the hydroquinone, as showed in Figure 20 for the internal standards and in 
Figure 21 for the natural standards. 
  
 
Figure 20: Overlay of the ion 114 (hydroquinone D6 internal standard of all the runs: 
10.000pg/ml) the R.T. is variable and also the peak shape not reliable, the peaks of samples 
B01 and B02 are sharper than the peaks of the standard solutions but the tailing of the peaks 
prevents a reproducible integration and quantification. 
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Figure 21: Overlay of ion 110 (hydroquinone) for all the standards and samples, the high 
concentrations (blue and yellow) are easily quantifiable, but in the low concentrations it is not 
possible to identify a definite peak, affecting negatively the quantification. 
 
The obtained data was analysed with the same method, the responses were normalized 
against the recovery standard P-terphenyl D14 and synthesized in the following table. 
 
Table 27: Responses of internal standards and natural standards, normalized against the 
recovery standard P-terphenyl D14. 
 Normalized response (Compound/P-ter) 
sample name and 
concentration (pg/µl) 
Benzoquinone 
D4 
Hydroquinone D4 Benzoquinone Hydroquinone 
100 n.d. 0.67 n.d. 0.02 
1,000 n.d. 0.55 n.d. 0.09 
5,000 n.d. 0.64 n.d. 0.30 
10,000 n.d. 0.60 n.d. 0.94 
20,000 n.d. 0.48 n.d. 1.08 
URINE B01 n.d. 0.47 n.d. 0.06 
URINE B02 n.d. 0.62 n.d. 0.06 
URINE B04 n.d. 0.47 n.d. n.d 
URINE B08 n.d. 0.61 n.d. 0.02 
URINE B10 n.d. 0.55 n.d. 0.01 
 
The natural standard/internal standard ratio was then calculated and compared with the 
theoretical value.  
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Table 28: Natural standard/internal standard ratio, compared with the theoretical values. 
 (Natural STD/Internal STD) 
sample name and concentration (pg/µl) Theoretical value Benzoquinone Hydroquinone 
100 0,01 N/A 0,03 
1,000 0,1 N/A 0,17 
5,000 0,5 N/A 0,46 
10,000 1 N/A 1,56 
20,000 2 N/A 2,27 
URINE B01 N/A N/A 0,12 
URINE B02 N/A N/A 0,10 
URINE B04 N/A N/A 0,00 
URINE B08 N/A N/A 0,04 
URINE B10 N/A N/A 0,03 
 
The sample B10 of urine was analysed previously (Table 26 for SPE, Table 15 for liquid 
extraction), showing a higher concentration according to the natural standard/internal standard 
ratio. It is also important to point out that depending on the integration of the peak, the results 
of the quantification can vary of a significant amount, therefore, especially at low 
concentrations, the quantification of hydroquinone was not considered to be reliable and 
feasible. This is underlined in Table 29 where the concentrations were calculated using the 
responses obtained. 
Table 29: Concentrations calculated using the responses of the standard points and the 
samples, calculated using the calibration curve obtained in this batch of extractions. The 
concentrations are generally overestimated, especially at low concentrations. 
Sample name and 
concentration 
(pg/µl) 
Hydroquinone 
concentration 
(pg/µl) 
100 334 
1,000 1544 
5,000 4956 
10,000 15604 
20,000 18062 
URINE B01 962 
URINE B02 1015 
URINE B04 n.d. 
URINE B08 364 
URINE B10 246 
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Due to the poor peak shape and the tailing of hydroquinone peak it was difficult to have 
an exact and reliable integration, hence the quantification of the hydroquinone could not be 
validated, due to the high variability. Benzoquinone was almost never detected, this is possibly 
due to the adsorption of the compound to the column which in some way promotes the 
rearrangement of benzoquinone in hydroquinone. Considering the concentration ranges 
expected in our study, although the extraction proved to be reliable and reproducible, this 
methodology could not be used, due to the chromatographic issues arising from hydroquinone.  
II.6 Extraction efficiency evaluation 
SPE with Bond Elut Plexa columns was chosen within the different SPE cartridges due 
to the higher efficiency of extraction over a broad range of compounds. Extraction efficiency 
was evaluated by the calculation of the recovery of the compounds. Recovery was calculated 
on the ratio between the responses of the compounds extracted from urine over the directly 
injected compounds. Urine from a non exposed subject was scanned to confirm the absence of 
the compounds of interest. The urine was then spiked with internal standards (2000 pg/µl final 
concentration) and different levels of natural standards (2, 20, 200, 2000 pg/µl final 
concentration). The extraction was performed following the acid loading protocol described 
above, diluting the urine with 1% formic acid. 2µl of the eluate were then injected in the GC-
MS for analysis. The control was performed by diluting the standards directly in 
dichloromethane and injecting 2 µl of the solution in the GC-MS. To assess the stability of the 
compounds in solution, two batches of standards were used, a fresh batch and a batch that was 
stored at -20C for two weeks. The standard solutions were made by dissolving the quinones 
in methanol. A summary of the results is reported in Table 30. 
Phenanthraquinone was not reported in the table because they were not detectable under 
200 pg/µl in all of the analyses. Analysing the results of the table it is possible to see that most 
of the recoveries were acceptable (over 60%), but most of the compounds showed a variable 
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rate of recovery. For example anthraquinone, which showed a good recovery rate, in some case 
presented a recovery of only 37%, while in other cases the recovery value was over 100%. The 
high value can be due to a standard spiking error, due to pipetting inconsistency, the low values 
could indicate a possible variability of the extraction methodology, although they could be 
arising from instrumental differences due to the conditions of the GC-MS system. More 
importantly, the two batches of internal standards (one stored for two weeks at -20C and one 
freshly prepared), showed a definite decay of the signal due to the storage. Using as an example 
anthraquinone d8, the oldest batch recoveries ranged from 9.22% to 13.96%, while the freshly 
prepared batch recoveries ranged from 43.53% to 61.24%, evidencing an important decay of 
the signal due to the storage. This behaviour was observed in all the internal standards. Overall, 
the recoveries were satisfactory, although for some compounds the difference of recovery 
between the different standard points was rather big.  
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Table 30: Summary of recoveries of quinones extracted from urine using SPE. 
    RECOVERY % 
Extraction 
batch 
Concentration 
1,4-
naphthoqui
none d6 
1,4-
Naphthoqui
none 
2,6-di-tert-
butyl-1,4-
benzoquino
ne 
2methyl-
1,4-
naphthoqui
none d8 
2-methyl-
1,4-
naphthoqui
none 
Acenaphtho
quinone 
Anthraquino
ne d8 
Anthraquinone 
2-methyl-
anthraquino
ne 
2,3-
dimethyl-
anthraquino
ne 
Benz[a]anthr
acenequinon
e-7,12-dione 
5,12-
naphthace
nequinone 
direct 
injection 
from DCM 
2 pg/µl 100.00% 100.00% n.d. 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% n.d. 
20 pg/µl 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 
200 pg/µl 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 
2000 pg/µl 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 
spiking in 
urine and 
SPE  
ISTD batch 
stored at 
-20C for 2 
weeks 
Blank 0.09% 5.17% n.d. 59.22% 61.40% 22.75% 11.80% 64.08% 133.06% 133.04% 125.09% n.d. 
2 pg/µl 0.08% 2.72% n.d. 55.85% 103.84% 22.07% 10.51% 93.19% 185.22% 199.48% 188.75% n.d. 
20 pg/µl 0.09% 0.36% 55.55% 65.42% 98.41% 7.64% 11.45% 96.35% 134.17% 136.70% 108.38% 107.58% 
200 pg/µl 0.15% 0.06% 36.85% 65.88% 70.74% 3.77% 13.96% 79.90% 85.40% 69.74% 50.65% 49.47% 
2000 pg/µl 0.11% 0.98% 25.36% 60.50% 64.57% 3.46% 9.22% 39.98% 38.84% 36.10% 36.61% 22.31% 
spiking in 
urine and 
SPE  
ISTD batch 
prepared 
fresh 
Blank 0.38% 5.32% n.d. 74.93% 30.46% 28.35% 47.69% 37.63% 44.71% 40.63% 46.41% n.d. 
2 pg/µl 0.31% 4.25% n.d. 74.82% 88.35% 28.55% 43.53% 80.87% 101.05% 94.54% 93.18% n.d. 
20 pg/µl 1.96% 1.09% 49.50% 86.75% 110.73% 12.19% 60.77% 118.89% 132.38% 133.20% 142.27% 106.86% 
200 pg/µl 1.91% 0.12% 67.39% 90.74% 104.96% 5.87% 61.24% 112.67% 111.24% 92.01% 75.54% 62.17% 
2000 pg/µl 0.76% 2.14% 36.30% 82.10% 80.24% 5.47% 54.01% 61.09% 61.44% 61.41% 71.90% 66.43% 
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II.7 Quinones GC-MS analysis 
Hydroquinone and benzoquinone were analysed using a GC-MS Agilent 5973 (Agilent 
technologies, USA). For the analyses an ultra inert liner and column (HP5-MS, ultra inert, 30m, 
i.d. 0.25mm, film thickness 0.25µm, Agilent technologies) were used, to improve the peak 
shape and maximise the sensitivity.  
The MS analysis of quinones was performed by EI (electronic ionization) and NCI 
(negative chemical ionization) using methane as ionization gas. The NCI gave better results in 
terms of sensitivity, and was used also to scan for other quinones that might occur from the 
metabolization of PAHs or arise from direct exposure: anthraquinone; 1,2-naphthoquinone; 
1,4-naphthoquinone; methyl-1,4-naphthoquinone; 2-methyl-1,4-naphthoquinone; 1,4-
acenaphthenequinone; 9,10-phenanthrenequinone; 2,6-di-tert-butyl-1,4-benzoquinone; 2,3-
dimethyl-anthraquinone; 2-methyl-anthraquinone; benz[a]anthracene-7,12-dione; 5,12-
naphthacenequinone. The MS analysis was performed in SIM (single ion monitoring) mode, 
to enhance the sensitivity for each compound. The GC separation was carried out with the 
injection port held at 250C and the oven temperature was ramped with a constant gradient for 
the oven from 60C to 300C at 4C/min. The ions scanned were: 122 (methyl-1,4-
benzoquinone), 158 (1,4-naphthoquinone and 1,2-naphthoquinone), 164 (1,4-naphthoquinone 
d6), 172 (2-methyl-1,4-naphthoquinone), 180 (2-methyl-1,4-naphthoquinone d8), 182 
(acenphthoquinone), 208 (anthraquinone and phenanthraquinone), 216 (anthraquinone d8), 
220 (2,6-di-tert-butyl-1,4-benzoquinone), 222 (2-methyl-anthraquinone), 236 (2,3-dimethyl-
anthraquinone), 258 (benz[a]anthracene-7,12-dione and 5,12-naphthacenequinone).  
II.8 Hydroquinone analysis by LC-MS/MS 
An LC-MS/MS system was made available for a short period, and an analysis of 
hydroquinone concentration in synthetic urine was attempted. Unfortunately, the time slot was 
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too short to develop a method and tune the instrument in order to obtain an optimized 
chromatogram. To identify the hydroquinone, the transition m/z 110/81 was selected, as the 
ion m/z 81 was identified as the collision induced fragment of hydroquinone (MW 110). 
As shown in Figure 22, even without an accurate tuning of the instrument, the 
chromatographic problems arising from hydroquinone were not present, and it was possible to 
identify the peak at low concentrations such as 10 pg/ml.  
The chromatographic separation was performed using a C-18 column at a flowrate of 
1ml/min. The elution was performed with methanol using a gradient from 20% to 100% in 
20min. Unfortunately, due to the limited time available, the method could not be refined 
further. These results underlined the better suitability of LC-MS methods for the analyses of 
polar metabolites such as hydroquinone, which had been difficult to analyse by GC-MS due to 
its physiochemical characteristics.  
 
Figure 22: Hydroquinone chromatogram (10 pg/ml) from LC-MS/MS. m/z 110/81 transition, 
the hydroquinone peak is identified between 3 and 3.5 min, on the Y axis are indicated the 
counts per second. 
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Due to the limited time and the impossibility of developing a refined method for 
hydroquinone analyses, the methodology was not considered further, and other biomarker of 
exposure were selected. 
II.9 Limit of detection 
The instrumental LOD (limit of detection) was calculated by dividing the standard 
concentration by 1/3 of the signal to noise ratio at the same concentration (Equation 1). The 
LOQ (limit of quantification) was calculated by dividing the standard concentration by 1/5 of 
the signal to noise ratio at the same concentration (Equation 2). The results are summarised in 
Table 31.  
Equation 1 
ܮܱܦ ൌ ܵݐ݀	ܥ݋݊ܿ݁݊ݐݎܽݐ݅݋݊1
3 	݈ܵ݅݃݊ܽ/݊݋݅ݏ݁		ݎܽݐ݅݋
 
 
Equation 2 
ܮܱܳ ൌ ܵݐ݀	ܥ݋݊ܿ݁݊ݐݎܽݐ݅݋݊1
5 	݈ܵ݅݃݊ܽ/݊݋݅ݏ݁		ݎܽݐ݅݋
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Table 31: LOD and LOQ of each of the quinones analysed in NCI. 
 Concentration pg/µl Signal/noise 
LOD 
(pg/µl) 
LOQ 
(pg/µl)
9,10-phenanthrenequinone 1058 3810 0.83 1.39 
acenaphthenequinone 20 974 0.06 0.10 
2-methyl-1,4-naphthoquinone 1002 128978 0.02 0.04 
1,2-naphthoquinone 1009 n.d. N/A N/A 
1,4-naphthoquinone 955 84885 0.03 0.06 
anthraquinone 1030 56069 0.05 0.09 
2,6-di-tert-butyl-1,4-
benzoquinone 1076 634 5 8 
2,3-dimethyl-anthraquinone 1036 152324 0.02 0.03 
2-methyl-anthraquinone 990 51057 0.06 0.1 
benz[a]anthracene-7,12-dione 1048 341562 0.01 0.01 
5,12-naphthacenequinone 1005 602 5 8 
methyl-1,4-benzoquinone 955 443 6 11 
 
II.10 Outcomes of method development for quinones in urine  
Extraction efficiency of the quinones from urine was evaluated through analysis by GC-
MS. High concentrations of quinones could be easily detected, even though the 
chromatographic separation was not excellent. Benzoquinone was proven unstable in solvents 
containing available hydrogens, reducing in hydroquinone (Roginsky et al., 1999), therefore 
using the SPE method we could not detect benzoquinone. In addition, the observed matrix 
effect generated by urine prevented the use of liquid extraction (liquid extraction from synthetic 
urine: Table 15; liquid extraction from water: Table 23). Hydroquinone has proven to be a 
difficult biomarker to analyse using GC-MS. Due to its chemically active nature it tends to 
interact with the column, preventing the formation of a sharp peak making impossible the 
quantification due to the formation of a tailing peak in chromatograms affecting the 
quantification, especially at low concentrations. Furthermore, hydroquinone appeared to be 
thermally unstable, preventing detection of low concentrations in EI-GC-MS chromatography. 
CI-GC-MS provided better results in terms of sensitivity, however the chromatographic issues 
prevented a reliable quantification. Derivatization was considered, but at low concentrations in 
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a complex matrix such as urine, adding a derivatization step would have increased 
quantification variability, invalidating the assay. Without the availability of an LC-MS system, 
the analysis of hydroquinone in urine as a biomarker of exposure to benzene was abandoned.  
The other species were analysed using CI-GC-MS, building a reliable and reproducible 
quantification method, but despite the low LODs (Table 31), urine samples from the higher 
exposure group did not provide quantifiable concentrations of any of the species. 
 
II.11 8-oxo-dG analysis by GC-MS 
A GC-MS methodology to analyse 8-oxo-dG was tested, following the protocol 
described by Lin et al. (2004). The methodology consisted of extraction of the 8-oxo-dG from 
the urine by SPE, derivatization of the extracted compounds by sylanization and GC-MS 
analysis. In the paper describing the methodology the urine volume is adjusted according to 
the creatinine concentration (3200µl for creatinine concentrations under 5 mM, 1600 µl for 
creatinine concentrations up to 10 mM, and 800 µl for creatinine concentrations above 10 mM). 
For the development of the methodology a constant volume of 1000 µl was used. Tests were 
performed using both synthetic and real urine, that were spiked with the standards (8-oxo-dG 
and [18 O]8-oxo-dG for internal standard).  
The extraction was performed using Oasis HLB cartridge 3 cc/60mg 30 µm (Waters, 
UK). The procedure used was as follows: 
1 volume of formic acid (10%) (Sigma Aldrich, UK) was added to 10 volumes of urine 
from a control subject. Acidified samples were incubated for 1h at 4°C, they were then 
centrifuged at 10,000G for 10min at 4°C.  
Supernatant was collected and the extraction with Oasis HLB vac cartridges was 
performed with the following steps:  
-Vac cartridges were preconditioned with 5ml methanol and 8 ml of 20 mM formic acid. 
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-Sample was diluted with 20 mM formic acid to a final volume of 5.8 ml and the sample was 
loaded  on the cartridge.  
-The diluted urine was passed through the column at a flowrate of 2ml/min. 
-The column was washed with 2 ml of 20 mM formic acid were loaded to wash the sample  
-Elution was performed with 1.5 ml of 17.5% methanol in 20 mM formic acid 
-After each step the cartridges were completely dried using vacuum flow 
8-oxo-dG is reported to be stable in 20mM formic acid for at least 5h at 4°C.  
The collected fraction was then transferred in an autosampler vial and frozen at -80, 
and then the sample was freeze-dried. 
Freeze-dried sample vials were purged with nitrogen and immediately sealed with caps 
with PTFE septa to prevent oxygen contamination. Acetonitrile/ethanethiol (20 µl: 3:1, v/v) 
was added to the vial to solubilize the urinary residue.  
80µl of bis(trimethylsilyl)trifluoroacetamide (containing 1% trimethylchlorosilane) 
(Sigma Aldrich, UK) were added to the vial for derivatization at room temperature for at least 
6h, which are reported to be enough for the derivatization of all the compounds. The samples 
were then analysed for 8-oxo-dG 
GCMS analysis: 
The analyses were performed directly after the derivatization step with no further sample 
preparation, injecting also the derivatization matrix.  
Injection port was kept at 250°C, GC-MS interface was kept at 290°C. 
The separation was made with the following column temperature gradient:  
-2min at 80°C  
-Increase up to 300°C at the rate of 15°C/min  
-10 min at 300°C  
Ion source maintained at 230°C  
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The selective ions were 383 and 643 for 8-oxo-dG, and 385 and 645 for [18 O]8-oxo-dG. 
The procedure proved to be complicated and prone to errors and problems: injection of the 
derivatization matrix in the GC-MS system resulted in formation of ghost peaks due to the 
unreacted sylanes that caused chromatographic problems. The freeze-drying procedure 
couldn’t be performed properly due to the presence of methanol which caused the sample to 
thaw prematurely, also the freeze-drying facilities were not located in the same laboratory and 
the transfer of the samples between the facilities affected negatively the procedure. After 
several replications, it was not possible to obtain a reliable extraction procedure. Alterations to 
the main procedure were tested: elution from the SPE column with 100% methanol followed 
by drying under nitrogen flow, evaporation of the organic phase under nitrogen flow prior the 
freeze-drying step. None of the procedures gave satisfactory results.  
The derivatization step was checked by diluting the 8-oxo-dG in water in high 
concentrations (1 high concentration standard and 2 consecutive dilutions, respectively 1/3 and 
1/4 of the original high concentration standard) and freeze-drying without the extraction step, 
then the derivatization protocol was applied. In this case we were able to identify the 8-oxo-
dG peak, due to the extremely high concentration, as showed in Figure 23, although the 
response is obviously unrealistic. The main problem we encountered by using this 
methodology, was to keep the instrument clean from contaminations. As showed in Figure 24, 
after a small number of injections, parasite peaks started to build up in the chromatograms, due 
to the injection of the derivatization matrix. This contamination was highly interfering with the 
measurements, because one of the main ions of the contaminants was ion 383, which we used 
to quantify 8-oxo-dG. The contamination could be quenched by trimming the GC column, 
extensively cleaning the injection syringe, and changing the injector liner, but these procedures 
were both time consuming and they affected the results by changing the retention times of the 
ions. A sample from a volunteering smoker was analysed, expecting higher levels of 8-oxo-
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dG, to test the methodology on a real sample. Even after a cleaning of the instrument, the 
parasite peaks were still present, and were interfering with the measurements (Figure 25). In 
this case it was possible to identify the 8-oxo-dG peak, but we were not able to quantify the 8-
oxo-dG due to the impossibility of calculating a reliable and reproducible calibration curve. 
 
 
Figure 23: Overlay of three ion chromatograms (m/z 383) high concentration 8-oxo-dG 
standards, the concentration was not measured, as the chromatographic run was used to 
determine the retention time of the substance. The used concentrations were the product of two 
sequential dilutions 1:2. 
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Figure 24: Blank ion chromatogram (methanol only) of m/z 383 after a small number of 
injections of derivatized 8-oxo-dG and derivatization matrix. 
 
 
 
Figure 25: Ion chromatogram of ion m/z 383, sample obtained from a volunteering smoker, 
the 8-oxo-dG peak is identified, however, the parasite peaks were a major confounding factor. 
 
The derivatization procedure, proved to be a not reliable and reproducible method. The 
retention time of 8-oxo-dG was found, but the response and the peak shape were not 
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satisfactory for analyses of low concentrations. Furthermore, the analysis procedure proved to 
be unreliable and error prone with our facilities. After considering the problems with the 
methodology it was decided to analyse the samples in an external laboratory with a simpler 
method, using SPE extraction and analysing the 8-oxo-dG by LC-MS. 
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III. Methodologies 
This chapter describes the various sampling campaigns and the analytical procedures for urine 
samples from volunteers. The sampling campaigns were completed in collaboration with Ms. 
Barbara Macias Hernandez under the FIXAT project.   
Part of the sampling was carried out in collaboration with a private highway maintenance 
company and a landscape gardening company. Some of the chemical analyses were completed 
in collaboration with Prof. Silvia Fustinoni, University of Milan. This study was funded by 
CEFIC and Wellcome Trust. 
 
 
The sampling campaign and the FIXAT project were divided in two main parts: one consisted 
in biomarker discovery and biomonitoring, on which this work is based on, while the other one 
consisted in the characterization of the personal exposures and modelling of the lung dose for 
such exposures. The latter was performed by Mrs. Barbara Macias Hernandez, and will be 
included in her PhD thesis. The personal exposure data was however available for comparisons 
and correlation analyses with the urinary biomarkers, however no further analyses could be 
performed with the personal exposure data set. All of the urine analyses of FIXAT project were 
performed in first person, except the 8-oxo-dG and the creatinine measurements, which were 
performed in external laboratories.  
The analytical procedures were a significant part of the learning process involved in the project. 
The analyses performed in Milan were performed in first person by the author, who gratefully 
acknowledges the department of occupational health for the training opportunity.  
In the same way, the unmetabolized VOCs from MATCH project were performed in first 
person. Furthermore, another training opportunity was given by the University of Leicester for 
8-oxo-dG analyses, where only a part of the analyses were performed. Due to unforeseen 
circumstances, the analyses were later performed in fullness by an external laboratory.  
Chemical analyses of the samples collected during the campaigns was conducted at the 
University of Birmingham (UoB) (UK) and University of Milan (UoM) (Italy). Urinary 
hydroxy PAH (OH-PAH) were analysed for MATCH project in university of California, San 
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Francisco (UCSF). Jeddah schoolchildren urinary PAHs were analysed by the Institute and 
Outpatient Clinic of Occupational, Social and Environmental Medicine of the University of 
Erlangen-Nuremberg (UoE) (Germany).8-oxo-dG was analysed in an external laboratory at 
Department of Public Health, Chung Shan Medical University (CSMU), Taichung, Taiwan. 
Table 32 summarizes the type of analysis conducted for each set of samples. 
Table 32: Summary of the chemical analyses. 
Project Sample type 
Sample 
collection 
Sample
r 
Airborn
e VOC 
and 
PAH 
Urinary 
VOC 
and 
cotinine  
Creatinin
e 
8-oxo-
dG  
Urinar
y OH-
PAH 
FIXAT 
Personal 
exposur
e VOC 2011-
2013 
Sorbent 
tubes UoB   CSMU  
Urine 
Mid-
stream 
urine 
sample 
 UoM UoB CSMU  
MATCH 
Personal 
exposur
e VOC 2005-
2007 
Sorbent 
tubes UoB   CSMU  
Urine 
Mid-
stream 
urine 
sample 
 UoM UoB CSMU UCSF 
Independent 
Measurement
s 
Urine 2011-2013 
Mid-
stream 
urine 
sample 
 UoM UoB CSMU  
Jeddah 
schoolchildren Urine 2013 
Mid-
stream 
urine 
sample 
  UoE / CSMU CSMU UoE 
  
 
III.1 FIXAT and MATCH studies 
Samples analysed in this study were collected under the FIXAT (FIngerprints of eXposure to 
Air Toxics) project. The study included 44 subjects divided in three main groups: a control 
group, a home/workplace exposed group, and an occupationally exposed group. All of the 
groups were formed by non-smokers (declared), with no distinction of sex or ethnicity, with an 
age range from 18 to 45 years old, with a majority of subjects in the 26-35 range. The objective 
of FIXAT study was to compare and characterise the exposure to building materials, furniture 
and consumer products in new and recently refurbished buildings, and further compare the 
exposure levels with occupationally exposed subjects.  
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MATCH project was a previous project that took place across the smoking ban in UK (2005-
2007). The project aimed to identify the microenvironments that were the main contributors 
towards the overall exposure to VOCs and PAHs, together with the contribution of ETS 
(Aquilina et al., 2010; Delgado-Saborit et al., 2011; Harrison et al., 2009). Due to the 
differences in the volunteers recruitment and the indoor smoke regulations, the volunteers from 
MATCH project were exposed to higher concentrations of VOCs and PAHs. Furthermore, the 
urine samples that were chosen for the analysis along with the FIXAT ones, were the ones 
belonging to volunteers that had the highest personal exposures (data obtained by MATCH 
database) and had given the consent for further analyses. MATCH project focused on personal 
exposure to VOCs and PAHs, together with biological monitoring of selected biomarkers: 
urinary cotinine and hydroxycotinine for ETS exposure, urinary hydroxy PAHs (1-
hydroxypyrene and 1-hydroxyphenanthrene). The analyses performed along with FIXAT 
samples, added the measurements of unmetabolized VOCs and urinary cotinine for the samples 
that were not analysed for that biomarker.  
When added to the FIXAT samples, the MATCH samples provided a high level exposure group 
that was not classified as occupationally exposed, representing a fourth subgroup with a 
different kind of exposure, characterized mostly by ETS exposure. 
 
III.2 Questionnaires and volunteers 
The suitable volunteers for the study were selected within the recruited subjects using 
questionnaires. A screening questionnaire was produced to assess the suitability of the 
volunteers that applied for the experiments (see template in annex, section X.2). Each volunteer 
was selected through the screening questionnaire, where questions about the household and the 
volunteer’s job were asked. In the screening questionnaire, questions on everyday activities 
and smoking habits were also included to assess the baseline level of exposure of the subject, 
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in order to rule out volunteers that were not suitable for the sampling campaign. Based on the 
answers to the questionnaire, the subjects were first divided in two groups- suitable and not 
suitable for the sampling campaign, and subsequently in one of the three groups as described 
below.  
The subjects of the control group (N=17) were subjects living in a house or work in a 
building that was built or refurbished more than one year before the sampling. Also these 
subjects needed not to have jobs or perform regularly any other activity that would put them in 
contact with VOCs or PAHs in high concentrations. A set of questionnaires was prepared to 
collect information on each subject on all of the possible variables of each sampling event. 
The subjects of the home/workplace exposed group (N=14) were subjects that at the 
time of the sampling were living or working in a building that was built or refurbished recently 
(<1 year before the sampling).  
For groups 1 and 2, subjects were screened based on their occupations exposure to 
VOCs and PAHs in high concentrations. Any potential subjects with jobs/activities that would 
lead to high VOC/PAH exposure were not included in the study group. 
The subjects of the occupationally exposed group (N=14) were recruited among 
workers that are exposed to VOCs and PAHs in their daily work activities. In our case, the 
volunteers were recruited from a highway maintenance company that kindly accepted to 
collaborate and from a landscape gardening company. In both cases the volunteers worked in 
an expected medium-high VOC and PAH concentration environment. The volunteers from the 
highway maintenance company were working on the roadside, while the landscape gardeners 
were using petrol engine powered tools.  
 
The questionnaires were then analysed and the obtained information was used in conjunction 
with the data obtained for the personal exposure.  
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III.3 Personal exposure and sampling 
 
Figure 26: Sampling briefcase, containing a VOC pump (top), connected to a sorbent tube and 
a PAH pump (bottom, black) connected to a quartz filter and the micro aethalometer (bottom, 
blue). 
Personal exposure sampling was performed based on the methodology used in MATCH 
project (Harrison et al., 2009), with minor modifications and the addition of more sampling 
devices. Volunteers were provided with personal air monitors in a suitcase or a backpack, 
depending on the volunteer preferences, consisting of: one VOC sorbent tube and one quartz 
filter connected to a pump for active VOC and PAH sampling and one BC (black carbon) 
microaethalometer. In some cases, we were able to provide an accelerometer to log the physical 
activity of the subject. The equipment was delivered in the morning, before the volunteer left 
the house, so the subject would be able to perform the everyday tasks as normal. The sampling 
lasted 24 hours and the following morning the researchers collected the equipment and a mid-
stream sample of the first morning urine. 
 
At the time of the sampling, the volunteer was provided with a set of questionnaires to 
track their daily activities and dietary information. These included:  
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1. An activity diary (see template in annex, section X.3), where the subject could 
indicate each activity performed and the time when it was performed, with additional 
information on the level of exercise involved.  
2. A travelling questionnaire (see template in annex, section X.8), to track the 
commuting of the subject, in order to track the commuting journeys and the condition of the 
commute (i.e. commuting in traffic, car’s air conditioned on or off, window opened or closed).  
3. A dietary questionnaire (see template in annex, section X.6), where volunteers 
could indicate any food and drink they had during the sampling day. Together with the food, 
they were asked to indicate if they were taking any self-medication or prescribed drugs (see 
template in annex, section X.5). Another section was dedicated to the intake of caffeinated 
drinks. 
Volunteers were also given several forms for ETS exposure (see template in annex, 
section X.7), where they could indicate the time and the details of the exposure in case that 
they were exposed to ETS during the sampling day. 
III.4 Urine sampling and storage 
After the 24h sampling event a urine sample was collected. The subjects were instructed 
to collect a first morning mid-stream urine sample, which was then collected as soon as possible 
by the researchers and placed in refrigerated carrying boxes. If the subject’s house was not 
easily reachable, or the sample was going to be collected far from office hours, the subjects 
were provided with instant ice packs to refrigerate the urine before the collection. The sample 
was then centrifuged for 10min at 10.000G and the supernatant was divided in 2ml aliquots 
and transferred to a -80°C freezer. A similar procedure was used for the urine sampling of both 
MATCH project and Jeddah schoolchildren (Chapter V, Trasande et al., 2015), however, in 
these cases, no centrifugation was performed and the samples were transferred to a -80°C 
freezer after the sampling. In Jeddah schoolchildren, three urine samples were collected, over 
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three days for two sites (nearby an oil refinery and nearby a busy ring road) and over another 
three days in the control site (rural background). Unfortunately, only part of these samples were 
made available (only one of the three days) and the control samples were not made available.  
III.5 Sample analyses and quality control 
All of the samples were checked for quality control by analysing replicates. The 
standard protocol for the analyses included a replicate of a sample and a mid-range standard 
every 5 analysed samples, in order to assess the reproducibility of the analyses and to check 
the conditions of the instrument. When the samples were analysed in external laboratories, an 
adequate number of duplicates were provided, in order to have a double blind control. When 
the difference between duplicate measurements more than 10%, the analyses were not 
considered valid and were repeated. Variations in the mid-range standard would suggest 
problems with the instrument, therefore, when variations in the measurement of the standard 
were detected, the instrument was then stopped and checked for problems.  
Together with the quality control, a calibration curve was performed at the beginning of the 
sample sequence and one was performed at the end. In case of long queues, a third calibration 
curve was included in the middle of the sequence. To avoid carryover contaminations, after 
each calibration curve and mid-range standard, a blank run was performed, which provided 
further information on the condition of the instrument. These quality control steps were used 
for unmetabolized VOCs and airborne VOCs. The external laboratories, however, applied 
similar controls, which were double checked by the double blind replicates. The creatinine 
measurements were performed in multiple laboratories, and the results were found to be 
identical. 
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III.6 VOCs and PAHs analysis from personal exposure measurement 
VOCs and PAHs were sampled using the methodology described previously in section 
III.3 and in MATCH project with some minor modifications (Delgado Saborit et al., 2009; 
Harrison et al., 2009; Delgado-Saborit et al., 2013).  
VOCs from sorbent tubes were analysed using a thermal desorption autosampler, 
connected to a GC-MS. The analytical procedure was kept unchanged from MATCH project, 
however, more compounds were analysed. The compound list, with retention times and 
quantifying ion of each compound is presented in Table 33. 
Table 33: Analysed VOCs, with retention time and quantifier ion. 
Compound Retention time Quantifier ion 
Benzene 7.003 78 
Toluene 9.666 91 
Ethylbenzene 12.412 91 
p-xylene 12.666 91 
m-xylene 12.874 91 
pyridine 14.229 79 
o-xylene 14.276 91 
cumene 13.927 105 
dipentene 14.767 68 
n-propylbenzene 15.054 91 
styrene 16.576 104 
p-isopropyltoluene 16.955 119 
1,3,5-trimethylbenzene 16.154 105 
1,2,4-trimethylbenzene 17.297 105 
1,2,3-trimethylbenzene 18.930 105 
Benzaldehyde 24.095 77 
Octaldehyde 17.532 43 
2-ethyl-1-hexanol 23.048 57 
3-vinylpyridine 27.217 105 
Naphthalene 29.312 128 
 
PAHs measurements were performed using the methodology described by Delgado-
Saborit et al. (2013). 
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FIXAT project personal exposure samples were analysed by Mrs Barbara Macias 
Hernandez, for the following PAHs: naphthalene, acenaphthylene, acenaphthene, fluorene, 
phenanthrene, anthracene, fluoranthene, pyrene, benzo(a)anthracene, chrysene, 
benzo(b)fluoranthene, benzo(k)fluoranthene, benzo(a)pyrene, indeno(1,2,3-cd)pyrene, 
dibenz(a,h)anthracene, benzo(ghi)perylene, coronene, benzo(e)pyrene.  
 
The analysed airborne quinones derived from PAHs were: 1,4-naphthoquinone, 2,6-di-
tert-butyl-1,4-benzoquinone, 2-methyl-1,4-naphthoquinone, acenaphthenequinone, 9,10 
anthraquinone, 2-methyl-anthraquinone, 2,3-dimethyl-anthraquinone, benz(a)anthracene 7,12-
dione, 5,12-naphthacene-quinone. 
 
MATCH project data was obtained for urinary concentrations of: 2-naphthol, 1-
hydroxyfluorene, 2-hydroxyfluorene, 1-hydroxyphenanthrene, 2-hydroxyphenanthrene, 1-
hydroxypyrene.  
 
III.7 Unmetabolized BTEX and naphthalene in urine 
Unmetabolized BTEX (benzene, toluene, ethylbenzene, o- m- p-xylene) and 
naphthalene were analysed in urine. The analyses were carried out at the University of Milan 
thanks to a collaboration with Prof. Silvia Fustinoni. Unmetabolized BTEX concentrations 
were analysed using the Headspace SPME-GC-MS following the procedure described in 
Fustinoni et al. (1999). Briefly, 0.6ml of urine were poured in a 2ml crimp cap vial (GERSTEL 
GmbH & Co.KG, Germany) containing 300mg NaCl and 1µl of internal standard solution 
(Benzene d6, Toluene d8, M-xylene d10, Naphthalene d10 in methanol) was added to the 
sample. The vial was immediately sealed by crimping, using silicone-PTFE septa caps 
(GERSTEL GmbH & Co.KG, Germany). The vials and NaCl were baked overnight at 60°C to 
79 
 
avoid contamination before use. The vials were then loaded on the instrument for the 
Headspace SPME GC-MS analysis. The analysis was performed by using a Gerstel MPS2 
autosampler (GERSTEL GmbH & Co.KG, Germany) equipped on an Agilent 6890 (Agilent 
Technologies, CA, United States). The measurement was performed with a PDMS 100 µm 
SPME fibre, sampling the headspace of the sample for 5 minutes at room temperature, followed 
by desorption for 3 minutes by inserting the fibre in the chromatographic injection port. GC-
MS separation was performed using helium as carrier gas at a constant flowrate of 1ml/min, 
the injector temperature was held at 250°C and the GC oven temperature was held for 3 minutes 
at 40°C, ramped to 70°C at 3°C/min, held for 1 minute and then ramped up to 250°C at 
20°C/min. The final temperature was held for 5 minutes. Signals from the ions were acquired 
using the single ion monitoring mode (SIM), m/z ratios acquired were: 78 for benzene, 84 for 
benzene d6, 91 for toluene, 98 for toluene d8, 106 for ethylbenzene, M+P_xylene, 115 for M-
xylene d10, o-xylene, 128 for naphthalene and 136 for naphthalene d10. Analyses were 
performed using Electron Impact (EI) ionization with the ion source kept at 250°C using an 
energy of 70eV.  The column used was a DB1 (60m, 0.25mm i.d., 1µm film thickness) J&W 
scientific (Agilent Technologies, CA, United States). According to the methodology described, 
LOQs were of 15 ng/L for Benzene, Toluene, O-, M-, P-Xylene and 8 ng/L for Ethylbenzene 
(Fustinoni et al. 2010; Fustinoni et al. 2010). Quality control points and samples replicates were 
inserted in the analytical sequence every 10 samples to validate the readings. All the data 
obtained was then normalized against creatinine concentration. 
III.8 8-oxo-dG measurement 
8-oxo-dG has been measured in an external laboratory (CSMU, Taiwan) using LC-MS 
methodology (Lam et al., 2012): briefly: 0.5ml of all urine samples were processed by SPE 
extraction after being spiked with 3pMol of internal standard (8-[15N5]oxo-dG). The samples 
were then diluted 1:1 with deionized water and spun at 16,000G for 1 minute at room 
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temperature to precipitate impurities. SPE cartridges Env+Isolute (1ml, 50mg, Biotage, 
Uppsala, Sweden) were then preconditioned with 1ml methanol and equilibrated with 1ml 
deionized water. Samples were loaded on the cartridges and the flow was kept at approximate 
1ml/min. The cartridges were then flushed twice with 1ml 2% methanol to wash the 
interferences. The cartridges were vacuumed dry to prevent any water to contaminate the 
eluate. The elution was performed with 20% (v/v) acetonitrile in methanol and then the eluate 
was dried under nitrogen flow and stored at -20°C until analysis, which was performed by LC-
MS. All the data obtained was normalized against creatinine concentration. 
III.9 Creatinine concentration measurement 
Creatinine concentration was calculated with Jaffe’s colorimetric method (Kroll et al., 1986). 
III.10 Urinary 1-hydroxypyrene and hydroxyphenanthrenes measurement 
Urinary 1-hydroxypyrene and 1- 2- 3- 4- 9-hydroxyphenanthrenes were measured in 
external laboratories, MATCH samples were analysed by the UCSF (USA) by LC-MS/MS 
(Aquilina et al., 2010), while Jeddah schoolchildren samples were analysed by the UoE 
(Germany) by fluorescence liquid chromatography following the procedure described by 
Hemat et al. (2012).  
III.11 Urinary cotinine measurement 
Urinary cotinine was measured by LC-MS/MS analysis, with the methodology described by 
Fustinoni et al. (2013). Urine was spiked with an internal standard (cotinine d3) and diluted 1:2 
with HPLC grade water and injected in a LC-MS/MS. The separation was performed by a C-
18 reverse phase column, and the precursor ion was 177 m/z (180 m/z for the internal standard), 
while the quantitation ion was 80 m/z. As described in the paper, the LOD was 0.1 µg/L for 
urinary cotinine, but in our case we used different cut off values for the different groups due to 
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the distribution of the measurements (urinary cotinine <1µg/L for non-ETS exposed, <50µg/L 
for ETS exposed, >50µg/L for active smokers).  
III.12 Peak integration 
Chromatograms from GC-MS were analysed using Agilent Chem Station. The 
responses obtained by peak integration were inserted in a spreadsheet that was then analysed 
with Microsoft Excel 2013. All the responses refer to the area of the integrated peak. 
III.13 Data analysis 
The obtained data was analysed with SPSS Statistics V.21 and Microsoft Excel 2013.  
III.14 Subject recruitment and group assignment 
Subjects’ urine analysed in this study included urine samples of 41 volunteers from MATCH 
(measurement and modelling of exposure to air toxics concentrations for health effects studies) 
project (Delgado Saborit et al., 2009) and  44 from FIXAT project. Further 24 samples, marked 
as IM (independent measurements), were obtained from a pilot study on indoor and outdoor 
measurement, and some independent measurement campaigns in London and Birmingham 
(UK) with different routes and modes of transport. Due to the high variability of the exposure 
and subjects’ behaviour, this group was not included in the statistical analyses. FIXAT group 
was further divided in three subgroups: a control group, a group formed of volunteers living or 
working in a new or recently refurbished building, and an occupationally exposed volunteer 
group. The three groups were composed as described in section III.1 based on the information 
gathered from the screening questionnaires. The volunteers living or working in recently 
built/refurbished buildings received two sampling visits, one at the beginning of the project, 
and one 1 year later, in order to measure any difference on the exposure arising from building 
materials and any other material that was used in the building or refurbishment of the house or 
workplace.  The three main groups were divided by exposure level: the exposure levels were 
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firstly estimated using screening questionnaires in FIXAT project, and then measured by 
personal exposure sampling with sorbent tubes. In MATCH group the samples were chosen 
within the higher VOC exposure, which was measured by the analysis of the personal exposure 
data in the same study (data available from Saborit et al. 2009). The IM group was a pilot study 
involving different subjects that were not screened before, but contained several smokers, 
which placed the expected exposure levels variable between low and high. MATCH samples 
were collected between 2005 and 2007, while the sampling of the other groups was performed 
between 2011 and 2014. In the FIXAT project the control volunteers were selected within the 
general population using a screening questionnaire asking for smoking habits, exposure to 
environmental tobacco smoke (ETS), occupation, commuting habits and a description of the 
house. All of the subjects that showed a possible high level exposure behaviour or storing 
solvents/fuels in the house were evaluated and in case of effective exposure, were excluded 
from the control group. The second group from FIXAT project (exposed subgroup) is formed 
of subjects with the same requisites as the control group, but living in a recently built or 
refurbished house (<1 year). The occupationally exposed group volunteers were selected within 
workers that use petrol powered tools or work in the traffic, as for that reason they are exposed 
to higher level of VOCs compared to the general population. The subjects from the pilot study 
were not screened with the questionnaires, so the group included general population, subjects 
exposed to ETS, commuters on busy roads. The subjects from MATCH samples were chosen 
within the higher VOC concentrations in the personal exposure within the sample pool of the 
study. 
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III.15 Exposure System 
 
Figure 27: Exploded representation of the exposure vessel with all the part of the assembly. 
 
 
Figure 28: Cross section of the assembled exposure vessel, arrows indicate the gas flow.  In 
use, the two vessels to the right are also fitted with the gas delivery system and permeable 
insert. 
An exposure vessel was custom designed based on the CULTEXs system (Vitrocell, Germany) 
described by Pariselli et al. (2009). The system consisted of three wells milled into a 
polymethyl methacrylate (PMMA) block, suitable to fit a permeable 6-well insert (Corning 
Inc., NL) into each one, and 6ml of media under the inserts (Figure 27, Figure 28 and Figure 
29). The capacity to circulate cell culture media was included by adding two 5mm holes at the 
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bottom and on the side of each well. These could be capped if the circulation of the media was 
not needed. 
 
Figure 29: Detailed cross-section of the gas-cell interface, with the level of the cell culture 
media indicated in yellow. 
 
 
Figure 30: Assembled exposure vessel in working order, hosted inside the GC oven. 
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Figure 31: Exposure vessel assembly. 1: GC oven; 2: heater/bubbler; 3: MFC controller and 
MFCs; 4: Computer controlling MFCs and gas flows. 
 
The lid was constructed with threaded holes to fit gas delivery inserts, and the wells were sealed 
using nitrile O-rings. The gas delivery tubes were designed with a trumpet shape in order to 
reduce the linear velocity of the delivered gas to reduce mechanical stress to the cells, and to 
allow maximum mixing and even delivery of the gas along each insert (Figure 28). Each tube 
was threaded externally to screw into the lid allowing fine adjustments of the distance between 
the nozzle and the cell layer. The tubes were provided with holes to allow the delivered gas to 
flow out to the exhaust, providing a continuous flow. The vessel was kept in a gas 
chromatograph (GC) oven at 37°C during the exposure to maintain the cells at an optimal 
temperature. The vessel was kept in an incubator at 37°C between the exposures. The gas 
delivery to the cells was regulated by mass flow controllers (MFCs) (Brooks Instrument, NL). 
One 500 sccm (standard cubic centimeters/minute) MFC was used to regulate the synthetic air 
(BOC gases, UK) flow, and a 100 sccm MFC was used to regulate the benzene flow (1ppm 
balanced in nitrogen, BOC gases, UK). A total flow rate of 30 ml/min was used, split between 
the three wells, with a theoretical flow rate of 10 ml/min in each well.  
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The synthetic air passed through a bubbler heated at 37°C to humidify the air to prevent 
desiccation of cells, and the pollutant delivery (benzene 1ppm balanced in nitrogen, BOC, UK) 
was regulated by a second MFC. The two gases were then mixed in a glass mixing chamber 
hosted inside the GC oven, filtered through a 0.45µm filter and delivered to the cells. The 
system worked with positive pressure of the exposure gases to ensure sterility.  
 
III.16 Cell Culture 
A549, epithelial lung carcinoma cells (HPA, 86012804) have been previously used as a model 
for lung epithelium exposure (Pariselli et al., 2009; Saint-Georges et al., 2008; Shang et al., 
2013). Furthermore, this cell line has been reported to express CYP2E1, the cytochrome P450 
involved in the metabolism of benzene (Foster et al., 1998; Medinsky et al., 1994; Snyder and 
Hedli, 1996; Sørensen et al., 2003a; Mögel et al., 2011), and therefore represents a suitable 
model of study for benzene and VOC toxicology.  
 
A549 cells were cultured in 6-well plates using RPMI 1640 medium (2.5 ml), containing 25mM 
HEPES and NaHCO3 to maintain the pH constant during the exposure period (CO2 was not 
contained in the synthetic air). The medium was further supplemented with glutamine (2mM), 
penicillin (100 U/ml), streptomycin (100 µg/ml), amphotericin B (0.25 µg/ml) and 10% foetal 
bovine serum (FBS). Cells were passaged regularly using a standard trypsin-EDTA protocol 
into 6-well plates once they reached approximately 90% confluence. The standard protocol for 
trypsinization consisted in washing the cells with phosphate buffer solution (PBS), followed 
by a 5 minute incubation at 37C in 0.5 ml per well of 0.25% trypsin-EDTA solution. After the 
trypsin digested the adhesion proteins, the cells were recovered by pipetting, diluted and seeded 
in new plates. For the exposure experiments, 0.3  106 cells were seeded into 1.5 ml RPMI 
1640 on the collagen coated Transwell inserts with pores of 1µm (Corning, NL) and 2 to 2.5 
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ml RPMI 1640 were added at the bottom of the well, and the plate was placed in an incubator. 
Once the cells reached 90% confluence (24–36 hours) they were serum starved for 12 hours by 
exchanging the medium containing FBS with FBS free medium, to synchronize the cell cycle 
prior exposure (Campisi et al., 1984). After the exposure, the cells were washed with PBS for 
5 minutes before trypsinization. 
 
III.17 Synthetic Air and Benzene Exposure 
For each exposure experiment, 3 Transwell inserts cells from the same 6-well plate were 
exposed for 2 hours to synthetic air (controls). Afterwards, the exposure vessel was then rinsed, 
washed with 70% ethanol and allowed to dry. Subsequently, the remaining 3 Transwell inserts 
were exposed to one of three different concentrations of benzene (0.03 ppm; 0.1 ppm; 0.3 ppm), 
which were reported to have cytotoxic effects (Pariselli et al., 2009). A first exposure 
experiment was performed with 3 technical replicates simultaneously exposed to each benzene 
concentration accompanied by an air-exposed control. The obtained results were then 
confirmed by an independent exposure experiment replicate. The low (0.03 ppm) and high (0.3 
ppm) benzene concentrations were further tested by a third independent exposure experiment 
replicate.  
Each exposure experiment was accompanied by a set of incubator controls, which consisted in 
a 6-well plate left for 2 hours in the incubator, where 3 wells contained cells with media 
(Incubator Media), and 3 wells contained cells with the media removed (Incubator Dry). The 
removal of the media from the 3 wells was considered the start point of the 2 hours incubation 
of the incubator controls. 
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III.18 ROS Assay 
Reactive oxygen species were assessed by measuring the oxidation of the redox sensitive dye 
2’,7’-dichlorodihydrofluorescein diacetate (H2DCF-DA, Sigma-Aldrich, UK). Following 
hydrolysis by intracellular esterases, the resultant H2DCF is unable to leave the cell and is then 
oxidised by ROS, to form the fluorescent DCF (dichlorofluorescein) molecule. The level of 
fluorescence is proportional to the degree of oxidative stress in the cells. Briefly, the cells were 
preloaded with H2DCF-DA dissolved in the growth medium (10 µM, final concentration) for 
30 minutes. After the loading of the cells, both in the exposed samples and in the incubator 
controls a first fluorescence reading was taken and marked as pre-exposure. After the treatment 
(air/benzene exposure or 2 hours in the incubator), a second fluorescence reading was taken, 
marked as post-exposure.  
DCF fluorescence was quantified before and after exposure using a Tecan Ifinite F200 pro plate 
reader (excitation wavelength: 485 nm, emission wavelength: 535 nm) using I-control V.1.9 
software. To minimise the exposure of the cells to air, quantification of the fluorescence before 
the exposure was performed without removing the apical medium from the inserts. Three 
controls and three exposed samples were analysed. Cells that had not been loaded with H2DCF-
DA were used as a negative control and to take into account background levels of fluorescence. 
III.19 Comet Assay 
DNA strand breaks were assessed by the alkaline comet assay (Singh et al., 1988). Briefly, 
after trypsinization, the cells were re-suspended in 150 µl PBS. 15 µl of the suspension were 
added to 150 µl of 0.5% (v/v) warm low melting point agarose (LMPA) and the cell suspension 
was added to a microscope slide that had been previously coated with 0.5% (v/v) normal 
melting point agarose (NMPA). After a coverslip was added, the slides were left on an ice-cold 
tray to allow the agarose to solidify. Once the agarose had solidified, the coverslip was removed 
and the slides were incubated for 1 hour at 4 C in lysis buffer (2.5 M NaCl, 0.1 M Na2EDTA, 
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10 mM Tris base, 1% sodium N-lauryl sarcosinate, 10% DMSO and 1% Triton X-100, pH 10).  
Next, the slides were then transferred to a horizontal electrophoresis tank containing 
electrophoresis buffer (NaOH 300 mM, EDTA 1 mM, pH 13.0) and DNA allowed to unwind 
for 20 minutes. DNA was then subjected to electrophoresis (32 V, 0.8 V/cm) for 20 minutes. 
The slides after the electrophoresis were transferred to the neutralization buffer (Tris HCl 0.4 
M, pH 7.5) and washed 3 times for 5 minutes, followed by 1 wash in H2O for 5 minutes. Finally, 
slides were stained with 50 µl of Sybr gold (Invitrogen, 10 solution in neutralisation buffer, 
UK). Slides were examined at 320 magnification using a fluorescence microscope (Zeiss 
axiovert 10, Zeiss, UK) fitted with a 515–560 nm excitation filter and a barrier filter of 590 
nm. A USB digital camera (Merlin, Allied Vision Technologies, UK) received the images, 
which were analysed using a personal computer-based image analysis system Comet Assay IV 
(Perceptive instruments, UK). The software analysed each cell by assigning a proportion 
between the % of DNA in the tail and the % of DNA in the head. Other variables can also be 
analysed, such as the tail migration, which is the length of the tail and the tail moment, which 
is a product of both the tail migration and the % DNA in the tail. Due to the software limitations, 
it was not possible to include heavily damaged cells (“hedgehogs”) in the count, as the nuclei 
and the whole cells would not be recognized by the software, leading to wrong results. 
However, they were taken in account by counting a standard number of cells and calculating 
the percentage of hedgehogs (therefore unquantifiable cells) over the total number of counted 
cells. 
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Figure 32: Comet examples.  
A: control cells exposed to synthetic air for 2h;  
B: Cells exposed to 0.1ppm benzene for 2h. 
B shows higher tail intensities, which are indicative of DNA damage, a “hedgehog” is visible 
at the bottom left corner of B. 
 
A random sample of at least 300 nuclei on each slide was assessed and categorised into 
quantifiable or not quantifiable. Unquantifiable nuclei consisted largely of “hedgehogs”, 
indicative of nuclei where most of the DNA was in the tail and probably represent nuclei from 
apoptotic and necrotic cells. A minimum of 60 nuclei were quantified per slide (N = 64 – 200). 
Percent tail DNA (TD %) was chosen to assess the extent of DNA damage in quantifiable cells, 
as this has been shown to suffer much less from inter-run variation than other Comet parameters 
because it is largely independent of electrophoresis voltage and run time (Olive and Durand, 
2005).   
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IV. Assessment of VOC and PAH exposure in different population groups in 
Birmingham, UK 
This chapter discusses urinary VOC and PAH concentrations across high- and low-exposure 
subjects, and associated oxidative stress drivers. The aim of the study was to assess the impact 
and contribution of various behaviours and sources of pollutants to the human exposure, 
assessing early biomarkers of effect.  
Some of the data used in the analysis was generated as part of an HEI project (Harrison et al., 
2009). 
 
IV.1 Study population 
The participating subjects were assigned to the different groups following the rules 
described in the Methodologies, section III.14 and III.1. Table 34 contains a summary of the 
demographic information gathered from the questionnaires. After analysing the data available 
from the questionnaires, it was observed that 38% of the MATCH volunteers had a garage 
attached to the house, the majority of which had the garage directly accessible from the house. 
12.2% of MATCH volunteers declared to be exposed to ETS at home and 7.3% in the 
workplace. In the FIXAT project, 14.9% of the subjects declared to be exposed to ETS at home 
and 17.6% in the workplace. The samples from FIXAT and MATCH projects were analysed 
for urinary cotinine following the methodology described by Fustinoni et al. (2013) to estimate 
the effective ETS exposure and smoking habits of the subjects. We used different cut off 
concentration values from the ones reported in Fustinoni’s reference paper to divide smokers 
from non-ETS exposed and ETS exposed subjects (urinary cotinine <1µg/L for non-ETS 
exposed, <50µg/L for ETS exposed, >50µg/L for active smokers). Analysing the results of the 
test, it was clear that some subjects, although declaring to be non-smokers, were actively 
smoking (2.8% of subjects in FIXAT project). Interestingly, there was a difference between 
the subjects that declared to be exposed to ETS, and the outcome of the cotinine test: 14.9% of 
the subjects declared to be exposed to ETS at home, and 17.6% to be exposed to ETS in the 
workplace, while only 11.1% of the total sample pool was found positive for ETS. Only 6.3% 
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of the control subjects were found positive for ETS exposure, and no subject from the 
living/working in a recently built/refurbished building were exposed to ETS according to the 
urinary cotinine analysis.  
The main age group is between 26 and 35 years old for both FIXAT and MATCH 
subsets, however, the population is not evenly distributed along the subgroups as showed in 
Table 34. Genders are evenly represented in the total sample pool but the occupationally 
exposed subgroup was formed only by male subjects, which caused an uneven distribution 
among the subgroups. 2 test showed that the population of the subgroups was not evenly 
distributed for many of the variables such as average annual mileage and age range. The most 
important differences in distribution are the ones that are linked to higher exposure to VOCs, 
such as the use of a motor vehicle for work (85.7% of occupationally exposed) and average 
yearly mileage, which is generally higher on occupationally exposed subjects. 
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Table 34: Summary of demographic information for FIXAT and MATCH project. 
 Project name 
2 
P value 
(FIXAT) 
FIXAT (%) MATCH 
(%) 
Group Group 
Control 
(N=16) 
Living/working 
in a new or 
refurbished 
building (N=15)
Occupationally 
exposed 
(N=14) 
Total
(N=45)
MATCH 
project 
(N=41) 
Gender 
Male 33.3% 29.4% 100.0% 52.2% 34.1% 
<0.001 
Female 66.7% 70.6% 0.0% 47.8% 65.9% 
Classified as a 
smoker (urinary 
cotinine 
measurement) 
Non-ETS 
exposed 
(Cotinine < 1 µg/L) 
93.8% 100.0% 67.9% 86.1% 12.2% 
0.010 
ETS exposed 
(Cotinine < 50 µg/L) 6.3% 0.0% 25.0% 11.1% 34.1% 
Smoker  
(Cotinine > 50 µg/L) 0.0% 0.0% 7.1% 2.8% 2.4% 
Missing data 0.0% 0.0% 0.0% 0.0% 51.2% 
Classified as a 
smoker (urinary 
cotinine 
measurement) 
ETS threshold 
10µg/L 
Non-ETS 
exposed  
(Cotinine < 10 µg/L) 
100% 100% 85.7% 94.6% 39% 
0.136 
ETS exposed  
(Cotinine < 50 µg/L) 0% 0% 7.1% 2.7% 7.3% 
Smoker 
(Cotinine < 50 µg/L)  0% 7.1% 2.7% 2.4% 
Missing data 0% 0% 0% 0% 51.2% 
ETS at home 
No 81.3% 94.1% 78.6% 85.1% 87.8% 
0.417 
Yes 18.8% 5.9% 21.4% 14.9% 12.2% 
ETS at work 
N/A 0.0% 43.3% 50.0% 36.5% 0.0% 
<0.001 No 87.5% 53.3% 14.3% 45.9% 92.7% 
Yes 12.5% 3.3% 35.7% 17.6% 7.3% 
Age range 
18-25 20.0% 17.6% 50.0% 28.3% 7.3% 
0.003 
26-35 80.0% 76.5% 14.3% 58.7% 26.8% 
36-45 0.0% 5.9% 0.0% 2.2% 19.5% 
46-55 0.0% 0.0% 21.4% 6.5% 19.5% 
56-65 0.0% 0.0% 14.3% 4.3% 19.5% 
>65 0.0% 0.0% 0.0% 0.0% 7.3% 
Home-work 
commute 
N/A 13.3% 11.8% 0.0% 8.7% 22.0% 
<0.001 
<5 Miles 86.7% 58.8% 14.3% 54.3% 29.3% 
5-10 Miles 0.0% 11.8% 71.4% 26.1% 34.1% 
10-15 Miles 0.0% 0.0% 14.3% 4.3% 7.3% 
15-20 Miles 0.0% 17.6% 0.0% 6.5% 2.4% 
20-30 Miles 0.0% 0.0% 0.0% 0.0% 4.9% 
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Commute 
method 
N/A 13.3% 11.8% 0.0% 8.7% 24.4% 
0.010 
Car 6.7% 35.3% 78.6% 39.1% 43.9% 
Train 6.7% 17.6% 0.0% 8.7% 4.9% 
Bus 26.7% 17.6% 7.1% 17.4% 7.3% 
Cycle 46.7% 17.6% 7.1% 23.9% 9.8% 
Walk 0.0% 0.0% 7.1% 2.2% 9.8% 
Travel time 
N/A 13.3% 11.8% 0.0% 8.7% 22.0% 
0.258 
<5 minutes 0.0% 0.0% 7.1% 2.2% 2.4% 
5-15 minutes 46.7% 23.5% 14.3% 28.3% 22.0% 
15-30 
minutes 
33.3% 41.2% 64.3% 45.7% 36.6% 
30-45 
minutes 
6.7% 23.5% 14.3% 15.2% 9.8% 
>60 minutes 0.0% 0.0% 0.0% 0.0% 7.3% 
Vehicle used 
for work 
No 93.3% 82.4% 14.3% 67.4% 75.6% 
<0.001 
Yes 6.7% 17.6% 85.7% 32.6% 24.4% 
Time spent in 
work vehicle 
N/A 93.3% 82.4% 14.3% 65.2% 73.2% 
<0.001 
<30 minutes 0.0% 17.6% 0.0% 6.5% 9.8% 
30-60 
minutes 
6.7% 0.0% 21.4% 8.7% 9.8% 
1-3 hours 0.0% 0.0% 50.0% 15.2% 0.0% 
More than 3 
hours 
0.0% 0.0% 14.3% 4.3% 7.3% 
Average yearly 
mileage 
N/A 53.8% 47.1% 0.0% 34.1% 14.6% 
0.003 
<5,000 miles 38.5% 35.3% 21.4% 31.8% 29.3% 
5,000-15,000 
miles 
7.7% 11.8% 50.0% 22.7% 24.4% 
15,000-
30,000 miles 
0.0% 5.9% 28.6% 11.4% 24.4% 
>30,000 miles 0.0% 0.0% 0.0% 0.0% 7.3% 
Garage 
attached to the 
house 
No 93.8% 76.5% 64.3% 78.7% 61.0% 
0.139 
Yes 
6.3% 23.5% 35.7% 21.3% 39.0% 
Garage 
accessible from 
the house 
No 93.8% 100.0% 64.3% 87.2% 68.3% 
0.008 
Yes 
6.3% 0.0% 35.7% 12.8% 31.7% 
Number of 
people living in 
the house 
1 12.5% 5.9% 7.1% 8.5% 12.2% 
0.970 2-3 62.5% 64.7% 64.3% 63.8% 51.2% 
4 or more 25.0% 29.4% 28.6% 27.7% 36.6% 
 
 
95 
 
IV.2 Urinary BTEX, airborne VOCs and 8-oxo-dG concentration comparisons between 
FIXAT and MATCH populations 
Unmetabolized BTEX, cotinine and 8-oxo-dG were measured in the urine samples 
using the methodologies described in sections III.7, III.8 and III.10 (Methodologies). Airborne 
VOCs from personal exposure were measured following the methodology described in III.5. A 
summary of the results is presented in Table 35. In order to avoid statistical problems due to 
the skewness of the data, the medians were used for the comparisons, which were performed 
with nonparametric tests. The median of urinary benzene did not show major differences 
between the various groups, except for the occupationally exposed subgroup. Although the 
MATCH samples were chosen within the higher exposure samples, the urinary benzene 
concentration appear to be the lowest of all the subgroups, even though the concentration range 
is the highest. It is important to remember that the MATCH samples were collected between 
2005 and 2007, and they were not collected with the purpose of HS-SPMA-GC-MS analysis. 
This might have caused part of the VOCs to evaporate from the urine before the analyses. This 
loss affects mostly the compounds with the lowest relative concentrations, as they are closer to 
the LOD. When the same group is analysed for toluene, the expected higher concentration is 
reflected by the observed median.  
Toluene is generally more abundant than benzene, therefore it is possible to measure it also in 
samples that have not been suitably stored for headspace analyses.  
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Table 35: Summary of urinary BTEX, cotinine and 8-oxo-dG with the available P.E. data. 
 Group 
Control Living/working in a new or recently refurbished 
building 
Occupationally exposed MATCH project high 
exposed subjects 
Sampling event Sampling event Sampling event Sampling event 
Single sampling First sampling Second sampling First sampling Second sampling Single sampling 
Median Minimum Maximum Median Minimum Maximum Median Minimum Maximum Median Minimum Maximum Median Minimum Maximum Median Minimum Maximum
Cotinine (µg/L) .14 <LOD 1.19 .13 <LOD .45 .18 <LOD .45 .27 <LOD 346.50 .27 <LOD 1125.29 3.46 <LOD 120.91
8-oxo-dG (nMol/M creatinine) 1.29 .52 2.34 1.25 .72 2.36 1.14 .90 2.16 1.15 .51 2.24 1.09 .80 2.04 1.28 .70 2.41
Urinary Benzene (ng/L) 75 58 121 69 51 98 69 53 134 89 60 271 95 61 282 55 15 306
Urinary Toluene (ng/L) 134 73 731 139 69 977 141 72 838 174 91 428 156 98 497 444 77 7003
Urinary Ethylbenzene (ng/L) 19 15 24 24 16 49 22 17 40 20 15 37 28 <LOD 67 62 18 465
½ Urinary m+p-xylene (ng/L) 34 30 42 36 30 52 36 30 41 35 32 52 44 31 87 92 15 228
Urinary o-xylene (ng/L) 27 22 118 35 21 84 33 23 82 36 23 50 36 26 83 35 <LOD 210
Urinary Naphthalene (ng/L) 46 29 402 44 27 98 45 30 125 43 26 56 42 26 57 28 <LOD 134
P.E. benzene (µg/m^3) 1.36 .52 2.70 1.54 .61 5.84 1.64 .65 1.99 5.95 .58 27.60 N/A N/A N/A 3.48 1.30 30.25
P.E. toluene (µg/m^3) 8.04 1.82 692.03 20.15 7.00 159.48 12.99 7.64 38.33 19.53 4.25 437.79 N/A N/A N/A 14.80 2.47 312.82
P.E. ethylbenzene (µg/m^3) 1.17 .31 3.71 1.61 .40 2.49 4.99 .28 6.35 7.03 1.39 247.54 N/A N/A N/A 2.24 .44 59.99
P.E. p-xylene (µg/m^3) .92 .24 1.40 1.02 .30 2.25 4.29 .19 5.60 N/A N/A N/A N/A N/A N/A 1.88 .05 74.70
P.E. mxylene (µg/m^3) 2.38 .63 4.36 2.68 .75 5.15 10.00 .44 14.82 N/A N/A N/A N/A N/A N/A 5.14 .82 144.22
P.E. o-xylene (µg/m^3) 1.49 .37 3.22 1.70 .41 3.10 5.60 .25 9.55 N/A N/A N/A N/A N/A N/A 2.65 .13 75.78
P.E. naphthalene (µg/m^3) .76 .36 25.51 1.62 .08 47.58 1.31 .12 2.82 N/A N/A N/A N/A N/A N/A .72 .06 14.21
P.E. pyridine (µg/m^3) .37 .16 3.55 .56 .13 5.42 .54 .38 2.11 .07 .06 .09 N/A N/A N/A .18 .03 2.23
P.E. octaldehyde (µg/m^3) 6.93 2.59 10.81 5.58 1.71 27.86 9.12 1.82 16.38 N/A N/A N/A N/A N/A N/A N/A N/A N/A
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The measured level of benzene is generally low in all of the personal exposure 
measurements, well under the 8 hours tolerated concentration level for occupational exposure 
to benzene, which is 1 ppm (3.195 mg/m³) (HSE, 2011).  
Toluene is the compound that is found in the higher concentrations, due to the various 
sources of exposure. In this case, although the median for both airborne and urinary toluene is 
coherent with the expected exposure (control < living/working in recently built or refurbished 
building < occupationally exposed), the higher concentrations (range) of airborne toluene are 
found in the control group, most likely due to certain activities of some subjects. Interestingly, 
urinary ethylbenzene appears to be much higher in the occupationally exposed subjects than in 
the other groups, which could indicate a source of ethylbenzene that is typical of some activities 
of the occupationally exposed group. 
The urinary BTEX show a similar pattern, although the differences in the concentration 
between the different groups are not as high as the ones observed in the personal exposure. 
Benzene shows a remarkable difference between the occupationally exposed group and the 
others, however the most relevant difference between the groups is represented by the toluene 
again. Interestingly, urinary ethylbenzene does not show a pattern that is comparable to the 
personal exposure data in the occupationally exposed subjects.  
When the first and the second sampling were compared (first sampling at the end of the 
working week and second sampling at the beginning of the working week), in some cases it 
was observed an increase of some of the urinary BTEX. This finding suggests that some of the 
subjects’ activities of the weekend led the subjects to be exposed to some sources of the 
analysed compounds. Unfortunately, it was not possible to measure the personal exposure 
during the day off for the occupationally exposed subjects. In general, it was found that urinary 
BTEX concentrations are consistent with previously published data from Fustinoni’s research 
group where the analyses were performed with the same methodology (Fustinoni et al., 2010).  
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Together with the urinary BTEX, urinary 8-oxo-dG was also analysed as a biomarker 
of DNA damage due to oxidative stress. Urinary 8-oxo-dG median and range were found to be 
very similar between all of the groups, no significant difference could be identified for any of 
the groups. In previous papers, it was reported that in general, the variation range of 8-oxo-dG 
is generally small, even for populations that are different, therefore it is plausible to expect a 
small variation in our sample subset which is formed mostly of general population (Evans et 
al., 2010).  
The median urinary concentration of each compound in each subgroup was compared 
with the median concentrations of the other subgroups by nonparametric independent samples 
median test in SPSS, and the distributions were analysed with Kruskal-Wallis (KW) test and 
Kolmogorov-Smirnov (KS) test. Kruskal-Wallis test is a nonparametric equivalent of the 
ANOVA, however, it is used to compare the distributions of the cases, where the null 
hypothesis is that all the cases of the groups have the same type of distribution (Kruskal and 
Wallis, 1952). Kolmogorov-Smirnov (KS) test is used instead of KW when distributions of 
only two groups are compared (Kolmogorov–Smirnov Test, 2008).  
No significant difference was observed in the distribution and in the median concentration of 
any urinary compound between the two sampling events in the living/working in a recently 
built/refurbished building group. Only in one case (urinary m+p-xylene) the null hypothesis 
(same distribution in all the groups) was rejected in the occupationally exposed group 
(p=0.043).  
The same analysis was performed also comparing the medians and the distributions 
between the different subgroups, divided also by the sampling event when possible. The results 
evidenced a significant difference in the medians (p=0.006) and the distribution (KW p<0.001) 
of urinary cotinine within the groups. This finding could be explained by the presence of two 
active smokers in the occupationally exposed group, but also from the ETS exposure that is 
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typical in some groups (Table 34). As shown in Table 34, 100% of the subjects living/working 
in a recently built/refurbished building, are classified as non-ETS exposed, and only a small 
fraction of the controls is classified as ETS exposed. In MATCH project and in the 
occupationally exposed group, the distribution of the subjects classified with the same 
parameters, is much different, showing a significant change in the distribution when compared 
to the control and living/working in new/recently refurbished buildings. Since these 
classifications were based on the urinary cotinine levels, this difference in the distribution of 
the subjects are reflected in the analyses when the groups are compared.  The null hypothesis 
for 8-oxo-dG median and distribution was retained (p=0.473 for the median), showing that the 
changes in the urinary concentration of 8-oxo-dG between the subgroups are not statistically 
significant. On the other hand, the medians of benzene (p=0.002), toluene (p<0.001) and 
ethylbenzene (p<0.001) showed significant differences between the groups together with their 
distributions (KW p<0.001 for all of the distributions). As mentioned before, these differences 
could be arising from the presence of ETS exposed subjects and some active smokers, as 
suggested from the similar results of the urinary cotinine. In order to investigate this possibility, 
the groups were further divided in smokers, ETS exposed and non-ETS exposed, and the 
analysis was repeated. For the non-ETS exposed subjects, the only compound that showed a 
statistically significant difference in the median, was ethylbenzene (p=0.016), while the 
distribution of benzene (KW p=0.021), toluene (KW p=0.033), ethylbenzene (KW p<0.001) 
and m+p-xylene (KW p=0.024) showed a statistically significant difference. For the ETS 
exposed subgroup, the medians of benzene (p=0.028), toluene (p=0.028) and ethylbenzene 
(p=0.002) showed a statistically significant difference.  Similarly, the distribution of benzene 
(p=0.022), toluene (KW p=0.009) and ethylbenzene (KW p=0.002) were not the same in all 
the groups. The smokers’ subgroup did not show any significant difference, possibly due to the 
high levels of urinary VOCs arising from smoking, but it could be also due to the small number 
100 
 
of subjects. In Table 36 are reported the median concentrations of the urinary VOCs, together 
with the observed statistically significant differences between the medians and the distributions 
of each category. Most of the highest values are recorded in the MATCH group, except for the 
urinary benzene for the ETS exposed subjects, which is found higher in the control group. 
 
Table 36: Overview of the median urinary BTEX concentrations for each group, classified 
based on the ETS exposure. 
(- indicates that none of the subjects were classified in that category, * indicates a statistically 
significant difference between the medians of the groups of the same category, + indicates a 
statistically significant difference between the distributions in the groups of the same category) 
 
Group 
Control 
Living/working in a new or 
recently refurbished building Occupationally exposed 
MATCH project high exposed 
subjects 
Classified as a smoker Classified as a smoker Classified as a smoker Classified as a smoker 
Non-
ETS 
exposed 
ETS 
exposed Smoker 
Non-
ETS 
exposed
ETS 
expose
d Smoker
Non-
ETS 
exposed
ETS 
expose
d Smoker
Non-
ETS 
exposed 
ETS 
expose
d Smoker
Median Median Median Median Median Median Median Median Median Median Median Median 
Urinary 
Benzene 
(ng/L) 
73+ 121+ - 69+ - - 89+ 103*+ 179 58+ 67*+ 65 
Urinary 
Toluene 
(ng/L) 
144+ 106*+ - 133+ - - 158+ 166*+ 190 499+ 530*+ 583 
Urinary 
Ethylbenzen
e (ng/L)  
19*+ 20*+ - 22*+ - - 27*+ 17*+ 36 61*+ 67*+ 247 
Urinary 
M+P-xylene 
(ng/L) 
34+ 33 - 36+ - - 41+ 33 47 83+ 179 118 
Urinary O-
xylene (ng/L) 27 34 - 33 - - 37 29 63 32 85 80 
Urinary 
Naphthalene 
(ng/L) 
46 54 - 45 - - 42 39 50 93 24 28 
 
 
These findings suggest that the smoking habits, together with the ETS exposure might 
represent a confounding factor for the analyses, as one of the main sources of the urinary BTEX 
could be represented by ETS exposure, although significant differences were observed between 
the groups even after being divided according to ETS/smoking classification. Another 
important factor to take in account is that each of the groups is formed by 14-15 subjects (except 
MATCH project with 41 subjects). Therefore when a further division of each group (control, 
living or working in a recently built/refurbished building, occupationally exposed and 
MATCH) in other subgroups, generates one or more subgroups with few cases, and it is 
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possible that the number of cases is too small to observe significant differences. Moreover, the 
distribution of the ETS exposed samples consisted in two main groups of high ETS exposure 
and low ETS exposure, causing the median concentration of both cotinine and urinary VOCs 
to shift towards higher values, as shown in Figure 33. To counter for this problem, also taking 
in account the differences observed in the distribution in Table 34, a different division in 
subgroups was performed, using a higher value of urinary cotinine to define non-ETS exposed 
subjects (10µg/L). Due to the generally low ETS exposure of the subjects, this passage allowed 
to create two main subgroups based on higher and lower ETS exposure, maintaining a high 
number of cases throughout the subgroups.  
 
Figure 33: distribution of the FIXAT and MATCH samples based on the cotinine concentration. 
The red continuous line indicates the 1µg/L treshold of cotinine, the dashed red line indicates 
the 10µg/L threshold, and the green line represents the threshold for the smokers (50µg/L). 
When the median concentrations of the urinary markers were compared after this 
subgroup division, the median concentrations of cotinine of each subgroup were found to be 
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statistically different between the groups (FIXAT groups + MATCH) (p=0.008). Moreover, 
the distribution of the data for cotinine concentration was found to be different between the 
groups (p<0.001). In this case, the medians of urinary benzene (p=0.032), toluene (p<0.001) 
and ethylbenzene (p<0.001) showed a statistically significant difference between the groups. 
Also the distribution of benzene (p=0.001), toluene (p=0.001) and ethylbenzene (p<0.001) 
were found to be different between the groups.  
In the other subgroup (high ETS exposure and smokers) the medians of urinary toluene 
(p=0.007) and ethylbenzene (p=0.012) showed a difference, together with the distributions 
(p=0.014 and p=0.029 respectively). No significant difference was observed for the urinary 
cotinine. Table 37 shows that the main difference for urinary cotinine is observed in MATCH 
project subjects. When the MATCH subjects were excluded from the statistical analyses, the 
median concentration of urinary cotinine did not show statistically significant differences 
between the groups, only the distribution showed a difference (p=0.042). After excluding the 
MATCH subjects, only the median concentration of urinary benzene showed a difference 
between the groups (p=0.008), while the distribution showed a difference for urinary benzene 
(p=0.011) and urinary ethylbenzene (p=0.008).  
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Table 37: Summary of the median concentrations of the measured urinary metabolites in all 
the groups. The sample pool was obtained including only the subjects with urinary cotinine 
concentration <10µg/L. (* indicates a statistically significant difference in the median between 
the groups, + indicates a statistically significant difference in the distribution between the 
groups) 
 Group/sampling event 
Control 
Single 
sampling 
Living/workin
g in a new or 
recently 
refurbished 
building First 
sampling 
Living/working in 
a new or recently 
refurbished 
building Second 
sampling 
Occupationall
y exposed, 
First sampling
Occupationally 
exposed 
Second 
sampling 
MATCH 
single 
sampling
Median Median Median Median Median Median 
Cotinine (µg/L)* + 0.14 0.12 0.18 0.24 0.23 1.80
8-oxo-dG (nMol/M creatinine) 1.29 1.37 1.15 1.15 1.06 1.25
Urinary Benzene (ng/L)* + 75 69 70 89 92 64
Urinary Toluene (ng/L)* + 134 126 134 174 152 459
Urinary Ethylbenzene (ng/L)* + 19 24 21 23 28 61
Urinary m+p-xylene (ng/L) 34 36 35 35 44 166
Urinary o-xylene (ng/L) 27 35 33 36 36 37
Urinary Naphthalene (ng/L) 46 44 46 41 42 28
 
 
Table 38: Summary of the concentrations of urinary metabolites for the group with urinary 
cotinine >10 µg/L. Control and living/working in new or recently refurbished building groups 
did not include any subject with such urinary concentrations of cotinine. 
 
Cotinine >10µg/L 
Control 
Living/working in a new or 
recently refurbished building 
Occupationally 
exposed 
MATCH project high 
exposed subjects 
Median Median Median Median 
Cotinine (µg/L) . . 196.66 22.73
8-oxo-dG (nMol/M creatinine) . . 1.48 1.46
Urinary Benzene (ng/L) . . 152 34
Urinary Toluene (ng/L) . . 198 840
Urinary Ethylbenzene (ng/L) . . 18 304
Urinary M+P-xylene (ng/L) . . 34 180
Urinary O-xylene (ng/L) . . 38 105
Urinary Naphthalene (ng/L) . . 48 28
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These findings suggest that although smoking and ETS exposure are one of the main 
sources of urinary BTEX and exposure, a significant contribution to the exposure can also be 
attributable to different sources and activities. In Table 37 is shown a summary of the medians 
of each group after the elimination of smokers and subjects with high ETS exposure. The 
observed BTEX values are compatible with previously reported data for non smoking subjects 
(Fustinoni et al., 2010). It is still possible to identify a trend, especially with toluene, where 
higher levels of urinary cotinine tend to be associated with higher levels of urinary BTEX, and 
the results show that the difference is statistically significant.  
As mentioned above, the main difference in urinary BTEX concentrations are 
represented by the MATCH subjects, where the median concentrations of most compounds 
(except benzene, o-xylene and naphthalene) are much higher than in any of the other groups. 
For the FIXAT project, toluene is found to be higher in the occupationally exposed subjects, 
together with benzene. Interestingly, most of the compounds did not show a significant change 
between the first and the second sampling, although a slight reduction of 8-oxo-dG median 
concentration is observed. Taking in account the work from Evans et al. (2010), where they 
reported changes in 8-oxo-dG around 20-30%, we could conclude that the change observed in 
both occupationally exposed and living/working in recently built/refurbished buildings 
between the first and the second sampling are relevant regarding the oxidative stress. There is 
a decrease of 17% between the median concentration of 8-oxo-dG of the first and the second 
sampling of the living/working in a recently built or refurbished building, and a decrease of 8% 
between the first and the second sampling of occupationally exposed subjects. These variations, 
however were found to be not statistically significant, due to the inter-personal variation of 
urinary 8-oxo-dG and the differences in the distribution of the data, and the relatively small 
sample pool. The difference in the concentration of urinary 8-oxo-dG between the two 
sampling events in two of the groups, although not being statistically significant, is highly 
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valuable, as it is obtained from two different samplings of the same subjects. This procedure, 
especially in the case of the occupationally exposed group that were sampled twice in a short 
period of time, minimizes the inter-sample variations.  
A paired samples t-test was performed where two samplings were performed, in order 
to investigate any differences between the first and the second sampling. No statistically 
significant differences were observed for any of the urinary VOCs nor for the 8-oxo-dG, 
although for this last variable the significance was p=0.072. Marginally significant differences 
were observed for urinary ethylbenzene (p=0.027) and m+p-xylene (p=0.026) between the two 
samplings of the occupationally exposed subjects. These results could be due to the small 
number of samples in each subgroup, however the observed p values, except in the mentioned 
cases, were always found >0.200.  
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IV.3 Sub-categories comparisons 
The collected data was analysed for skewness in order to determine the distribution. All 
of the biomarkers and the personal exposure data was found to be skewed towards the right 
(skewness value >0). All the following analyses were performed on the log transformed data. 
Even after the log transformation, urinary BTEX and naphthalene, showed a skewness 
coefficient ranging between 0.7 and 1.7, indicating that the data distribution is still not 
symmetrical after the transformation, this is probably due to the high variability between the 
different samples. A similar behaviour was observed also when the skewness was analysed for 
each group.  
The mean concentrations of the compounds in each of the groups were compared using 
the ANOVA test followed by Bonferroni post hoc comparison, for each of the grouping 
variable obtained from the questionnaire data with multiple answers and T test for dichotomies. 
This procedure was performed in order to identify the groups that showed statistically 
significant differences in the urinary concentrations of the metabolites. Taking in account the 
results obtained in the previous section and due to the skewness of the data, the results obtained 
with the ANOVA test and the Bonferroni post hoc comparisons were then verified by 
nonparametric median comparison, and the distributions were compared by Kruskal-Wallis 1-
way ANOVA and Kolmogorov-Smirnov tests.  
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Differences between genders: 
Table 39: Representation of the analysed subgroups. 
Control 
Living/working in 
recently built or 
refurbished buildings 
Occupationally exposed MATCH 
Males Females Males Females Males Females Males Females
 
No significant difference was observed in the variance of any of the urinary metabolites 
when the two genders were compared, while a significant difference was observed for the 
personal exposure data for benzene (p=0.003), toluene (p=0.027) and ethylbenzene (p<0.001). 
This result can be explained by the high difference on the personal exposure data of 
occupationally exposed subjects, which are only male volunteers, and the rest of the volunteers’ 
personal exposure. This finding was confirmed by the nonparametric comparisons, which did 
not show any significant differences between the two genders. Only the personal exposure 
measurements of o-xylene (p=0.042) and m-xylene (p=0.027) showed a difference in the 
distribution between male and female subjects in the control subgroup.  
 
FIXAT subgroups and MATCH comparison: 
Table 40: Representation of the analysed subgroups. 
Control 
Living/working in 
recently built or 
refurbished buildings 
Occupationally exposed MATCH 
 
Table 41: Summary of the statistically significant differences observed in the ANOVA test 
between the sampling subgroups. 
 ANOVA test p 
value 
Subgroup showing 
significant difference 
PE benzene <0.001 Occupationally exposed 
PE ethylbenzene <0.001 Occupationally exposed 
PE toluene 0.044 Occupationally exposed 
Urinary naphthalene 0.004 MATCH 
Urinary VOCs  <0.001 MATCH 
Urinary o-xylene 0.124  
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ANOVA test was performed with Bonferroni post hoc multiple comparison, to evaluate 
the differences in the measured concentrations of airborne VOCs between the various groups. 
A significant difference was observed in the personal exposure data for benzene (p<0.001) and 
ethylbenzene (p<0.001), while a marginally significant difference was observed for toluene 
(p=0.044). These results are due to the major difference observed in the personal exposure data 
of the occupationally exposed subgroup, which is generally higher than all the other subgroups 
(FIXAT and MATCH). All of the urinary VOCs showed a statistically significant difference 
between the subgroups, with p values all under 0.001, except for o-xylene (p=0.124) and 
naphthalene (p=0.004). The findings were confirmed by the nonparametric comparisons, 
which showed similar results, except for all of the xylenes, which did not show significant 
differences. 
Bonferroni post hoc comparison showed that only the MATCH project samples showed 
a statistically significant difference from the other groups.  
Table 42: Summary of the statistically significant differences observed in the ANOVA test 
between the sampling subgroups, after elimination of MATCH subset. 
 ANOVA test 
p value 
Subgroup showing 
significant difference 
(FIXAT only) 
Urinary Benzene <0.001 Occupationally exposed 
Urinary Cotinine 0.001 Occupationally exposed 
Urinary Ethylbenzene 0.028 Occupationally exposed 
Urinary m+p xylene 0.015 Occupationally exposed 
Urinary Naphthalene 0.036 Occupationally exposed 
PE Benzene <0.001 Occupationally exposed 
PE Ethylbenzene <0.001 Occupationally exposed 
PE Toluene 0.044 Occupationally exposed 
 
To further evaluate the differences in the FIXAT subgroups only, the MATCH samples 
were removed from the calculations, and another ANOVA test was performed for the same 
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variables. In this case, statistically significant differences were observed only in the 
concentration urinary benzene (p<0.001) and cotinine (p=0.001). Marginally significant 
differences were observed for urinary ethylbenzene (p=0.028), m+p-xylene (p=0.015) and 
naphthalene (p=0.036). The personal exposure data showed statistically significant differences 
only for benzene (p<0.001) and ethylbenzene (p<0.001), and a marginally significant 
difference for toluene (p=0.044). Nonparametric comparisons confirmed the findings for 
benzene (p=0.005) and m+p-xylene (p=0.036) but not for urinary cotinine (p=0.148), 
however, the distribution of cotinine showed to be not the same between all the groups (KW 
p=0.005), suggesting non-homogeneous groups regarding the ETS exposure and the smoking 
habits. The nonparametric comparison of the personal exposure data showed significant 
differences between the subgroups for benzene (p=0.001), toluene (p=0.029), ethylbenzene 
(p<0.001) and pyridine (p<0.001).  
Bonferroni post hoc comparison showed that the significant differences were mostly to 
be attributed to the occupationally exposed subjects. The cotinine levels were found to be the 
lowest in the living/working in a recently built or refurbished building, which however showed 
a statistically significant difference only with the occupationally exposed group. The control 
group, although having a higher mean concentration of urinary cotinine, showed a statistically 
significant difference with the occupationally exposed subjects. It is important to remember 
that the occupationally exposed group contained actively smoking and high ETS exposed 
subjects. Due to the strong correlation between smoking habits and urinary benzene, the results 
should be evaluated carefully. For urinary benzene, the difference was significant between the 
occupationally exposed and all the other subgroups, while for urinary ethylbenzene, m+p-
xylene and naphthalene, the difference was significant only between the occupationally 
exposed and the control group. The personal exposure data showed a significant difference for 
benzene and ethylbenzene between the occupationally exposed subgroup and all the others, 
110 
 
while for toluene the significant difference was only between the occupationally exposed 
subjects and the control group.  
 
Table 43:Summary of the statistically significant differences observed in the ANOVA test 
between the sampling subgroups after elimination of ETS exposed and smoking subjects. 
 ANOVA test 
p value 
Subgroup showing significant 
difference  
(FIXAT non-ETS exposed only) 
Urinary Benzene 0.011 Occupationally exposed 
Urinary Ethylbenzene 0.002 Occupationally exposed 
Urinary m+p xylene 0.010 Occupationally exposed 
PE Benzene <0.001 Occupationally exposed 
PE Ethylbenzene <0.001 Occupationally exposed 
PE pyridine <0.001 Occupationally exposed 
PE styrene 0.035 Occupationally exposed 
 
Further comparison analyses were performed for the non-ETS exposed subjects 
(urinary cotinine <1µg/L), in order to eliminate the ETS exposure as a confounding factor.  
When the non-ETS exposed subjects’ measurements (urinary cotinine <1µg/L) were compared 
between the different groups with the ANOVA test, no statistically significant difference was 
observed for urinary cotinine, between the different groups. Statistically significant differences 
were observed for urinary benzene (p=0.011), ethylbenzene (p=0.002), m+p-xylene 
(p=0.010). The personal exposure data showed a similar pattern, with statistically significant 
differences between the groups for benzene (p<0.001), ethylbenzene (p<0.001) pyridine 
(p<0.001) and styrene (p=0.035). These results were confirmed in the nonparametric tests, 
except for m+p-xylene. In addition, the median concentration of toluene in the personal 
exposure measurement showed a statistically significant difference between the groups.  
 The post hoc comparisons showed that only the difference between occupationally 
exposed and living/working in a recently built/refurbished building  subgroups was statistically 
significant, with the occupationally exposed showing the higher concentration. 
111 
 
Urinary ethylbenzene concentration difference was found to be statistically significant between 
occupationally exposed and control subgroups. Urinary m+p-xylene difference was found to 
be statistically significant between the occupationally exposed group and all the others.  
The personal exposure measurements all showed statistically significant differences 
between the occupationally exposed and all of the other subgroups. This could be due not only 
to the different airborne concentrations, but also to the different sorbent tubes used in the 
measurements of that subgroup. However, the fact that these differences are reflected in the 
urinary measurements, supports the hypothesis that the difference is due to the higher exposure 
of the subjects to those compounds. 
  
FIXAT occupationally exposed and living/working in a recently built or refurbished 
building, first and second sampling comparison: 
Table 44: Representation of the analysed subgroups. 
Control 
Living/working in 
recently built or 
refurbished buildings 
Occupationally exposed MATCH 
Single sampling 1
st 
sampling 
2nd 
sampling 
1st 
sampling 
2nd 
sampling Single sampling 
 
Table 45: Summary of the ANOVA test results comparing the first sampling events of the 
various subgroups. 
 ANOVA test 
p value 
Subgroup showing significant difference  
(First sampling and single sampling) 
Urinary benzene 0.006 Occupationally exposed 
PE benzene <0.001 Occupationally exposed 
PE ethylbenzene <0.001 Occupationally exposed 
 
The sample pool, after being divided in groups, was then further separated, since both 
occupationally exposed subjects and living/working in a recently built/refurbished building had 
two sampling events. For the first sampling event, the significant differences were observed 
only for urinary benzene (p=0.006). Personal exposure data showed significant differences 
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between the subgroups for benzene (p<0.001) and ethylbenzene (p<0.001). The findings were 
confirmed by the nonparametric comparisons. 
Post hoc comparisons in this case showed a statistically significant difference between 
occupationally exposed subjects and subjects living or working in a recently built or 
refurbished building, while the difference was not significant between any of the other groups 
and the control group, due to the high variance in the group. The personal exposure data showed 
a statistically significant difference for the benzene and ethylbenzene concentration between 
the occupationally exposed group and the others.   
Table 46: Summary of the ANOVA test results comparing the second sampling event of the 
various subgroups. 
 ANOVA test 
p value 
Subgroup showing significant difference  
(First sampling and single sampling) 
Urinary benzene 0.035 Occupationally exposed 
Urinary m+p xylene 0.014 Occupationally exposed 
PE benzene 0.008 Post-hoc could not be performed 
PE ethylbenzene 0.050 Post-hoc could not be performed 
 
The second sampling event for the occupationally exposed subjects took place after the 
weekend, to allow the work related exposure build-up of the working week to be eliminated, 
but in this occasion the personal exposure was not measured, while for the subjects living or 
working in a recently built or refurbished building, the second sampling took place after one 
year. ANOVA test showed a marginally significant difference between the groups for urinary 
benzene (p=0.035) and for m+p-xylene (p=0.014) but not for any other urinary biomarker. 
However, in this case no significant difference was observed in the nonparametric 
comparisons. Post hoc comparison revealed that the difference was again between the 
occupationally exposed group and all the others for urinary benzene, and between 
occupationally exposed group and control group for urinary benzene and m+p-xylene. Taking 
in account the results of the nonparametric comparisons, it is possible that the difference 
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observed in the ANOVA test is due to the difference in the distribution of the occupationally 
exposed subgroup. 
Airborne benzene (p=0.008) and ethylbenzene (p=0.050) showed a statistically 
significant difference for personal exposure, but due to the missing data for the occupationally 
exposed subjects, post hoc comparisons could not be performed.   
 
8-oxo-dG comparison between FIXAT and MATCH subgroups: 
Table 47: Representation of the analysed subgroups. 
Control 
Living/working in 
recently built or 
refurbished buildings 
Occupationally exposed MATCH 
 
8-oxo-dG concentration did not show significant differences between any the groups in 
any of the tests performed. 
 
ETS exposure classification based on urinary cotinine comparison: 
Table 48: Representation of the analysed subgroups. 
Control 
Living/working in 
recently built or 
refurbished buildings 
Occupationally exposed MATCH 
Non 
ETS 
exposed 
ETS 
exposed Smokers 
Non 
ETS 
exposed 
ETS 
exposed Smokers 
Non 
ETS 
exposed 
ETS 
exposed Smokers Not included in the analyses 
 
Another set of ANOVA tests were performed for the different ETS exposure groups. 
The ETS exposure classification, based on the urinary cotinine concentration (non-ETS 
exposed, ETS exposed, smoker), underlined a strong linkage between tobacco smoke and 
urinary benzene, as mentioned previously in section IV.2 and as reported in previous works 
(Manini et al., 2010; Lovreglio et al., 2011). Only the subjects from FIXAT project were 
selected, as the samples chosen from MATCH project were chosen on purpose along the 
highest exposures, including ETS.  
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Table 49: Summary of the results from ANOVA test between the three different ETS groups 
based on the urinary cotinine concentration. 
 ANOVA test 
p value 
Subgroup showing significant difference  
(First sampling and single sampling) 
Urinary benzene <0.001 Non-ETS exposed (lower conc.) 
PE ethylbenzene <0.001 Non-ETS exposed (lower conc.)
 
Only the urinary benzene showed a statistically significant difference between the 
subgroups (p<0.001), where the non-ETS exposed had the lowest urinary benzene 
concentration, with a statistically significant difference with the other two groups. The subjects 
classified as smokers and ETS exposed, showed a significant difference only with the non-ETS 
exposed, which is however coherent with previously published data (Manini et al., 2010). 
Furthermore, in the same work, the levels of 8-oxo-dG were found to be generally higher than 
the levels measured in our study, and showed a statistically significant difference between 
smokers and non-ETS exposed only in the higher concentrations. In our case, the smokers were 
a small portion of the total sample pool and, as mentioned in section IV.2, most of the ETS 
exposed subjects had very low ETS exposures.  
Another significant difference was observed for personal exposure levels of ethylbenzene. In 
that case, although the majority of the smokers are occupationally exposed subjects, that have 
a generally higher exposure to ethylbenzene, the difference was found between the non-ETS 
exposed and the ETS exposed subgroups. The ETS exposed subjects, however, are more 
represented in the occupationally exposed group, which have a generally higher measured level 
of personal exposure to ethylbenzene.  
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Age range comparison: 
Table 50: Representation of the analysed subgroups. 
Control 
Living/working in 
recently built or 
refurbished buildings 
Occupationally exposed MATCH 
Age ranges Age ranges Age ranges Age ranges 
 
The age range subgroups were compared with the ANOVA test. Due to the distribution 
of the population, the results could not be taken in account, as the age range that showed 
statistically significant difference was the age range 36-45. This age range is represented 
mainly in MATCH project subjects and only a small proportion is represented in FIXAT 
project (Table 34), this would cause biased analyses due to the grouping of a single age range 
in high exposure group.  
 
Commuting method comparison: 
Table 51: Representation of the analysed subgroups. 
Control 
Living/working in 
recently built or 
refurbished buildings 
Occupationally exposed MATCH 
Commuting methods Commuting methods Commuting methods Commuting methods 
 
Table 52: Summary of the results of ANOVA test between the various commuting methods for 
urinary and PE VOCs. 
 ANOVA test 
p value 
Subgroup showing significant difference  
(Commuting method) 
Urinary toluene 0.006 
Commuting on foot (higher conc.) vs. 
cycling (lower conc.) 
Urinary naphthalene 0.009 
Commuting on foot (higher conc.) vs. 
cycling (lower conc.) 
Urinary o-xyene 0.024 
Commuting on foot (higher conc.) vs. 
cycling (lower conc.) 
PE ethylbenzene 0.023 
Commuting on foot (higher conc.) vs. 
cycling (lower conc.) 
PE pyridine 0.040 
Commuting on foot (higher conc.) vs. 
cycling (lower conc.) 
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The different commuting methods (Table 34), when compared with the ANOVA test, 
showed statistically significant differences between the different commuting subgroups for 
urinary toluene (p=0.006) and naphthalene (p=0.009), and marginally significant differences 
for o-xylene (p=0.024). Post hoc test revealed that the higher levels of urinary toluene were 
measured in the subjects that commuted on foot, and the lowest for subjects who commuted by 
cycling. However, these findings were not confirmed by the nonparametric comparisons, where 
only o-xylene median concentration showed a statistically significant difference between the 
method of commute. The analysis of the personal exposure data showed a statistically 
significant difference of ethylbenzene (p=0.023) and pyridine (p=0.040) between the different 
commuting methods.  
 
Table 53: Summary of the results of the nonparametric comparison tests between the different 
methods of commuting. 
 Nonparametric 
test p value 
Kind of difference observed in 
nonparametric test 
(Commuting method) 
8-oxo-dG 0.040 Distribution 
PE benzene 0.013 
Median (Walking, highest concentration, 
cycling, lowest concentration)
 
Interestingly, MATCH project showed a statistically significant difference in the 
distribution of 8-oxo-dG between the different method of commute (p=0.040), together with a 
statistically significant difference of the median concentration of airborne benzene measured 
in the personal exposure (p=0.013). The statistically significant differences were observed 
between commuting by cycling, car and walking. Interestingly the commuting by car was not 
significantly different from commuting by walking, which showed the highest levels of urinary 
benzene. Also in this case, the distribution of the volunteers in the various commuting 
subgroups could play an important role on the interpretation of the data, but it is interesting to 
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notice that urinary toluene did not show any particular variation in the concentration for any of 
the other groupings. Interestingly, urinary naphthalene was found in the higher concentrations 
in the group that commute by cycling, and it showed a significant difference with the subjects 
that did not commute and that commuted by car.  
 
Comparison between subjects using a vehicle for work and others: 
Table 54: Representation of the analysed subgroups. 
Control 
Living/working in 
recently built or 
refurbished buildings 
Occupationally exposed MATCH 
Vehicle 
used for 
work 
No 
vehicles 
used for 
work 
Vehicle 
used for 
work 
No 
vehicles 
used for 
work
Vehicle 
used for 
work 
No 
vehicles 
used for 
work
Vehicle 
used for 
work 
No 
vehicles 
used for 
work
 
Urinary benzene was found to be significantly different when grouped by the subjects 
that used a vehicle for work and the subjects who did not (p=0.003), even in this case the 
distribution of the subjects shows that most of the subjects that use a vehicle for work are in 
the occupationally exposed subgroup.  
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Comparison between groups based on average yearly mileage: 
Table 55: Representation of the analysed subgroups. 
Control 
Living/working in 
recently built or 
refurbished buildings 
Occupationally exposed MATCH 
Average yearly mileage Average yearly mileage Average yearly mileage Average yearly mileage 
 
Table 56: Summary of ANOVA results on the comparisons between the various categories 
based on the yearly mileage. 
 ANOVA test 
p value 
Subgroup showing significant difference  
(Average yearly mileage) 
8-oxo-dG 0.003 
<5,000 miles/year (vs. >30,000 miles/year) 
lowest concentration observed for subjects 
between 5,000 and 15,000 miles/year 
Urinary toluene 0.004 >30,000 miles/year 
Urinary benzene 0.016 <5,000 miles/year (vs. >30,000 miles/year) 
Urinary ethylbenzene 0.014 >30,000 miles/year 
Urinary m+p-xylene 0.033 <5,000 miles/year (vs. >30,000 miles/year) 
Urinary o-xylene 0.032 <5,000 miles/year (vs. >30,000 miles/year) 
PE benzene 0.003 <5,000 miles/year (vs. >30,000 miles/year) 
PE ethylbenzene 0.016 <5,000 miles/year (vs. >30,000 miles/year) 
 
When the sample pool is grouped by the average yearly mileage, it is interesting to 
notice that the 8-oxo-dG shows a statistically significant difference between the subgroups 
(p=0.003) together with urinary toluene (p=0.004), while a marginally significant difference 
is observed for urinary benzene (p=0.016), ethylbenzene (p=0.014), m+p-xylene (p=0.033) 
and o-xylene (p=0.032). These results are confirmed in the nonparametric comparisons for 8-
oxo-dG, toluene and ethylbenzene, but not for the xylenes and ethylbenzene.  
Interestingly, this pattern is not replicated for personal exposure, where a significant difference 
is observed for benzene (p=0.003) and a marginally significant difference is observed for 
ethylbenzene (p=0.016), while toluene does not show any significant difference between the 
subgroups (p=0.825). Similar results were observed also in the nonparametric comparisons.  
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Post hoc comparisons showed that 8-oxo-dG concentrations are lowest for the group that drives 
between 5,000 and 15,000 miles per year, and the difference is statistically significant between 
the groups of subjects that drive less than 5,000 miles per year and more than 30,000 miles per 
year. Also in this comparison, the distribution of the subjects in the subgroups can contribute 
to the observed differences, as most of the control subjects are driving 5,000 miles or less, 
while occupationally exposed subjects and MATCH project subjects have generally higher 
yearly mileages. In particular, MATCH project is the only group where the >30,000 miles/year 
subgroup is represented. However, the lowest observed concentrations for 8-oxo-dG were 
observed in the subgroup formed by subjects with an average yearly mileage between 5,000 
and 15,000. This subgroup is largely represented by the occupationally exposed subjects, 
which, in general have slightly higher urinary concentrations of unmetabolized VOCs, but not 
higher levels of urinary 8-oxo-dG. This separation characterizes a group with higher levels of 
oxidative stress which can be correlated to the average yearly mileage that is compatible with 
a more intensive use of the car. Another interesting factor to observe, is the high level of 8-
oxo-dG found in the groups with the least yearly mileage, or that do not commute using a car. 
This finding could suggest that the intensive use of a car (compatible with more time spent in 
traffic) contributes to the oxidative stress, but also a very minimal use of the car, with intensive 
use of alternative forms of transportation, could as well contribute to the oxidative stress. The 
results are summarised in Figure 34 where an increasing trend can be observed with the higher 
yearly mileages, but a high variability of the data is observed for the lower yearly mileages. 
Urinary toluene and ethylbenzene were found to be higher in the subjects that drive 
more than 30,000 miles per year, while the other groups did not show statistically significant 
differences between them. That particular subgroup is represented only in the MATCH project, 
therefore the difference that is observed can be related to the higher urinary concentration of 
toluene in the MATCH subjects that might be arising from other sources.  
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Figure 34: Boxplot showing the mean concentration of 8-oxo-dG in each category defined by 
the average yearly mileage (full data set). 
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Discussion of the data and conclusions on key comparisons and groups: 
In conclusion, the data shows a linkage between ETS exposure and urinary VOCs. 
However, when the higher ETS exposure subjects are removed from the database, it is still 
possible to observe variations in the urinary VOC concentrations between the various groups. 
The most valuable differences were observed between the urinary VOCs concentration in the 
various subgroups when the higher ETS exposed subjects were removed from the database. 
Although the difference of median concentration of urinary cotinine between the groups was 
not found to be statistically significant, the urinary VOCs median concentrations still showed 
a statistically significant difference, suggesting that sources different from ETS are 
contributing to the exposure.  
Another remarkable difference that was observed is the general reduction of the median 
concentration of 8-oxo-dG in the second samplings of occupationally exposed subjects (Table 
37). Although this reduction is found to be not statistically relevant, it is still an important 
finding, as the observed variation is coherent with previously reported data for other activities 
(i.e. smoking) (Evans et al., 2010). Unfortunately, in our case due to the relatively small number 
of subjects and the high inter-personal variability of 8-oxo-dG, although a difference was 
observed, this was not found to be statistically significant between the two subgroups. A larger 
population would make this comparison more meaningful, because of the many factors that 
can influence oxidative stress, such as diet, health condition or inflammatory response to 
pollution-unrelated sources, which would be mitigated in a larger sample (Chen et al., 1999; 
Evans et al., 2010; Halliwell, 2007; Knaapen et al., 2006).   
It is also important to underline the difference observed in the urinary concentration of 
8-oxo-dG when the sample pool was divided by the average yearly mileage (Figure 34). 
Although this division is strictly connected with the distribution of the subjects between the 
subgroups (MATCH and occupationally exposed subjects generally had higher yearly 
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mileages), the outcome is still valuable, as it is possible to identify a significant difference in 
the oxidative stress biomarker between different categories. Moreover, the data suggests the 
existence of a threshold, which will be discussed in the next section, under which it is not 
possible to determine any differences, due to the contribution of other factors to the oxidative 
stress.  
One of the most important factors to take in account in our dataset is the contribution 
of active smoking and ETS exposure to both oxidative stress and urinary VOCs. When the 
cases were pooled together, including non-ETS exposed subjects and low ETS exposed 
(urinary cotinine <10µg/L) in the same subgroup, it was possible to identify differences 
between the subgroups for all of the urinary VOCs, in some cases for the 8-oxo-dG, but the 
cotinine levels did not show significant differences. This finding underlines the importance of 
eliminating confounding factors such as ETS exposure, which can bias the data due to the high 
impact that it has on urinary VOCs even when a small number of samples is affected. Figure 
35 shows also that the ETS exposure is not related to the 8-oxo-dG levels when the subjects 
are divided based on the average yearly mileage. 
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Figure 35: Boxplot showing the mean concentration of 8-oxo-dG in each category defined by 
the average yearly mileage, after the elimination of subject exposed to high levels of ETS and 
smokers. 
 
Similar results were obtained when the urinary concentrations of 8-oxo-dG were 
compared between the different subgroups including and excluding the higher ETS exposed 
subjects and the smokers (Figure 36 and Figure 37). When the concentrations were compared 
including the smokers and higher ETS exposed subjects, no difference was observed between 
the groups (Figure 36). The distribution of ETS exposed subjects prevented the comparison of 
only non-ETS exposed subjects, due to the uneven distribution of ETS exposed subjects.  
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Figure 36:Boxplot showing the mean concentrations of 8-oxo-dG for each group (full data set). 
 
 
Using a less stringent division, it was possible to eliminate the outliers (high ETS 
exposed and smoking subjects), without affecting the urinary cotinine median distribution, 
which, in fact, did not show statistically significant differences between the FIXAT and 
MATCH groups after the removal (as mentioned previously in this section). When only the 
subjects with higher ETS exposure and the smokers were removed from the database, it was 
possible to observe differences in the mean concentrations of urinary 8-oxo-dG (Figure 37). 
Although the observed differences were not statistically significant, it was possible to assess a 
decrease in the oxidative stress in the second sampling event in both living/working in a 
recently built or refurbished building, and occupationally exposed group. 
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Figure 37: Boxplot showing the mean concentrations of 8-oxo-dG for each group and sampling 
event after the removal of high ETS exposed subjects and smokers. 
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IV.4 Correlation analyses 
Urinary BTEX correlations in different subgroups and categories of ETS exposure 
A bivariate Pearson correlation matrix was created with all the measured variables 
(Table 61). When the urinary metabolites were analysed, benzene was found to be negatively 
correlated with the rest of the urinary VOCs, while it was correlated with urinary naphthalene. 
This finding is in contrast with previously reported data, where benzene was found to be 
correlated to the other urinary VOCs (Fustinoni et al., 2010). Toluene instead, showed a 
significant correlation with the other VOCs, except for naphthalene. Due to these findings, 
three different variables were created, using the sum of different groups of compounds. The 
variable “Sum of BTEX + naphthalene” included the sum of all the urinary VOCs, ”Sum of 
BTEX” included the sum of all the VOCs excluding naphthalene, and “Sum of TEX” included 
the sum of the urinary VOCs excluding benzene and naphthalene. The correlations were 
analysed again with the sample pool divided by subgroup, obtaining a correlation matrix for 
each subgroup of subjects. The obtained correlation coefficients maintained a pattern similar 
to the one observed for the complete pool only for the occupationally exposed group (p values 
all ≤0.010, with benzene showing no correlation and naphthalene showing a negative 
correlation), as shown in Table 58, and the MATCH project samples (p values all <0.001, 
except for benzene and naphthalene where, again, the correlation coefficients are negative), as 
shown in Table 57.  
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Table 57: Summary of correlations between urinary BTEX and naphthalene in the MATCH 
subgroup. 
MATCH subgroup 
 
Urinary 
Benzene 
(ng/L) 
(Log10) 
Urinary 
Toluene 
(ng/L) 
(Log10) 
Urinary 
Ethylbenzene 
(ng/L) 
(Log10) 
Urinary 
M+P-xylene 
(ng/L) 
(Log10) 
Urinary O-
xylene 
(ng/L) 
(Log10) 
Urinary 
Toluene (ng/L) 
(Log10) 
Pearson 
Correlation 
-.117 1  
Sig. (2-tailed) .498   
Urinary 
Ethylbenzene 
(ng/L) (Log10) 
Pearson 
Correlation 
-.277 .686** 1  
Sig. (2-tailed) .102 .000   
Urinary M+P-
xylene (ng/L) 
(Log10) 
Pearson 
Correlation 
-.491* .763** .907** 1  
Sig. (2-tailed) .024 .000 .000   
Urinary O-
xylene (ng/L) 
(Log10) 
Pearson 
Correlation 
-.085 .740** .697** .781** 1 
Sig. (2-tailed) .621 .000 .000 .000  
Urinary 
Naphthalene 
(ng/L) (Log10) 
Pearson 
Correlation 
.184 -.551** -.209 -.288 -.431* 
Sig. (2-tailed) .412 .006 .340 .340 .040 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
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Table 58: Summary of the correlations between the urinary BTEX and naphthalene for the 
occupationally exposed subgroup. 
Occupationally exposed subjects subgroup (FIXAT) 
 
Urinary 
Benzene 
(ng/L) 
(Log10) 
Urinary 
Toluene 
(ng/L) 
(Log10) 
Urinary 
Ethylbenzene 
(ng/L) 
(Log10) 
Urinary 
m+p-xylene 
(ng/L) 
(Log10) 
Urinary O-
xylene 
(ng/L) 
(Log10) 
Urinary 
Toluene (ng/L) 
(Log10) 
Pearson 
Correlation 
.373 1    
Sig. (2-tailed) .050     
Urinary 
Ethylbenzene 
(ng/L) (Log10) 
Pearson 
Correlation 
.316 .490** 1   
Sig. (2-tailed) .101 .008    
Urinary M+P-
xylene (ng/L) 
(Log10) 
Pearson 
Correlation 
.261 .616** .899** 1  
Sig. (2-tailed) .179 <0.001 <0.001   
Urinary O-
xylene (ng/L) 
(Log10) 
Pearson 
Correlation 
.290 .478* .592** .629** 1 
Sig. (2-tailed) .135 .010 .001 <0.001  
Urinary 
Naphthalene 
(ng/L) (Log10) 
Pearson 
Correlation 
-.123 -.443* -.400* -.492** -.179 
Sig. (2-tailed) .534 .018 .035 .008 .363 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
 On the other hand, in the subjects of control group and those living/working in a 
recently built or refurbished building, not all the urinary VOCs were correlated with each other. 
The urinary VOCs from the group with volunteers living/working in recently build or 
refurbished buildings showed correlations between toluene and ethylbenzene (p=0.048), 
ethylbenzene and m+p-xylene (p=0.004) and m+p-xylene with o-xylene (p<0.001). The results 
are summarized in Table 59. 
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Table 59: Summary of the correlations between urinary BTEX and naphthalene for the FIXAT 
subgroup living/working in a new or recently refurbished building. 
Living/working in a new or recently refurbished building subgroup (FIXAT) 
 
Urinary 
Benzene 
(ng/L) 
(Log10) 
Urinary 
Toluene 
(ng/L) 
(Log10) 
Urinary 
Ethylbenzene 
(ng/L) 
(Log10) 
Urinary 
M+P-xylene 
(ng/L) 
(Log10) 
Urinary O-
xylene 
(ng/L) 
(Log10) 
Urinary 
Toluene (ng/L) 
(Log10) 
Pearson 
Correlation 
-.389* 1  
Sig. (2-tailed) .034   
Urinary 
Ethylbenzene 
(ng/L) (Log10) 
Pearson 
Correlation 
-.219 .376* 1  
Sig. (2-tailed) .262 .048   
Urinary M+P-
xylene (ng/L) 
(Log10) 
Pearson 
Correlation 
-.143 .115 .521** 1  
Sig. (2-tailed) .451 .544 .004   
Urinary O-
xylene (ng/L) 
(Log10) 
Pearson 
Correlation 
-.280 .211 .263 .605** 1 
Sig. (2-tailed) .134 .264 .176 .000  
Urinary 
Naphthalene 
(ng/L) (Log10) 
Pearson 
Correlation 
-.120 .081 -.215 -.153 .007 
Sig. (2-tailed) .534 .677 .281 .428 .971 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
Urinary VOCs of the control group showed statistically significant correlations only 
between ethylbenzene and m+p-xylene (p=0.003) and between toluene and naphthalene 
(p=0.019), as shown in Table 60. 
.  
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Table 60: Summary of the correlations between the urinary BTEX and naphthalene in the 
control subgroup. 
Control subgroup (FIXAT) 
 
Urinary 
Benzene 
(ng/L) 
(Log10) 
Urinary 
Toluene 
(ng/L) 
(Log10) 
Urinary 
Ethylbenzene 
(ng/L) 
(Log10) 
Urinary 
M+P-xylene 
(ng/L) 
(Log10) 
Urinary O-
xylene 
(ng/L) 
(Log10) 
Urinary 
Toluene (ng/L) 
(Log10) 
Pearson 
Correlation 
.204 1  
Sig. (2-tailed) .449   
Urinary 
Ethylbenzene 
(ng/L) (Log10) 
Pearson 
Correlation 
-.011 -.293 1  
Sig. (2-tailed) .969 .289   
Urinary M+P-
xylene (ng/L) 
(Log10) 
Pearson 
Correlation 
.064 .136 .705** 1  
Sig. (2-tailed) .814 .616 .003   
Urinary O-
xylene (ng/L) 
(Log10) 
Pearson 
Correlation 
.076 .211 -.082 .349 1 
Sig. (2-tailed) .779 .433 .772 .185  
Urinary 
Naphthalene 
(ng/L) (Log10) 
Pearson 
Correlation 
.147 .578* -.487 -.255 .339 
Sig. (2-tailed) .588 .019 .066 .340 .199 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
These changes of the correlation patterns, might suggest a different contribution of the 
single VOCs in the different groups, which could be caused by the different levels of exposure 
or by differences in the lifestyle of the subjects of each subgroup. 
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Table 61: Correlation table for urinary BTEX + naphthalene of FIXAT and MATCH projects. 
FIXAT and MATCH projects urinary BTEX + naphthalene (N=121) 
 
Urinary 
Benzene 
(ng/L) 
(Log10) 
Urinary 
Toluene 
(ng/L) 
(Log10)
Urinary 
Ethylben
zene 
(ng/L) 
(Log10) 
Urinary 
m+p-xylene 
(ng/L) 
(Log10) 
Urinary o-
xylene (ng/L) 
(Log10) 
Urinary 
Toluene (ng/L) 
(Log10) 
Pearson 
Correlation 
-.243** 1    
Sig. (2-tailed) .007     
Urinary 
Ethylbenzene 
(ng/L) (Log10) 
Pearson 
Correlation 
-.342** .726** 1   
Sig. (2-tailed) <0.001 <0.001    
Urinary m+p-
xylene (ng/L) 
(Log10) 
Pearson 
Correlation 
-.317** .670** .810** 1  
Sig. (2-tailed) .001 <0.001 <0.001   
Urinary o-
xylene (ng/L) 
(Log10) 
Pearson 
Correlation 
-.123 .591** .567** .735** 1 
Sig. (2-tailed) .181 <0.001 <0.001 <0.001  
Urinary 
Naphthalene 
(ng/L) (Log10) 
Pearson 
Correlation 
.260** -.259** -.362** -.324** -.207* 
Sig. (2-tailed) .007 .007 <0.001 .001 .033 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Correlations between urinary BTEX, cotinine and oxidative stress biomarker (8-oxo-dG) 
According to previously reported data, exposure to benzene is correlated with DNA 
damage, and in particular to 8-oxo-dG (Manini et al., 2010).  
A correlation matrix was created to investigate correlations between urinary VOCs and 8-oxo-
dG (Table 62). The correlation between the variables created with the sum of the different 
urinary VOCs and each of the VOCs were analysed, and most were found to be statistically 
significant, with a high correlation coefficient. Table 62 shows also the correlation between the 
urinary VOCs and the urinary cotinine. In this case, 16 of the cotinine measurements (N=90) 
were under the detection limit (0.1 µg/L), and were left in the analysis substituting them with 
½ LOD. Since the samples under the detection limit were a considerable fraction of the total 
(17%), the same analyses were performed again with the samples under the LOD for urinary 
cotinine removed from the database. This allowed us to evaluate the contribution of ETS 
exposure to the urinary VOC excretion. 
The single VOCs showed relevant correlation with the DNA damage biomarker 8-oxo-
dG for ethylbenzene (p=0.045) and xylenes (p=0.019 and p=0.035), which were generally 
measured at low concentrations in the samples. Urinary benzene was found to be not correlated 
to any of the other VOCs, as shown on Table 62, nor to any of the variables obtained by 
summing the concentration of each VOC, except for TEX, where it showed a negative 
correlation. Furthermore, no correlation between urinary benzene and 8-oxo-dG was observed, 
in contrast with previously reported data (Manini et al., 2010) which, however, focused on 
populations with higher exposure and active smokers. A marginally significant correlation was 
found between urinary benzene and urinary cotinine (p=0.048), which is consistent with 
previous work (Fustinoni et al., 2005). Interestingly, also all of the other measured VOCs 
except naphthalene were correlated to the urinary cotinine, suggesting a possible contribution 
of ETS to the VOC exposure. In Table 63 are shown the correlations between urinary cotinine 
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and VOCs after the removal of the points under the limit of detection. This passage was 
performed in order to investigate the contribution of tobacco smoke to the exposure in subjects 
that showed a measurable exposure. The correlations showed to be affected by the removal of 
the data points, becoming weaker, especially the correlation between urinary benzene and 
urinary cotinine became non-statistically significant. In general, all of the correlation 
coefficients decreased, together with the relative P values. Also, it is important to mention that 
2 samples from the occupationally exposed were classified as smokers, and 22 other samples 
were classified as ETS exposed. The analyses were repeated separating the groups in ETS 
exposed and non-ETS exposed, no statistical analyses could be performed on the smokers due 
to the small sample pool (N=2).  
In addition, the same analysis was performed with the independent measurements 
performed along with FIXAT project, which contained several samples from smokers and ETS 
exposed subjects, confirming a strong correlation between urinary cotinine and benzene 
(R=0.667, p=0.050) although the number of samples is limited (N=9). Another significant 
correlation in the independent measurements group was found between urinary benzene and 8-
oxo-dG (R=0.732, p=0.025) and urinary naphthalene, again with cotinine (R=0.700, p=0.036). 
Also, urinary cotinine was found to be strongly correlated with 8-oxo-dG (R=0.706, p=0.022). 
These findings confirm that tobacco smoke is an important source of urinary benzene, and that 
there is a strong correlation between smoking habits and oxidative stress (Evans et al., 2010; 
Manini et al., 2006). Although the results obtained using the independent measurements were 
interesting, it is important to underline that the number of samples was very small (N=9) and 
therefore, the correlation values would be higher. Due to the small number of samples and the 
statistical issues that this might cause, the results obtained for this particular subgroup were not 
taken in account for further conclusions.  
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Table 62: Correlation table for the sums of the main urinary VOCs with the single VOCs, 
cotinine and 8-oxo-dG (full data set). 
 Cotinine 
(µg/L) 
(Log10)
8-oxo-dG 
(nMol/M 
creatinine
) (Log10) 
Sum of urinary 
BTEX + 
naphthalene 
(ng/L) (Log10) 
Sum of 
urinary 
BTEX 
(ng/L) 
(Log10) 
Sum of 
urinary TEX 
(ng/L) 
(Log10) 
8-oxo-dG (nMol/M 
creatinine) (Log10) 
Pearson 
Correlation 
.013 1    
Sig. (2-tailed) .901     
Sum of urinary 
BTEX+naphthalene 
(ng/L) (Log10) 
Pearson 
Correlation 
.449** .194* 1   
Sig. (2-tailed) <0.001 .041    
Sum of urinary 
BTEX (ng/L) (Log10) 
Pearson 
Correlation 
.453** .206* .995** 1  
Sig. (2-tailed) <0.001 .030 <0.001   
Sum of urinary TEX 
(ng/L) (Log10) 
Pearson 
Correlation 
.417** .194* .987** .992** 1 
Sig. (2-tailed) <0.001 .041 <0.001 <0.001  
Urinary Benzene 
(ng/L) (Log10) 
Pearson 
Correlation 
.209* -.052 -.161 -.143 -.245* 
Sig. (2-tailed) .048 .592 .092 .137 .010 
Urinary Toluene 
(ng/L) (Log10) 
Pearson 
Correlation 
.399** .165 .967** .975** .987** 
Sig. (2-tailed) <0.001 .083 <0.001 <0.001 <0.001 
Urinary 
Ethylbenzene (ng/L) 
(Log10) 
Pearson 
Correlation 
.434** .193* .778** .782** .794** 
Sig. (2-tailed) <0.001 .045 <0.001 <0.001 <0.001 
Urinary m+p-xylene 
(ng/L) (Log10) 
Pearson 
Correlation 
.424** .240* .748** .751** .745** 
Sig. (2-tailed) <0.001 .019 <0.001 <0.001 <0.001 
Urinary o-xylene 
(ng/L) (Log10) 
Pearson 
Correlation 
.378** .200* .687** .681** .673** 
Sig. (2-tailed) <0.001 .035 <0.001 <0.001 <0.001 
Urinary Naphthalene 
(ng/L) (Log10) 
Pearson 
Correlation 
-.102 -.178 -.170 -.279** -.281** 
Sig. (2-tailed) .359 .083 .099 .006 .006 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Table 63: Correlation table between urinary VOCs and cotinine after the removal of the 
cotinine measurements under the limit of detection.  
 Cotinine (µg/L) 
(Log10) 
8-oxo-dG (nMol/M creatinine) (Log10) 
Pearson Correlation .043 
Sig. (2-tailed) .714 
Sum of urinary BTEX+naphthalene (ng/L) 
(Log10) 
Pearson Correlation .403** 
Sig. (2-tailed) <0.001 
Sum of urinary BTEX (ng/L) (Log10) 
Pearson Correlation .409** 
Sig. (2-tailed) <0.001 
Sum of urinary TEX (ng/L) (Log10) 
Pearson Correlation .371**
Sig. (2-tailed) .001 
Urinary Benzene (ng/L) (Log10) 
Pearson Correlation .200 
Sig. (2-tailed) .089 
Urinary Toluene (ng/L) (Log10) 
Pearson Correlation .335** 
Sig. (2-tailed) .003 
Urinary Ethylbenzene (ng/L) (Log10) 
Pearson Correlation .419** 
Sig. (2-tailed) <0.001 
Urinary m+p-xylene (ng/L) (Log10) 
Pearson Correlation .415** 
Sig. (2-tailed) .001 
Urinary o-xylene (ng/L) (Log10) 
Pearson Correlation .443** 
Sig. (2-tailed) <0.001 
Urinary Naphthalene (ng/L) (Log10) 
Pearson Correlation -.132 
Sig. (2-tailed) .286 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
 
 
The two analysed groups were non-ETS exposed and ETS exposed. The non-ETS 
exposed group was analysed also with the full data set, without the removal of the samples with 
cotinine concentration <LOD. All of the variables were analysed for correlation with cotinine 
and 8-oxo-dG (Table 64). Interestingly, in this case, the 8-oxo-dG was not correlated to any of 
the BTEX nor to the urinary cotinine in both the non-ETS exposed subgroups (full data set and 
dataset without samples with cotinine <LOD). Urinary cotinine was correlated to all of the 
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combinations of BTEX sums, toluene and o-xylene, with the highest significance with the sum 
of BTEX + naphthalene (p=0.010). In the ETS exposed subgroup a very strong correlation 
between urinary cotinine and 8-oxo-dG was observed, suggesting a possible contribution of 
ETS (univocally identified by the cotinine) to the oxidative stress. Moreover, 8-oxo-dG was 
found to have statistically significant correlation with all of the urinary combinations of BTEX 
sums and all of the single urinary VOCs except benzene, while for naphthalene the observed 
correlation coefficient was negative. Although the sample size for the ETS exposed subgroup 
is not very large, the group is composed of subjects that belong to all of the FIXAT subgroups 
and MATCH. These findings were confirmed by the analysis of the same correlations using 
Spearman nonparametric correlations, which provided similar results.    
It is interesting to observe that the in the ETS exposed subjects no significant correlation 
between urinary cotinine and urinary BTEX was observed. Although our sample pool for ETS 
exposed subjects is relatively small, this observation is in contrast with previous literature 
(Manini et al., 2006). One of the possible explanations to the lack of correlation, could be 
related to the groups where the ETS exposed subject come from, which are mainly MATCH 
and FIXAT occupationally exposed (Table 34). Occupationally exposed subjects are exposed 
to higher VOCs concentrations, which in this particular case act as confounding factor for ETS 
exposure. Another important information to take in account is that urinary BTEX and cotinine 
have different half-lives. Although they have a similar route of excretion which involves 
glomerular reabsorption (Jatlow, 2003), VOCs generally have an half-life that is shorter than 
cotinine. VOCs blood concentration drops to 20-30% of the initial concentration in 2-4 hours 
(Janasik et al., 2008; Bois et al., 1996; Fustinoni et al., 2009), while cotinine half-life is longer. 
Cotinine has been reported to reach T1/2 in approximately 17 hours (Benowitz, 1996). This 
difference between the half-lives of the compounds could affect the results, depending on the 
ETS exposure time, as cotinine would not be at T1/2 while the VOCs would be past that point. 
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Since the urine sampling was performed in the morning, it is possible that for some of the 
subjects the ETS exposure or smoking event happened several hours before. This, together with 
one or more bladder voiding, would cause variability in the measured VOCs, although it is still 
possible to measure the trace of the exposure, this would be affected by the time gap, while 
urinary cotinine would not. 8-oxo-dG, being a marker of oxidative stress and inflammation, is 
produced also after the exposure event. The correlation found between urinary cotinine and 8-
oxo-dG would suggest that these two compounds have similar half-lives, and are good 
biomarkers of ETS exposure, even after several hours from the exposure event.  
The correlation in the non-ETS exposed subjects between urinary cotinine and urinary 
VOCs would both place the exposure events later in the sampling day or, more likely, suggest 
a low ETS contamination that was not reported, as it was not detected. One possible route of 
exposure would be a contamination coming from outdoor air.  
Another route of exposure to ETS would be third hand smoke. Third hand smoke 
exposure is defined as the exposure arising from residual tobacco smoke contamination that 
remains after a cigarette has been extinguished (Winickoff et al., 2009). Third hand smoke is 
proven to be a source of most of the compounds associated with second hand smoke and 
cigarette smoke, however, many of the compounds last for a short time in the gas phase, and 
are found on surfaces, due to adsorption. One of the compounds that is absorbed on the surfaces 
is nicotine, together with particulate matter, which can be resuspended by mechanic action (i.e. 
dusting, vacuum cleaning) (Sleiman et al., 2014; Matt et al., 2008). Third hand ETS exposure 
can also be caused by the off gassing of smoke residuals from clothing of smokers that the 
subjects might have been in contact with (Chien et al., 2011; Fleming et al., 2012). 
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Table 64: Correlation table for urinary cotinine, 8-oxo-dG and urinary VOCs divided by ETS 
exposure (FIXAT + MATCH). 
 NON-ETS EXPOSED 
(Full data set N=66) 
NON-ETS EXPOSED 
(Cotinine <LOD 
removed N=50) 
ETS EXPOSED 
(N=22) 
Cotinine 
(µg/L) 
(Log10) 
8-oxo-dG 
(nMol/M 
creatinine) 
(Log10 
Cotinine 
(µg/L) 
(Log10) 
8-oxo-dG 
(nMol/M 
creatinine) 
(Log10) 
Cotinine 
(µg/L) 
(Log10) 
8-oxo-dG 
(nMol/M 
creatinine) 
(Log10) 
8-oxo-dG (nMol/M 
creatinine) (Log10) 
Pearson Corr. -.025 1 .003 1 .556** 1 
Sig. (2-tailed) .840  .982  .007  
Sum of urinary 
BTEX + 
naphthalene (ng/L) 
(Log10) 
Pearson Corr. .347** -.028 .365** .074 .152 .449* 
Sig. (2-tailed) .004 .826 .010 .611 .500 .036 
Sum of urinary 
BTEX (ng/L) 
(Log10) 
Pearson Corr. .334** .013 .354* .112 .139 .470* 
Sig. (2-tailed) .006 .920 .013 .445 .536 .027 
Sum of urinary 
TEX (ng/L) (Log10) 
Pearson Corr. .314* -.015 .329* .094 .118 .475*
Sig. (2-tailed) .010 .907 .021 .520 .600 .026 
Urinary Benzene 
(ng/L) (Log10) 
Pearson Corr. .215 .097 .281 .049 -.014 -.208 
Sig. (2-tailed) .083 .439 .050 .739 .952 .353 
Urinary Toluene 
(ng/L) (Log10) 
Pearson Corr. .345** -.031 .321* .068 .072 .458* 
Sig. (2-tailed) .005 .802 .025 .643 .749 .032 
Urinary 
Ethylbenzene 
(ng/L) (Log10) 
Pearson Corr. -.026 -.169 -.129 -.120 .184 .500* 
Sig. (2-tailed) .842 .186 .388 .421 .413 .018 
Urinary m+p-
xylene (ng/L) 
(Log10) 
Pearson Corr. .059 .015 .085 .016 .132 .579* 
Sig. (2-tailed) .643 .906 .570 .917 .627 .019 
Urinary o-xylene 
(ng/L) (Log10) 
Pearson Corr. .082 .075 .415** .156 .245 .474* 
Sig. (2-tailed) .514 .551 .003 .285 .273 .026 
Urinary 
Naphthalene (ng/L) 
(Log10) 
Pearson Corr. .115 -.231 .079 -.179 .243 -.492* 
Sig. (2-tailed) .369 .069 .599 .229 .347 .045 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Urinary BTEX and metabolites correlations with personal exposure data 
Personal exposure data was analysed for correlations with the urinary data, the relevant 
correlations are reported in Table 65. Urinary cotinine was found to be correlated with benzene 
(p=0.039), ethylbenzene (p=0.015) and m-xylene (p=0.044) from the personal exposure 
measurement. Surprisingly none of the personal exposure BTEX were correlated to the 8-oxo-
dG. Interestingly 8-oxo-dG was correlated to pyridine and octaldehyde. Pyridine is an ETS 
marker  that is measured in the personal exposure (Brunnemann et al., 1996; Bi et al., 2005), 
while octaldehyde is compound that is commonly used in perfumes and it showed the capability 
of triggering inflammatory response in lung cells (Song et al., 2013). Octaldehyde was 
measured only in FIXAT project, while pyridine was available also from the MATCH analyses 
(Aquilina et al., 2010).  
Pyridine was analysed for correlation with urinary cotinine, as both are markers for 
ETS. Interestingly, when the full data set was analysed (MATCH + FIXAT), no significant 
correlation was found between the two, which is in contrast to what has been reported before 
(Aquilina et al., 2010). When the data set was separated and each database (FIXAT and 
MATCH) was analysed alone, we observed that in MATCH project urinary cotinine and 
pyridine were significantly correlated (p<0.001) with a high Pearson coefficient (0.774). 
FIXAT database did not show significant correlation between pyridine and urinary cotinine. 
This finding can be explained from the fact that MATCH project involved the study of the 
effects of ETS exposure before and after the smoking ban, therefore higher levels of ETS were 
measured. In addition, the selected samples from MATCH were the samples with higher VOC 
exposure, which involved also higher ETS exposure, as demonstrated in the urinary cotinine 
concentrations. On the other hand, the selection of the volunteers in FIXAT project was aimed 
to maintain ETS exposure as low as possible, due to the known role of ETS exposure as a 
confounder and source of VOCs. Furthermore, the higher levels of ETS exposure, measured 
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from the urinary cotinine, were recorded in the occupationally exposed subjects, which were 
monitored for P.E. only during the work shift, missing out the rest of the day, and therefore not 
allowing us to measure the extent of ETS exposure through pyridine. 
The different combinations of the sums of urinary BTEX, did not show any significant 
correlation with any of the VOCs measured in the personal exposure. On the other hand, the 
sum of the BTEX measured in the personal exposure, was correlated with the urinary benzene 
(p=0.021). Many of the VOCs from the personal exposure data were found to be correlated 
with the urinary benzene: toluene (p=0.023), ethylbenzene (p<0.001), p-xylene (p=0.027), m-
xylene (p=0.029) and o-xylene (p=0.010), as reported in Table 65. The only positive 
significant correlation between the same airborne and urinary VOC was found for naphthalene 
(p<0.001). Interestingly, pyridine was found to be negatively correlated with urinary benzene 
(p=0.032), considering that pyridine is a marker of ETS and the concentration of urinary 
benzene is affected by ETS exposure, this finding would be in contrast with previously reported 
evidence. Moreover, pyridine did not show any correlation with urinary cotinine (p=0.844). 
The measured pyridine levels were low in FIXAT project, and in several of the cases under the 
LOD (0.1µg/m³). Also in this case, the readings under the LOD were substituted with ½LOD. 
This passage, due to the amount of samples <LOD, could create an artifactual correlation. To 
counter that possibility, the data points under the LOD for pyridine were removed and the 
correlations were analysed again (Table 66). After this correction, all the urinary VOCs except 
benzene showed an increased statistical significance and correlation coefficient with urinary 
cotinine, suggesting a possible contribution of ETS exposure to the urinary VOC concentration, 
despite the lack of correlation between pyridine and urinary cotinine. Interestingly, when the 
samples from MATCH project only were analysed for the same correlations, urinary cotinine 
was found to be strongly correlated with pyridine (R= 0.774, p<0.001). This could be due to 
the higher levels of ETS to which the subjects were exposed in MATCH project.  
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Table 65: Correlation table for P.E. VOCs and urinary cotinine, 8-oxo-dG and VOCs (full data set, N=83). 
 Cotinine 
(µg/L) 
(Log10) 
8-oxo-dG 
(nMol/M 
creatinine) 
(Log10) 
Sum of urinary 
BTEX + 
naphthalene 
(ng/L) (Log10) 
Sum of 
urinary BTEX 
(ng/L) 
(Log10) 
Sum of 
urinary 
TEX (ng/L) 
(Log10) 
Urinary 
Benzene 
(ng/L) 
(Log10) 
Urinary 
Toluene 
(ng/L) 
(Log10) 
Urinary 
Ethylbenzen
e (ng/L) 
(Log10) 
Urinary m+p-
xylene (ng/L) 
(Log10) 
Urinary o-
xylene 
(ng/L) 
(Log10) 
Urinary 
Naphthalene 
(ng/L) (Log10)
Sum of personal 
exposure BTEX 
(Log10) 
Pearson 
Correlation .220 -.029 -.069 -.041 -.060 .278
* -.051 .045 -.164 -.089 -.125 
Sig. (2-tailed) .117 .806 .572 .738 .626 .021 .675 .715 .237 .469 .363 
P.E. benzene (µg/m^3) 
(Log10) 
Pearson 
Correlation .255
* -.045 .047 .067 .059 .116 .074 .173 -.059 -.103 -.137 
Sig. (2-tailed) .039 .682 .676 .550 .596 .297 .504 .121 .635 .354 .261 
P.E. toluene (µg/m^3) 
(Log10) 
Pearson 
Correlation .239 -.141 -.076 -.057 -.083 .250
* -.074 -.043 -.151 -.052 -.024 
Sig. (2-tailed) .054 .192 .495 .610 .454 .023 .508 .702 .219 .640 .842 
P.E. ethylbenzene 
(µg/m^3) (Log10) 
Pearson 
Correlation .298
* -.093 -.042 -.016 -.058 .392** -.038 -.043 -.151 -.119 -.077 
Sig. (2-tailed) .015 .392 .709 .884 .601 <0.001 .732 .700 .220 .284 .528
P.E. p-xylene (µg/m^3) 
(Log10) 
Pearson 
Correlation .243 .101 .058 .095 .081 .267
* .099 .188 -.102 -.087 -.290* 
Sig. (2-tailed) .082 .394 .637 .436 .511 .027 .416 .128 .463 .477 .032 
P.E. m-xylene 
(µg/m^3) (Log10) 
Pearson 
Correlation .281
* .102 .092 .128 .113 .263* .132 .200 -.073 -.055 -.281* 
Sig. (2-tailed) .044 .389 .454 .293 .355 .029 .280 .104 .602 .651 .037 
P.E. pyridine (µg/m^3) 
(Log10) 
Pearson 
Correlation -.025 .242
* .044 .023 .027 -.258* -.034 .058 .231 .220* .049 
Sig. (2-tailed) .844 .024 .693 .839 .809 .019 .763 .607 .058 .046 .692 
P.E. o-xylene (µg/m^3) 
(Log10) 
Pearson 
Correlation .173 .134 .013 .049 .030 .310
** .047 .109 -.149 -.093 -.241 
Sig. (2-tailed) .221 .257 .912 .689 .806 .010 .700 .381 .281 .448 .076 
P.E. naphthalene 
(µg/m^3) (Log10) 
Pearson 
Correlation -.242 -.161 -.209 -.250
* -.261* .165 -.255* -.236 -.229 -.156 .494** 
Sig. (2-tailed) .084 .174 .085 .038 .030 .177 .034 .054 .095 .201 <0.001 
P.E. octaldehyde 
(µg/m^3) (Log10) 
Pearson 
Correlation -.016 .411* -.017 -.027 -.029 .086 -.053 -.088 -.060 .127 .033 
Sig. (2-tailed) .933 .019 .928 .885 .875 .638 .772 .645 .745 .487 .859 
**. Correlation is significant at the 0.01 level (2-tailed). ;  *. Correlation is significant at the 0.05 level (2-tailed). 
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Table 66: Urinary cotinine and 8-oxo-dG correlations with urinary VOCs and airborne 
pyridine after removal of points under the pyridine LOD (N=49) for the whole sample pool. 
 Cotinine (µg/L) 
(Log10) 
8-oxo-dG (nMol/M 
creatinine) (Log10) 
Cotinine (µg/L) (Log10) 
Pearson Correlation 1  
Sig. (2-tailed)   
8-oxo-dG (nMol/M creatinine) 
(Log10) 
Pearson Correlation .075 1 
Sig. (2-tailed) .609  
Sum of urinary BTEX+naphthalene 
(ng/L) (Log10) 
Pearson Correlation .683** .154 
Sig. (2-tailed) <0.001 .243 
Sum of urinary BTEX (ng/L) 
(Log10) 
Pearson Correlation .687** .183 
Sig. (2-tailed) <0.001 .166 
Sum of urinary TEX (ng/L) (Log10) 
Pearson Correlation .677** .170 
Sig. (2-tailed) <0.001 .199 
Urinary Benzene (ng/L) (Log10) 
Pearson Correlation -.099 -.087 
Sig. (2-tailed) .505 .514 
Urinary Toluene (ng/L) (Log10) 
Pearson Correlation .667** .132 
Sig. (2-tailed) <0.001 .319 
Urinary Ethylbenzene (ng/L) 
(Log10) 
Pearson Correlation .701** .192 
Sig. (2-tailed) <0.001 .153 
Urinary m+p-xylene (ng/L) (Log10) 
Pearson Correlation .690** .293* 
Sig. (2-tailed) <0.001 .037 
Urinary o-xylene (ng/L) (Log10) 
Pearson Correlation .527** .204 
Sig. (2-tailed) <0.001 .121 
Urinary Naphthalene (ng/L) (Log10) 
Pearson Correlation -.167 -.356* 
Sig. (2-tailed) .291 .011 
P.E. pyridine (µg/m^3) (Log10) 
Pearson Correlation .155 .161 
Sig. (2-tailed) .287 .207 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
 
The observed results suggest that ETS exposure plays a role in VOC exposure, 
especially when the whole dataset is analysed (Table 62 and Table 63). The findings are 
consistent with previously reported data (Fustinoni et al., 2010), where ETS exposure and 
active smoking are reported to be one of the main sources of benzene intake, although when 
the data points under the LOD of cotinine were removed, the correlation with urinary benzene 
143 
 
became not statistically significant. This behaviour could be related to the selection of the 
samples, which included mostly subjects with low ETS exposure, with only a small portion of 
subjects with higher ETS exposures. When the dataset is divided in different subgroups based 
on the measured urinary cotinine (Table 64), the correlation between ETS and benzene 
becomes weak and it loses significance. On the other hand, a strong correlation between urinary 
cotinine and 8-oxo-dG was observed for the ETS exposed subgroup. In the same subgroup, 
many urinary VOCs were found to be strongly correlated to the 8-oxo-dG (toluene, 
ethylbenzene and xylenes) but surprisingly, not urinary benzene. In the same group, urinary 
cotinine was found to be not correlated to any of the urinary VOCs or to any combination of 
sum of urinary BTEX. Interestingly the non-ETS exposed subgroup, showed a strong 
correlation between urinary VOCs and cotinine, but no correlation was found between the 
urinary VOCs and the 8-oxo-dG.  
Due to the distribution of the ETS exposed subjects in each subgroup, it is possible that 
the outcome is affected by the levels of exposure of each group. Although several ETS exposed 
subjects were found in the control group, in the occupationally exposed and in the MATCH 
project, no ETS exposure was recorded in the subjects living/working in a recently 
built/refurbished building. Since each group is characterized by different behaviour and 
exposure to different sources, the ETS contribution not being evenly distributed along the 
groups could cause a bias in the measurements. To assess the effect of the lack of ETS exposed 
subjects in one of the groups, an ANOVA test was performed to assess the differences of the 
urinary cotinine and VOCs between the various subgroups. The ANOVA test did not show 
significant difference between the subgroups when the urinary cotinine levels were compared 
for the ETS exposed subjects (p=0.517), indicating similar levels of ETS exposure throughout 
the subgroups. However, a significant difference between the subgroups was observed when 
the sums of the urinary BTEX were compared (BTEX + naphthalene p=0.039; BTEX p=0.038, 
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TEX p=0.016). For the single VOCs the only relevant differences were observed for toluene 
(p=0.013), ethylbenzene (p=0.004), m+p-xylene (p=0.010) and o-xylene (p=0.037). As 
described in section IV.3 under the ETS exposure classification comparison paragraph, the only 
significant difference between the different levels of ETS exposure was found in the levels of 
urinary benzene. On the other hand, in this case, only the ETS exposed subjects were analysed, 
and the different groups were compared identifying statistically significant differences between 
them. The main components of the ETS exposed subgroups were occupationally exposed and 
MATCH subjects. Referring to Table 37, it is possible to observe that occupationally exposed 
subjects have the highest levels of urinary benzene and naphthalene, while the MATCH 
subjects have generally higher urinary concentrations of toluene, ethylbenzene and m+p-
xylene. These findings might suggests that although the mean ETS exposure is homogeneous 
throughout the different subgroups, the different behaviour of the subjects of each subgroup 
affects the VOCs exposure. However, although the two groups are significantly different in 
terms of activities of the subjects and time of sampling (MATCH samples were collected before 
and immediately after the smoking ban), analysing the results reported in Table 64, it is possible 
to identify a threshold of exposure. This conclusion is based on the finding that for subjects 
exposed to low levels of VOCs, such as the control group and the living/working in recently 
built/refurbished buildings, one of the main sources of VOC exposure can be identified as ETS 
exposure, even though the urinary cotinine levels are very low and they are categorized as non-
ETS exposed. Only few subjects reported ETS exposure (N=11), however, only 2 were 
classified as ETS exposed based on the urinary cotinine. Most of the subjects did not report 
any ETS exposure, therefore we could assume that the subjects were not aware of the exposure. 
This conclusion, taking in account also the possibility that some subjects did not report an ETS 
exposure event even being aware of the exposure, draws the attention towards the sources of 
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urinary cotinine and VOCs. As mentioned previously, third hand smoke is a possible 
explanation, together with contamination from outdoor air.  
VOCs and ETS exposure do not seem to have an effect on 8-oxo-dG in these subjects, therefore 
the variability of the oxidative stress biomarker in these subjects is related to other sources.  
On the other hand, subjects that are exposed to higher levels of ETS, such as occupationally 
exposed subjects and MATCH project subjects, are most probably exposed also to other 
sources of VOCs (especially the occupationally exposed subjects) that, however, are 
confounded by the exposure generated by ETS, as shown in Table 34.  
IV.5 Threshold of effect 
The threshold of effect becomes very evident when the data is represented graphically: 
in Figure 38 is reported a scatter plot representing the relationship between urinary cotinine 
and 8-oxo-dG, where a reference line was placed at the corresponding cotinine concentration 
threshold between non-ETS exposed and ETS exposed subjects (1µg/L). There is an evident 
separation between the non-ETS exposed subjects (left side of the reference line) and the ETS 
exposed subjects (right side of the reference line). The variability of the 8-oxo-dG in the non-
ETS exposed subjects does not show any correlation with the urinary concentration of cotinine. 
The ETS exposed subjects and the smokers showed a correlation between the level of ETS 
exposure, measured by the urinary cotinine, and the amount of 8-oxo-dG measured.  
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Figure 38: Scatter plot representing the full data set for MATCH and FIXAT project showing 
the relationship between urinary cotinine and 8-oxo-dG. The vertical line represents the 
threshold of discrimination between ETS exposed and non ETS exposed subjects (urinary 
cotinine=1µg/L). 
 
Figure 39 shows the relationship between ETS exposure and the sum of the measured urinary 
BTEX + naphthalene (which showed the higher correlation between the various sums 
combinations with urinary cotinine in Table 66). The reference line is placed also in this case 
at the concentration threshold between non-ETS exposed and ETS exposed subjects. 
Interestingly, a correlation pattern is observed on the two sides of the reference line. A linear 
regression line was calculated, with an R2 value of 0.202. It is interesting to notice that even if 
the subjects are considered non-ETS exposed, the relationship of urinary VOCs with cotinine 
is still very strong, suggesting that in our project the main sources of BTEX exposure could be 
attributed to ETS exposure, even at very low levels. From the equation of the regression line, 
we calculated the intersection point with the reference line, in order to identify the threshold of 
effect for 8-oxo-dG, which was identified as 2.74 (550 ng/L of total BTEX + naphthalene). 
This value (“threshold of effect”) was then reported on a third graphic (Figure 40). 
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Figure 39: Scatter plot representing the full data set for MATCH and FIXAT project showing 
the relationship between the sum of urinary BTEX + naphthalene and cotinine. The vertical 
line represents the threshold of discrimination between ETS exposed and non ETS exposed 
subjects (urinary cotinine=1µg/L). 
 
In Figure 40 is possible to observe an effect threshold, where the urinary BTEX + 
naphthalene with a urinary concentration higher than the found threshold value show a 
correlation with 8-oxo-dG. Under the threshold of effect, the variability of 8-oxo-dG is not 
dependent on the urinary BTEX + naphthalene concentration.  
This findings suggest that VOC or ETS exposure are not responsible for oxidative stress 
under a certain level which is consistent with non-ETS exposed subjects, and the causes of the 
variation in the 8-oxo-dG for the non-ETS exposed subjects has to be searched elsewhere. 
However, the same findings suggest that in our samples, one of the causes of oxidative stress 
in ETS exposed subjects and smokers can be considered the VOCs, of which the ETS has 
proven to be one of the main sources. 
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Figure 40: Scatter plot representing the full data set for MATCH and FIXAT project showing 
the relationship between the sum of urinary BTEX + naphthalene and 8-oxo-dG. The vertical 
reference line identifies the intersection between the regression line of Figure 39 and the 
threshold of discrimination between ETS exposed and non ETS exposed subjects. 
 
 
 
In Table 65 and Table 66, is reported the correlation between personal exposure 
measurements and urinary VOCs and metabolites. As mentioned, airborne benzene is 
surprisingly not correlated with any of the urinary VOCs, however it showed a correlation with 
urinary cotinine. Airborne toluene, on the other hand, showed a significant correlation with 
urinary benzene, but not with urinary toluene. Similar results were obtained by using the sum 
of the airborne VOCs, which showed a correlation only with urinary benzene. Urinary benzene 
showed significant correlations with all of the airborne VOCs. This behaviour has been 
observed previously by Fustinoni et al. (2010) although in their study the airborne 
concentrations were found to be higher than in both FIXAT and MATCH. Moreover, in our 
study, subjects were selected among non-ETS exposed and a division was made between ETS 
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exposed and non-ETS exposed subjects. Our findings are coherent with the hypothesis that is 
made in Fustinoni’s work, where benzene is suggested as a potential marker of environmental 
exposure to BTEX (Fustinoni et al., 2010). However, in our study we observed a correlation 
between all of the urinary BTEX and cotinine, and between urinary cotinine and airborne 
measured pollutants, suggesting that for our population, one of the main sources of exposure 
to BTEX could be ETS, even at very low concentrations. This is confirmed for some of the 
airborne BTEX in personal exposure, as shown in Table 67, where the only compounds that 
showed a significant correlation with 8-oxo-dG were cotinine in the ETS exposed subgroup 
(p=0.007), and pyridine in the full data set (p=0.024). Moreover, benzene, ethylbenzene and 
m-xylene showed a significant correlation with urinary cotinine in the full data set, only toluene 
showed a significant correlation with urinary cotinine in the non-ETS exposed subgroup, and 
in the ETS exposed subgroup significant correlations were observed between urinary cotinine 
and airborne benzene, toluene and pyridine. These observations are in line with previously 
reported data that links cigarette smoke to BTEX, where the most abundant compounds are 
toluene and benzene (Darrall et al., 1998; Bi et al., 2005).  
Another important finding is that no combination of the sums of urinary BTEX + 
naphthalene, BTEX or TEX was found correlated with any of the airborne pollutants, except 
for pyridine (Table 65). Only urinary naphthalene showed a significant correlation (p<0.001), 
this could suggest a different source of exposure or metabolic pathway for naphthalene, which 
relates better than airborne BTEX to its urinary correspondent. Moreover, airborne and urinary 
naphthalene did not show any correlation with urinary cotinine, suggesting an alternative 
source of exposure other than ETS exposure, as previously observed by Aquilina et al. (2010). 
This would explain the high correlation observed between the airborne and the urinary 
compound, since it would not be affected by the confounding effect of ETS. This hypothesis is 
compatible with previously reported data on the BTEX and naphthalene content of cigarette 
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smoke, where naphthalene was found to have a significantly lower concentration in cigarette 
smoke, compared to the concentrations of the BTEX mixture (Bi et al., 2005; Ding et al., 2005; 
Darrall et al., 1998). Based on the same works, the ratios with the total VOCs of the single 
compounds of both personal exposure and urinary BTEX and naphthalene median 
concentrations were calculated. This procedure was performed for each of the FIXAT groups 
and MATCH, analysing the full data set, the smokers, the subjects with detectable levels of 
urinary cotinine and for subjects with urinary cotinine concentration <LOD. The subgroups 
obtained were then compared with the reported ratios of BTEX and naphthalene contained in 
mainstream cigarette smoke. 
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Table 67: overview of correlations between P.E. measurements, urinary cotinine and 8-oxo-
dG based on ETS exposure classification. 
  TOTAL (N=87)  NON ETS (N=47)  ETS (N=18) 
 
8-oxo-dG 
(nMol/M 
creatinine) 
(Log10) 
Cotinine 
(µg/L) 
(Log10) 
8-oxo-dG 
(nMol/M 
creatinine) 
(Log10) 
Cotinine 
(µg/L) 
(Log10) 
8-oxo-dG 
(nMol/M 
creatinine) 
(Log10) 
Cotinine 
(µg/L) 
(Log10) 
8-oxo-dG (nMol/M 
creatinine) (Log10) 
Pearson 
Correlation 1  1  1  
Sig. (2-
tailed)       
Cotinine (µg/L) 
(Log10) 
Pearson 
Correlation .013 1 -.025 1 .556
** 1 
Sig. (2-
tailed) .901  .840  .007  
P.E. benzene 
(µg/m^3) (Log10) 
Pearson 
Correlation -.045 .255
* -.181 .182 .355 .510* 
Sig. (2-
tailed) .682 .039 .224 .221 .149 .031 
P.E. toluene (µg/m^3) 
(Log10) 
Pearson 
Correlation -.141 .239 -.212 .303
* .020 .575* 
Sig. (2-
tailed) .192 .054 .152 .038 .939 .013 
P.E. ethylbenzene 
(µg/m^3) (Log10) 
Pearson 
Correlation -.093 .298
* -.147 .193 .086 .415 
Sig. (2-
tailed) .392 .015 .324 .194 .734 .087 
P.E. p-xylene 
(µg/m^3) (Log10) 
Pearson 
Correlation .101 .243 .248 -.004 .359 .285 
Sig. (2-
tailed) .394 .082 .133 .980 .207 .323 
P.E. m-xylene 
(µg/m^3) (Log10) 
Pearson 
Correlation .102 .281
* .251 -.005 .364 .321 
Sig. (2-
tailed) .389 .044 .129 .976 .201 .263 
P.E. pyridine 
(µg/m^3) (Log10) 
Pearson 
Correlation .242
* -.025 .250 -.243 .391 .492* 
Sig. (2-
tailed) .024 .844 .090 .099 .109 .038 
P.E. o-xylene 
(µg/m^3) (Log10) 
Pearson 
Correlation .134 .173 .278 -.015 .377 .269 
Sig. (2-
tailed) .257 .221 .091 .929 .184 .353 
P.E. naphthalene 
(µg/m^3) (Log10) 
Pearson 
Correlation -.161 -.242 -.248 .199 .067 .166 
Sig. (2-
tailed) .174 .084 .133 .230 .821 .571 
**. Correlation is significant at the 0.01 level (2-tailed). ;  *. Correlation is significant at the 0.05 level (2-tailed). 
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IV.6 Airborne and urinary BTEX ratios analysis  
Table 68: Comparison between the relative contributions of each compound to the total BTEX 
+ naphthalene amount. 
  
Benzen
e 
Toluen
e 
Ethylbenzen
e 
m+p‐
xylene 
o‐
xylene 
naphthalen
e    
Cigarette 
smoke  35.7%  49.5%  4.9%  8.1%  1.6%  0.2% 
Referenc
e values 
(airborne)
(Bi et al., 
2005) 
Indoor air  21.6%  59.5%  3.6%  11.2%  2.9%  1.2% 
Outdoor air  23.7%  49.0%  5.2%  16.9%  4.5%  0.6% 
Smoking 
home  29.6%  53.1%  3.5%  10.4%  2.5%  0.9% 
Non‐smoking 
home  15.5%  64.1%  3.6%  11.7%  3.4%  1.7% 
FIXAT smokers 
(occupationall
y exposed) 
31.7%  33.7%  6.4%  8.3%  11.1%  8.8% 
Urinary 
measured 
values  
 
IV.7 In Airborne and urinary BTEX ratios analysis  
Table 68 are reported the ratios of each BTEX compound and naphthalene in mainstream 
tobacco smoke (Bi et al., 2005), in other main microenvironments (Kim et al., 2001), and in 
the urine samples of the smokers found in FIXAT project. The smokers were present only in 
the occupationally exposed subjects, which carried the personal exposure sampling kit only 
during the work shift. Since the subjects did not smoke during the shift, the personal exposure 
data is not reported. A similarity of the ratios can be observed between the urinary BTEX of 
the smokers and the cigarette smoke, although toluene, naphthalene and o-xylene show a 
difference with the reference cigarette smoke ratios. As mentioned in section IV.2, 
occupationally exposed subjects showed higher levels of xylenes and ethylbenzene when 
compared to the other groups, therefore it is possible that the contribution of the occupational 
exposure is higher than the confounding effect of tobacco smoke. However, the differences in 
the proportions are relatively small, indicating a contribution of tobacco smoke towards the 
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overall exposure. However, the changes that can be observed between mainstream cigarette 
smoke and the different microenvironments, are mainly affecting the ratios of benzene and 
toluene, while the other measured compounds have either small variations or are present in 
such small concentrations that any small variation in the measurement would affect the 
calculated ratios. 
A similar comparison was performed with the full data set of personal exposure and 
urinary BTEX + naphthalene (Table 69, Figure 41). The personal exposure measurements 
showed a generalized different pattern of the BTEX and naphthalene, except for the MATCH 
project (sampling performed before and after the smoking ban). However, the apportionments 
of the VOCs in MATCH and FIXAT control, were very similar, while a higher contribution of 
toluene was observed for the subjects living/working in a recently built or refurbished building. 
These ratios however, are discordant with most of the reference values. This might be due to 
the lower amounts of benzene sources in outdoor air, or to a higher contribution of indoor 
sources of other VOCs, such as xylenes. The observed apportionments, however, show only 
one part of the data, since the total concentrations are not included. The median total BTEX + 
naphthalene measured in the various groups were 16.22 µg/m3 for FIXAT control, 30.32 µg/m3 
for FIXAT living/working in a new or recently refurbished building, and 30.91 µg/m3 for 
MATCH samples. FIXAT occupationally exposed subjects had a total of 32.51 µg/m3, only 
with benzene, toluene and ethylbenzene. Analysing these concentration differences, since the 
apportionments are similar for FIXAT control and MATCH, it is possible to conclude that the 
subjects could have been exposed to similar sources. Especially between FIXAT control group 
and MATCH, the airborne BTEX apportionment is extremely similar, however, the 
concentration of the total VOCs is significantly higher in MATCH subjects. Subjects living in 
a new or recently refurbished building showed higher total airborne VOCs concentrations in 
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the personal exposure, with a major contribution of toluene towards the total exposure (Figure 
41). 
Interestingly, the urinary concentrations of the compounds show a similar pattern to the 
reference values in most of the groups, except for MATCH (Table 69, Figure 42). The 
apportionments for each group do not change significantly, and the main affected compound 
appears to be the benzene. This finding would suggest common sources of VOCs. In the urinary 
VOCs from FIXAT living/working in a new or recently refurbished building, it was not 
observed the same increase of toluene relative concentration compared with the other groups. 
MATCH subjects showed a significantly lower relative concentration of urinary benzene. This 
could be due to the samples being stored for a long period with some cycles of 
freezing/thawing, causing the loss of different amounts of each compound, changing the 
relative proportions of some of the compounds.  
 
Figure 41: Graphical representation of BTEX + naphthalene apportionment in FIXAT and 
MATCH personal exposure and in the main microenvironments. 
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Figure 42: Graphical representation of urinary BTEX + naphthalene apportionment in FIXAT 
and MATCH. 
 
Table 69: Comparison between the relative contributions of each compound to the total BTEX 
+ naphthalene amount. Personal exposure and urinary concentrations are analysed for each 
group. 
   Benzene  Toluene  Ethylbenzene 
m+p‐
xylene  o‐xylene  naphthalene    
FIXAT control 
(P.E.)  8.4%  49.6%  7.2%  21.0%  9.2%  4.7% 
Full data set
personal 
exposure 
FIXAT 
living/working 
in new or 
refurbished 
building (P.E.) 
5.1%  66.5%  5.3%  12.2%  5.6%  5.3% 
FIXAT 
occupationally 
exposed (P.E.) 
18.3%  60.1%  21.6%  N/A  N/A  N/A 
MATCH (P.E.)  11.3%  47.9%  7.2%  22.7%  8.6%  2.3% 
FIXAT control 
(Urinary)  22.4%  40.0%  5.7%  10.1%  8.1%  13.7% 
Full data set
urinary 
BTEX + 
naphthalene
FIXAT 
living/working 
in new or 
refurbished 
building 
(Urinary) 
19.9%  40.1%  6.9%  10.4%  10.1%  12.7% 
FIXAT 
occupationally 
exposed 
(Urinary) 
22.4%  43.8%  5.0%  8.8%  9.1%  10.8% 
MATCH 
(Urinary)  7.7%  62.0%  8.7%  12.8%  4.9%  3.9% 
 
In order to investigate the contribution of ETS to the urinary VOC concentrations, the dataset 
was also divided according to the cotinine concentration. Taking into account the results in 
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156 
 
Figure 39, it was decided to also separate the subjects based on the detectability of urinary 
cotinine. This last group was created as it was shown that even under the threshold of 
discrimination between ETS exposed and non-ETS exposed subjects, a relationship between 
urinary cotinine and VOC concentration was still present. The obtained subgroups, based on 
the ETS exposure classification groups were compared in Figure 43. The graphical 
representation underlines that ETS exposure and active smoking affect mostly urinary benzene, 
while the other urinary VOCs tend to maintain the original proportions. 
Table 70: Comparison between the relative contributions of each compound to the total BTEX 
+ naphthalene amount for samples with detectable and non-detectable levels of urinary 
cotinine. Personal exposure and urinary concentrations are analysed for each group. 
   Benzene  Toluene  Ethylbenzene 
m+p‐
xylene  o‐xylene  naphthalene    
Cigarette smoke  35.7%  49.5%  4.9%  8.1%  1.6%  0.2%  Reference values
Non ETS‐exposed 
FIXAT (urinary)  20.7%  40.9%  6.1%  10.1%  9.5%  12.6% 
Urinary 
measures 
ETS exposed 
FIXAT (urinary)  26.8%  41.0%  4.8%  8.6%  8.0%  10.7% 
Smoker FIXAT 
(urinary)  31.7%  33.7%  6.4%  8.3%  11.1%  8.8% 
 
 
Figure 43: Graphical representation of urinary BTEX + naphthalene apportionments for each 
level of ETS exposure (FIXAT project only). 
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Table 70 shows the comparison of the proportions of each urinary VOC versus the 
mainstream cigarette smoke VOCs proportions. As mentioned previously, the apportionment 
that shows the most similarity is the urinary VOC profile of the smokers. However, the 
differences observed between the other groups are minimal, being mostly limited to benzene 
and toluene. Within the FIXAT project, also the sums of the total urinary VOCs were found to 
be consistent, with a median of 354 ng/L for the non-ETS exposed, 386 ng/L for the ETS 
exposed subjects. The smokers, unsurprisingly, had a total urinary VOCs concentration of 563 
ng/L. Considering the changes in the proportions observed in Figure 43, it is possible to 
conclude that smoking mainly affects urinary benzene, however it is also a source of toluene, 
ethylbenzene and xylenes, which are less affected in terms of proportions but showed higher 
urinary concentrations. 
In general, it was observed that the urinary naphthalene was found to be always in 
higher proportions, this would indicate a source of exposure other than ETS, however, when 
compared to the various microenvironments, also the other urinary VOCs showed higher 
proportions. As mentioned previously, naphthalene was also the only urinary VOC that showed 
a significant correlation with the airborne correspondent. This discrepancy of both urinary and 
airborne apportionments with the reference values could be explained by the different 
microenvironments visited by each subject. The overlapping contributions of each 
microenvironment or activity would make impossible to trace back the contribution of each 
microenvironment using only the apportionment. In these cases the availability of tracers for 
typical confounding factors or activities like urinary cotinine for ETS, becomes of crucial 
importance. 
The lack of correlation between personal exposure and urinary biomarkers has been 
observed previously for general population and described by Sørensen et al. (2003b). This 
could be explained referring to the half-life of the VOCs in the human body (see introduction, 
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section I.5). Since most of the VOCs have a rapid excretion curve in the first part of their half-
lives, it is possible that part of the VOCs absorbed during the exposure events of the first part 
of the sampling day were excreted or metabolized before the urine sampling. This dynamic 
absorption, metabolization and excretion, does not happen with the sorbent tubes, where all of 
the compounds that the subjects are exposed to throughout the sampling event, are adsorbed in 
the tube and are not released until the analysis.  
This hypothesis could explain the lack of correlation for most of the low concentration 
urinary VOCs and their personal exposure correspondents, which appear to be more affected 
by this effect. This effect is particularly evident when the personal exposure and urinary 
measurement apportionments of benzene and toluene in the living/working in a recently built 
or refurbished building are compared. In this case the observed apportionment of benzene in 
airborne benzene is less than 10%, while in the urine the relative amount is around 20%. This 
change can be due to the different time of sampling of the urine compared to the airborne 
sampling and the difference between sorption tubes and excretion. However, the analyses on 
the threshold of effect and on the pattern of the relative concentrations of the VOCs suggest 
that one of the sources for most of the samples could be ETS. Even when the samples were 
classified as non-ETS exposed, the urinary VOCs showed a tendency to increase with the 
increase of urinary cotinine, suggesting that any amount of ETS would contribute towards the 
exposure. FIXAT sample pool was composed by general population, with very low VOC 
exposures, therefore any source, even with a small contribution, could have affected the 
measurements. This effect is observable in Figure 43 for the different levels of urinary cotinine, 
where the urinary benzene shows an increasing trend with the increase of ETS exposure. 
Although no correlation was found between personal exposure and urinary VOC concentration, 
the obtained results show the importance of markers and tracers for specific activities that are 
known to generate exposure. The apportionment of both urinary and airborne VOCs can 
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provide information on different microenvironments, activities or sources. However, since both 
measurements only give a cumulative information on the exposure during the sampling event, 
it is not possible to separate the various contributions of each activity or source only analysing 
the VOC data. Furthermore, in our case the population had very low levels of exposure, which 
proved to be sensitive to confounding factors, such as ETS, at levels that are generally reported 
to have a negligible effect.  
 
IV.8 Considerations on 8-oxo-dG correlations 
As mentioned previously regarding the threshold of effect, the lack of correlation 
between urinary metabolites and 8-oxo-dG for the low level exposures (non-ETS exposed 
subgroup) could depend on a similar reason. It is likely that for low exposures such as the ones 
observed in the non-ETS exposed subgroup, other sources of oxidative stress could interfere 
with the observed levels of 8-oxo-dG, or that the measured exposure levels were not high 
enough to cause an observable effect. Furthermore, it is important to remember that the subjects 
that were analysed in this study were volunteers from the general population, which would 
have other sources of oxidative stress that were not included in this study. Another important 
aspect to consider is the level of 8-oxo-dG measured. In this study, the observed 8-oxo-dG 
levels were generally lower than other previously reported data for similar studies for 
occupationally exposed subjects, as shown in Table 71: 
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Table 71: Comparison between FIXAT + MATCH projects and previously reported data. 
Study 
sample subjects 
8‐oxo‐dG Geometric mean 
(µMol/M creatinine) 
8‐oxo‐dG 
Geometric Std Deviation 
FIXAT control  1.26  1.49 
FIXAT living /working in a new 
or recently refurbished 
building 
1.29  1.37 
FIXAT occupationally exposed  1.13  1.39 
MATCH high exposed subjects  1.31  1.38 
Manini et al. 2010  
Gasoline pump attendants  1.71  0.60 
Bagryantseva et al., 2010 
Bus drivers 
5.67 
(mean) 
2.50 
(std deviation) 
 
Within the measured airborne VOCs, another interesting correlation that was observed is the 
one between 8-oxo-dG and the airborne octaldehyde (p=0.019) measured in the personal 
exposure (Table 65). When translated in a graphic (Figure 44), the correlation appears evident. 
Unfortunately, only the measurements from control and living/working in a recently 
built/refurbished building groups were available for octaldehyde. However, the two groups are 
homogeneous, and the trend is present in both groups.  
Octaldehyde (also known as octanal) is a compound used in perfumes that provides a citrus 
smell. It can be found in many household products and in perfumes. It is classified as an irritant 
(Clayton, 1995), and in-vitro tests showed that exposure of A549 cells to octaldehyde results 
in production of interleukin-6 and interleukin-8 (IL-6 and IL8) which are known triggers of the 
inflammatory process. It is possible that exposure to octaldehyde might trigger an inflammatory 
response, that can result in an increase of oxidative stress due to the immune response to the 
inflammation (Knaapen et al., 2006; Klebanoff, 2005). Another possibility is that octaldehyde 
is an ingredient of some (or several) consumer product(s), which might contain a compound 
that has not been measured in our project, which causes an increase of oxidative stress. In the 
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last case, it would be possible to use octaldehyde to trace and identify the product or the group 
of products or behaviours that led to the increased oxidative stress.   
 
Figure 44: Scatter plot representing the relationship between octaldehyde and 8-oxo-dG. 
 
 
IV.9 Correlation among urinary biomarkers and personal exposure to PAHs and 
quinones 
In addition to airborne VOCs, airborne PAHs and quinones were also analysed for 
personal exposure, following the procedure described by Delgado-Saborit et al. (2013). Further 
data was obtained from MATCH project database for personal exposure measurements of 
PAHs and for urinary PAHs metabolites (Harrison et al., 2009; Delgado Saborit et al., 2009). 
All of the available measurements were analysed for correlations with urinary VOCs, cotinine 
and 8-oxo-dG.  
The data showed a positive skewness, therefore, the measurements were log10 transformed.  
When the full dataset (FIXAT + MATCH) was analysed, many of the analysed PAHs 
and quinones were found to be correlated mainly with cotinine and toluene, however, other 
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statistically significant correlations were observed with other markers. The statistically 
significant correlations are presented in Table 72: 
Table 72: Statistically significant correlations of airborne PAHs and quinones and urinary 
markers. 
Airborne PAH Correlation with urinary 
marker (full data set) (N=60) 
Correlation in non ETS 
exposed subjects 
(N=45) 
Acenaphthylene Cotinine (R=0.375, p=0.007) 
Toluene (R=0.343, p=0.010) 
Not significant 
Not significant 
Acenaphthene Cotinine (R=0.289, p=0.040) 
Ethylbenzene (R=0.450, 
p=0.001) 
Not significant 
Not significant 
Fluorene Ethylbenzene (R=0.401, 
p=0.006) 
m+p-xylene (R=0.298, p=0.040) 
Not significant 
Not significant 
Phenanthrene 8-oxo-dG (R=0.328, p=0.011) 
m+p-xylene (R= 0.457, p=0.001) 
Not significant 
Not significant 
Fluoranthene Cotinine (R=0.434, p=0.001) 
Toluene (R=0.450, p<0.001) 
Ethylbenzene (R=0.539, 
p<0.001)
Not Significant 
(R=0.405, p=0.006) 
Not significant 
Pyrene Cotinine (R=0.331, p=0.014) Not significant 
Chrysene Cotinine (R=0.331, p=0.017) Not Significant 
Benzo(b)fluoranthene Cotinine (R=0.278, p=0.042) 
Toluene (R=0.324, p=0.012) 
Ethylbenzene (R=0.360, 
p=0.006) 
Not significant 
(R=0.379, p=0.010) 
Not significant 
Benzo(k)fluoranthene Cotinine (R=0.297, p=0.029) 
Toluene (Not significant) 
Not significant 
(0.338, p=0.023) 
Indeno(1,2,3-cd)pyrene Toluene (R=0.290, p=0.024) Not significant 
Benzo[ghi]perylene Ethylbenzene (R=0.326, 
p=0.013) 
Not significant 
Coronene Toluene (R=0.332, p=0.026) Not significant 
9,10-anthraquinone Toluene (R=0.308, p=0.039) (R=0.341, p=0.027) 
 
As mentioned above, correlations were observed mainly with urinary cotinine and toluene, 
which is the most abundant compound between the measured urinary VOCs. This pattern of 
correlation might indicate a common source for both VOCs and PAHs. However, the 
correlations between urinary cotinine and most of the airborne PAHs suggest that one of the 
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sources of these compounds could be also ETS. As previously reported in other works, not only 
VOCs but also PAHs are present in high concentration in cigarette smoke (Bi et al., 2005). 
Another suggested source of ETS related PAHs could be third hand smoke (Fleming et al., 
2012). It has been previously reported that dust in smokers houses contains higher levels of 
PAHs and a correlation between cotinine in the dust and PAHs has been observed (Hoh et al., 
2012). When the sample pool is divided based on ETS exposure, the correlations of airborne 
PAHs with cotinine lose statistical significance in both the ETS exposed and the non ETS 
exposed subgroup. However, the correlation between some of the airborne PAHs and toluene 
is conserved, suggesting a different source for the PAHs, together with ETS. 9,10-
anthraquinone has been reported to be formed both as a derivate of oxidation of anthracene via 
UV light and ozone reaction, and directly emitted by diesel engines (Albinet et al., 2007). The 
traffic source would be in accordance with the observed correlation of anthraquinone with 
toluene. The correlation of PAHs with toluene strongly suggests a traffic related source, 
together with the ETS, since in the non ETS exposed subjects, although the correlation with 
cotinine is not significant, the correlation with toluene does not lose significance. Moreover 
fluoranthene, benzo(b)fluoranthene and benzo(k)fluoranthene have been linked with traffic and 
industrial emissions and are routinely monitored (Lodovici et al., 2003; Villar-Vidal et al., 
2014).  
In addition, benzo(k)fluoranthene, in this subgroup shows a statistically significant correlation 
with urinary toluene (R=0.338, p=0.023)  that was not observed in the full data set.  
The same analyses were performed on the ETS exposed subjects, however, the amount of 
samples with available measurements was very limited (N=8). In this case, we observed a 
similar behaviour to the one described in section IV.4: the urinary cotinine was not found to be 
correlated with any of the airborne PAHs while several PAHs showed a correlation with 8-oxo-
dG, suggesting the presence of a threshold of effect also in this case. Unfortunately, the 
164 
 
available number of data was too low to perform similar analyses and determine a threshold of 
effect for the oxidative stress.  
 
Table 73: Summary of the main correlations between airborne PAHs and urinary biomarkers 
for the ETS exposed subgroup.  
Airborne PAH Correlation with urinary marker 
(ETS-exposed)
Acenaphthene 8-oxo-dG (R=0.941, p=0.017) 
(N=5) 
Phenanthrene 8-oxo-dG (R=0.849, p=0.008)  
Urinary ethylbenzene (R=0.782, 
p=0.022) 
(N=8) 
Pyrene 8-oxo-dG (R=0.735, p=0.038) 
(N=8) 
Benzo[ghi]perylene 8-oxo-dG (R=0.717, p=0.035) 
(N=8) 
Benzo(a)anthracene o-xylene (R=0.710, p=0.048) 
(N=8) 
Chrysene o-xylene (R=0.739, p=0.036) 
(N=8) 
Dibenz(a,h)anthracene o-xylene (R=0.790, p=0.020) 
(N=8) 
Fluoranthene Urinary toluene (R=0.763, 
p=0.028)  
(N=8) 
 
In the ETS exposed group, significant correlations were observed between 8-oxo-dG and 
acenaphthene, phenanthrene, pyrene, benzo[ghi]perylene. Airborne PAHs were found to be 
correlated also with urinary VOCs, mainly with urinary o-xylene, which was correlated with 
benzo(a)anthracene, chrysene, dibenz(a,h)anthracene. The other correlations were observed 
between urinary ethylbenzene and phenanthrene, and between fluoranthene and urinary 
toluene. The results are summarized in Table 73. Negative correlations were observed between 
urinary naphthalene and most of the airborne PAHs, but unfortunately the number of available 
data was too small (N ≤ 5). Due to the very low number of cases, the results obtained for these 
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correlations were not considered in further analyses, although the results are interestingly 
similar to the ones observed with the urinary VOCs and the threshold of effect. The observed 
behaviour would suggest a similar effect, where ETS plays a role as a source of PAHs, but the 
effects (i.e. oxidative stress) are observed only for the higher levels. 
For the MATCH project samples, together with airborne measurements of PAHs, also 
some urinary PAH metabolites measurements were available. Despite the limited amount of 
available measurements (N=20), a Pearson correlation matrix was calculated. In general, the 
urinary PAH metabolites were found to be correlated within themselves, with R values ranging 
from 0.589 up to 0.892, consistent with the findings of previous analyses of the full data set 
(Aquilina et al., 2010). Unfortunately, no significant correlations were identified between the 
urinary PAH metabolites and the urinary VOCs, cotinine and 8-oxo-dG. However, both 1- and 
2-hydroxyphenanthrene showed a marginally significant correlation with airborne 
acenaphthylene (R=0.672, p=0.047, N=9) and 1-hydroxypyrene showed a marginally 
significant correlation with fluoranthene (R=0.613, p=0.045, N=11).  
It has been suggested that urinary metabolites of PAHs should be normalized versus urinary 
creatinine due to the excretion as glucuronide conjugates of the hydroxy-PAHs (Jongeneelen 
et al., 1987; Jongeneelen, 2001), therefore the urinary PAH metabolite data was used after 
normalization against creatinine. 
 Interestingly, although MATCH subjects were exposed to higher levels of ETS, no 
correlation was found between any of the urinary PAHs and urinary cotinine. It is important to 
mention that the sample size was relatively small, and this might have affected negatively some 
of the analyses. However, in this case, the single hydroxy PAHs did not show correlations with 
any of the airborne VOCs. The only correlations were found between 1- and 2-
hydroxyphenanthrene and hydroxypyrene with two airborne PAHs that are not their parent 
compounds (acenaphthylene and fuoranthene). This finding is consistent with previously 
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reported analyses on the full MATCH data set (Aquilina et al., 2010). This finding would also 
suggest a different source for both hydroxypyrene and hydroxyphenanthrene (e.g. dietary 
intake). The analysis of MATCH project data proposed dietary intake as a primary source of 
urinary PAH metabolites (Harrison et al., 2009; Aquilina et al., 2010). PAH exposure is known 
to cause DNA adducts and DNA breaks (Jongeneelen, 2001), and 1-hydroxypyrene, together 
with 2-naphthol, showed a significant correlation with 8-oxo-dG in leukocytes, although this 
relationship is affected by genetic polymorphism (Kim et al., 2003). However, we did not 
observe such correlations in our data. 
These findings suggest that most of the airborne PAHs are correlated with ETS, due to 
the relationship that has been observed with urinary cotinine. Moreover, the measured PAH 
species appear to have a common source with toluene, which is likely to be due to other sources 
such as traffic, in fact a loss of significance of the correlation with cotinine was observed when 
the non-ETS exposed group was analysed. This loss of significance was not observed for the 
unmetabolized VOCs, as showed in the results presented in section IV.4, suggesting that 
unmetabolized VOCs could be better biomarkers of low level ETS exposure. However, this 
same finding suggests that even low levels of ETS, which are generally classified as negligible, 
can be a confounding factor in general population.  
Another interesting finding was the correlation of phenanthrene with 8-oxo-dG, and the 
lack of correlation of the same PAH with urinary cotinine. These finding shows a weak but 
significant link between airborne phenanthrene with oxidative stress, suggesting an action 
(either direct or indirect) of this compound on the DNA, and at the same time, no evidence of 
ETS as a potential source. Although it has been observed that without metabolic activation in 
vitro, phenanthrene is inactive on DNA (Platt et al., 2008), a disruption on redox balance in 
neutrophils has been reported, where exposure led to reduction of neutrophils function. 
Phenanthrene is known to be subjected to metabolic activation and cause oxidative stress via 
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redox cycling (Asahi et al., 2014). Moreover, in a previous work from Singh et al. (2008), a 
correlation between PAH exposure and oxidative stress levels has been observed. Although in 
that case no specific DNA damage biomarkers were analysed, our findings are in line with the 
conclusion of that work, as we identified phenanthrene as a possible contributor to DNA 
damage via oxidative stress, even in general population.  
IV.10 Principal component analysis 
The correlations between the variables of the dataset were analysed with principal 
component analysis (PCA) in order to determine the main variables that influence the variance 
of the dataset. Due to the high number of variables and their different provenance and 
availability, the analysis was performed in successive steps, adding a group of variables at a 
time.  
Urinary cotinine is a biomarker of ETS exposure and smoking habits, while 8-oxo-dG is a 
biomarker of oxidative stress, which is one of the effects of exposure. Therefore, the two 
compounds were always kept in the analyses due to their relationship with all of the data.  
The first batch of analyses was performed introducing all the urinary VOC measurements 
(BTEX and naphthalene). Missing data was substituted with the mean for each variable as a 
standard procedure of the SPSS software in order to maximise the number of cases included in 
the analyses, that in case of missing values for a variable, would not be included. However, 
when variables containing substituted values, the analyses were repeated without the 
substitution. In the first batch, with the urinary BTEX and naphthalene, no data was missing, 
and only in a small amount of cases, the readings were under the LOD. The readings <LOD 
were substituted with ½ LOD. 
The full dataset was analysed, including all of the FIXAT and MATCH samples, the smokers 
were not excluded. Prior to analysis, the data was checked for adequacy with a Kaiser-Meyer-
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Olkin (KMO) test and a Bartlett’s test of sphericity. For the full data set, KMO score was 0.719 
(suggested minimum is 0.6) and Bartlett’s test was statistically significant (p<0.001).  
The communalities table showed a generally high coefficient of the extraction result for 
all of the variables, as shown in Table 74. 
 
Table 74: Communalities table for the full data set. 
Communalities 
 Initial Extraction
Cotinine (µg/L) (Log10) 1.000 .752
8-oxo-dG (nMol/M creatinine) (Log10) 1.000 .645
Urinary Benzene (ng/L) (Log10) 1.000 .829
Urinary Toluene (ng/L) (Log10) 1.000 .663
Urinary Ethylbenzene (ng/L) (Log10) 1.000 .870
Urinary M+P-xylene (ng/L) (Log10) 1.000 .922
Urinary O-xylene (ng/L) (Log10) 1.000 .677
Urinary Naphthalene (ng/L) (Log10) 1.000 .595
 
The components were extracted until an Eigenvalue<1 was obtained. Component 1 
explained 44.9% of the variance, component 2 16.3%, and component 3 13.2%. Coefficients 
under 0.1 were suppressed, due to their low relevance. The results of this extraction are reported 
in Table 75. 
Table 75: Component matrix for the full data set (urinary metabolites only). 
Component Matrix 
 Component 
(% of variance) 
1 
(44.9%)
2 
(16.3%)
3 
(13.2%)
Cotinine (µg/L) (Log10) .418 .759  
8-oxo-dG (nMol/M creatinine) (Log10) .292 -.227 .713
Urinary Benzene (ng/L) (Log10) -.207 .775 .430
Urinary Toluene (ng/L) (Log10) .780 .122 -.199
Urinary Ethylbenzene (ng/L) (Log10) .927  -.106
Urinary M+P-xylene (ng/L) (Log10) .958   
Urinary O-xylene (ng/L) (Log10) .811 -.136
Urinary Naphthalene (ng/L) (Log10) -.498 .237 -.540
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The components obtained reflect the results observed in the correlation analyses. The loadings 
of first component, which represents the majority of the total variance, indicate that the 
variance is mainly represented by the urinary VOCs and the urinary cotinine, while a minor 
contribution is given by the urinary 8-oxo-dG. Interestingly, in this component, urinary 
benzene and naphthalene have a negative coefficient. This component is likely to be related to 
the overall exposure to VOCs of the subjects, with a minor contribution from ETS (represented 
by the urinary cotinine), with a small significance of the oxidative stress biomarker towards 
the variance.  
The second component could be related to the ETS, as the main loadings are on urinary cotinine 
and urinary benzene, which are both linked to ETS exposure. Interestingly, in this case 8-oxo-
dG has a negative coefficient, in contrast to the coefficient found in component 1.  
The third component represents mainly urinary benzene and 8-oxo-dG, and could represent the 
linkage between benzene, which is the main compound responsible for DNA damage, with the 
relative DNA damage biomarker.  
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Figure 45: Scatter plot of component 1 and 2 obtained by PCA. Two main clustering are 
observed for occupationally exposed and MATCH subjects. 
 
Figure 45 shows a scatter plot obtained with the component 1 and 2 (61.2% of variance 
explained), where two clusters are defined, one with MATCH subjects and one with 
occupationally exposed subjects. No clustering or separation is observed between control and 
living/working in a recently built or refurbished groups. 
8-oxo-dG in the first two components does not show a high coefficient, and in addition, in the 
second component it shows a negative coefficient with a similar value observed in component 
1. Only in component 3 the coefficient value becomes significantly higher, taking in account 
the percent contribution towards the total variance of the third component (13.2%), this result 
suggests that oxidative stress does not contribute much towards the variance of this set of 
variables. A higher contribution is provided by urinary cotinine, which has generally high 
coefficients, especially in component 2, suggesting that ETS exposure accounts for a good 
portion of the variability of this set of variables in the full data set. Urinary TEX show very 
high coefficients in component 1, but the loadings become smaller in component 2 and some 
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of them have a negative coefficient in component 3. However, component 1 alone represents 
over 44% of the total variance, suggesting that urinary TEX are the main contributors towards 
the variance in our data pool. Considering the loading of urinary cotinine in component 1 and 
2, it is possible to include also cotinine as a main contributor towards the total variance. 
Interestingly, benzene shows a negative coefficient in component 1, but it shows a high 
coefficient in component 2, together with urinary cotinine, underlining the linkage between 
ETS exposure or smoking habits and urinary benzene concentration. Benzene is not the highest 
concentration compound in the observed samples, and the measurement showed a low amount 
of outliers, except in the cases of high ETS exposure and active smoking. This might explain 
the lower relevance of benzene in the first component and a higher loading in the second 
together with urinary cotinine. However, we did not observe a correlation between urinary 
benzene and cotinine in the ETS exposed subjects. This could be explained by an overall lower 
concentration of benzene in the exposure, that is associated with a higher metabolism, which 
has been suggested although there is an open debate on the topic (Rappaport et al., 2013; Price 
et al., 2013).  
Furthermore, all of the BTEX have similar half-lives, and the excretion rate is similar across 
the BTEX mixture, as mentioned in section I.5. All of the BTEX share a similar metabolic 
pathway, which involves CYP 2E1. Although different effects have been observed for 
exposures to mixtures such as metabolic suppressions and interactions, the particular cases 
consisted in high exposures (above 25ppm), which are significantly higher than the exoposures 
levels of our study (Bois et al., 1996; Heinrich-Ramm et al., 2000; Miller and Edwards, 1999).  
When in component 3 8-oxo-dG shows a high coefficient, urinary benzene is the only 
compound suggesting a linkage between the two, which would be compatible to the known 
benzene genotoxicity (Hartwig, 2010; Barreto et al., 2009; Snyder and Hedli, 1996). Taking in 
account the coefficients for benzene and 8-oxo-dG observed in component 2, this linkage 
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appears to be weak in this population. However, within all the compounds analysed, benzene 
is the only known carcinogen and a correlation between urinary benzene and oxidative stress 
have been previously observed (Andreoli et al., 2012; Snyder and Hedli, 1996; Manini et al., 
2010). 
Naphthalene does not appear to contribute much towards the variance of the dataset, 
and in components 1 and 3, it shows a negative coefficient. 
As a second step, personal exposure measurements were added to the variable set, and the same 
procedure was repeated. Within the personal exposure measurements, together with BTEX and 
naphthalene, also octaldehyde, pyridine, cumene, dipentene and styrene were included in the 
analysis. KMO test for this subset, returned a value of 0.769, and the sphericity test was 
significant (p<0.001). The components were extracted until an Eigenvalue<1 was reached. It 
is important to mention that the missing data was substituted with the mean in each variable. 
This operation was performed in order to avoid excluding variables that contained missing 
data. Since occupationally exposed and MATCH subjects’ samples were not analysed for all 
the compounds, the substitution with the mean allowed to use all of the variables. 
Occupationally exposed subjects’ personal exposure was sampled only in the first sampling 
day, and in that event, only benzene, toluene, ethylbenzene and pyridine were analysed. 
Substituting the mean in missing values can affect the test, therefore, the same procedure was 
performed again excluding the missing values. 
When the full data set with the substituted values were analysed, 7 components were 
extracted, which explained a total of 76.9% of the variance. However, the first 5 components 
explained a cumulative 68% of the variance. Also in this case, coefficients <0.1 were 
suppressed. The results of the extraction are reported in Table 76. 
. 
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Table 76: Component matrix for the full data set (urinary metabolites and personal exposure 
measurements). 
Component Matrix 
 Component 
(% of variance) 
1 
(28.6%)
2 
(14.7%) 
3 
(12.8%)
4 
(6.1%)
5 
(5.7%) 
6 
(4.6%) 
7 
(4.3%)
Cotinine (µg/L) (Log10) .116 .477 -.127 .245 .352 .346 .243
8-oxo-dG (nMol/M creatinine) (Log10) .312 .163 -.115 -.545 .202 .315
Urinary Benzene (ng/L) (Log10) .195 -.281 -.379 .229  .387 .482
Urinary Toluene (ng/L) (Log10) .819 .191   -.186
Urinary Ethylbenzene (ng/L) (Log10) .879 .116   -.218
Urinary M+P-xylene (ng/L) (Log10) .838 .297 .139   
Urinary O-xylene (ng/L) (Log10) .698 .284 .287 .125  .239
Urinary Naphthalene (ng/L) (Log10) -.149 -.424 .501  .130 -.248
P.E. octaldehyde (µg/m^3) (Log10) .322 .371 .145 -.386 .527 
P.E. benzene (µg/m^3) (Log10) .588 .137 -.441 .193 .126 -.233
P.E. toluene (µg/m^3) (Log10) .461 -.311 .196 .445 -.197 .308
P.E. ethylbenzene (µg/m^3) (Log10) .718 -.444 .103 .207 .197 
P.E. p-xylene (µg/m^3) (Log10) .861 .135 -.314 -.264 -.140 
P.E. m-xylene (µg/m^3) (Log10) .873 .164 -.321 -.219  
P.E. pyridine (µg/m^3) (Log10) .567 .111 -.230 -.265 .392
P.E. o-xylene (µg/m^3) (Log10) .885 -.257 -.284 -.106 
P.E. cumene (µg/m^3) (Log10) .676 -.108 .533 -.248 .293  
P.E. dipentene (µg/m^3) (Log10) .414 -.135 .497 .284  .253 -.251
P.E. n-propylbenzene (µg/m^3) (Log10) .657 .493 -.390 .302  
P.E. styrene (µg/m^3) (Log10) .513 -.246 .361 .151 .183 -.415 .189
 
 
In this case, a major contribution of the personal exposure was observed in the 
explanation of the variance. Coefficients in component 1 were higher for P.E. ethylbenzene 
and xylenes. P.E. benzene, toluene, cumene, n-propylbenzene and styrene showed moderate 
contribution towards the variance, while a minor contribution was observed for dipentene, 
octaldehyde and urinary benzene. This pattern reflects the main differences between the groups 
observed in section IV.3. Component 2 showed higher coefficients for urinary TEX and 
cotinine, similarly to the previous analysis (Table 75), suggesting that the main contribution 
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towards the variance of the data pool is provided by P.E. benzene, ethylbenzene, xylenes and 
urinary toluene, ethylbenzene and xylenes (cumulative coefficient loading for component 1 and 
2 = 43.3%). Component 3 shows a dominance of P.E. octaldehyde, pyridine, cumene, dipentene 
and styrene, with high coefficient, while a minor contribution towards the variance, is 
attributable to benzaldehyde and urinary benzene, this last one with a negative coefficient. 
From component 4 to component 7, we can observe a redundancy of the coefficients that, 
together with the low component relevance in explaining the variance (only 6.1% for 
component 4), suggest that those components are not significant towards the analysis.  
When the analysis was repeated eliminating the cases with missing values, the KMO 
score was not sufficient to validate the analysis (0.439). Taking in account the number of 
components extracted and the coefficients obtained in Table 76, this analysis could be 
considered inconclusive, due to the low percentage of variance explained by each component. 
The analysis was then repeated excluding the variables with missing data. For the 
personal exposure measurements, only benzene, toluene, ethylbenzene were used, obtaining a 
KMO score of 0.716. Bartlett’s test of sphericity was found to be significant (p<0.001).  
Interestingly, in the communalities table, the extraction coefficient of urinary benzene was 
found to be low (0.254).  Three components were extracted, the results of the analyses are 
reported in Table 77.  
In this case, component 1 showed a prevalence of high coefficients in the urinary VOCs, 
specifically toluene, ethylbenzene, and xylenes and a moderately high coefficient was observed 
for urinary cotinine and 8-oxo-dG. Component 2 showed high coefficients for all of the P.E. 
measurements, together with urinary cotinine, suggesting that the two variables are linked. 
Component 3 showed a high coefficient for urinary naphthalene and 8-oxo-dG, which showed 
a negative coefficient.  
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A possible interpretation of the components is similar to the one proposed for Table 75, 
where the first component represents the differences in the exposure to VOCs of the subjects, 
which are mostly represented by the urinary TEX and cotinine, and are not reflected by the 
P.E. measurements. The second component could represent the contribution of ETS towards 
the exposure, as urinary cotinine and urinary benzene have slightly higher coefficients, and a 
higher VOC exposure could be also the reason for the higher coefficients of the P.E. VOCs.  
While the third component in Table 75 clearly represents the linkage between exposure 
and effect, in this case (Table 77) it is not possible to determine any relationship with 8-oxo-
dG, which has a low coefficient in the first two components and a negative coefficient in the 
third.  
The variance is mainly related to different levels of exposures, and in particular the 
personal exposure measurements of benzene, toluene and ethylbenzene are to be considered 
the main contributors to the variance. Within the urinary metabolites, cotinine plays an 
important role in contributing towards the variance, both with personal exposure and urinary 
BTEX. Within the urinary BTEX and naphthalene, the main compounds responsible of the 
variance are generally toluene, ethylbenzene and xylenes. Urinary benzene contributes to the 
variance, but never in a measure that is comparable to the other urinary VOCs, moreover, 
benzene coefficient in component 1 and 2 has similar values, but in the first component it shows 
a negative contribution, while in the second component the contribution is positive. This 
suggests that the contribution of urinary benzene towards the variance is very limited, 
especially when also personal exposures are included in the analyses. These analyses also 
suggest that naphthalene is not responsible for the variance of the data, reflecting the previous 
observations in section IV.4. 
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Table 77: Component matrix for urinary metabolites and main personal exposure 
measurements (full data set). 
Component Matrix 
 Component 
1 
(35.8%)
2 
(22.5%) 
3 
(10.5%)
Cotinine (µg/L) (Log10) .425 .590 .342
8-oxo-dG (nMol/M creatinine) (Log10) .341 -.367 -.595
Urinary Benzene (ng/L) (Log10) -.379 .332  
Urinary Toluene (ng/L) (Log10) .790 .109 .343
Urinary Ethylbenzene (ng/L) (Log10) .927 .144  
Urinary M+P-xylene (ng/L) (Log10) .962   
Urinary O-xylene (ng/L) (Log10) .816   
Urinary Naphthalene (ng/L) (Log10) -.546  .666
P.E. benzene (µg/m^3) (Log10)  .815 -.274
P.E. toluene (µg/m^3) (Log10) -.255 .642  
P.E. ethylbenzene (µg/m^3) (Log10) -.238 .873 -.196
 
A third PCA analysis was attempted, including the measured PAHs and quinones in the 
variables. However, any combination did not return a KMO score that was acceptable for the 
analyses. Moreover, in the occupationally exposed subjects, airborne PAHs and quinones were 
not measured, significantly reducing the size of the data set.  
 
In conclusion, PCA analysis showed a dominance of urinary toluene, ethylbenzene and 
xylenes as responsible factors explaining the variance of urinary measurements, followed by 
cotinine and, lastly, by 8-oxo-dG (Table 75). When the variables were analysed together with 
personal exposure measurements, the P.E. showed to provide a higher contribution to the 
variance of the samples, compared to the urinary markers (Table 76). However, it must be 
considered that the lack of the measurements of some compounds in the occupationally 
exposed subjects might have affected the results. In fact, when only the measured airborne 
VOCs were added to the variable pool, the main contribution to the variance was provided by 
the urinary VOCs (Table 77). Cotinine, in both cases, showed to contribute towards the 
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variance, confirming the linkage between ETS and both urinary and airborne VOCs. 8-oxo-dG 
did not appear to be one of the main contributors towards the data variance, although it did 
show a moderate contribution.  
PCA analysis results suggest that urinary BTEX are a valuable tool for evaluating 
exposure, the findings also confirm that one of the sources of VOCs in our samples can be 
related to ETS exposure. Unfortunately, due to the lack of some measurements, airborne PAHs 
could not be included in the analyses. This last step could have provided further insights on the 
characterization of the groups, taking in account the results obtained in section IV.9.  
 
IV.11 Linear regressions  
Due to the gaps in available data for some of the variables, a single regression model 
was found to be unsuitable to model all the variables together. The model could be calculated 
only using the cases that did not have any missing data in any of the variables, unless a 
correction policy is applied. All of the models were calculated on 75% of the sample, and 
validated against the remaining 25%. A first linear regression was calculated including all of 
the measured urinary VOCs and cotinine, P.E. VOCs, airborne PAHs and the information 
gathered through the questionnaires. This was possible only for the control group and for both 
samplings of the living/working in a new or recently refurbished building group (N=44). The 
included variables, together with all of the measured airborne and urinary VOCs and airborne 
PAHs, were: group/sampling event, gender, age range. These variables for the groups included 
in the analysis were found homogeneous, only the age range showed a statistically significant 
difference in the occupationally exposed subjects (section IV.1). The dependent variable was 
set to be 8-oxo-dG, in order to investigate if it was possible to create a model that would 
estimate the oxidative stress based on the exposure.  
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The model was developed on SPSS, using the stepwise option, which allowed to add 
the optimum number of variables to obtain the best fit on the data. The obtained models only 
included airborne PAHs and the age range. This finding is compatible with the results shown 
in section IV.9 and IV.10. The results are summarized in Table 78. 
 
Table 78: Summary of the linear regression model for 8-oxo-dG based on FIXAT project 
samples. Occupationally exposed subjects were excluded due to the lack of airborne PAH data. 
Variables Entered/Removeda 
Model Variables Entered Variables Removed Method 
1 
Benzo(a)pyrene . Stepwise (Criteria: Probability-of-F-to-enter <= .050, 
Probability-of-F-to-remove >= .100). 
2 
Age range . Stepwise (Criteria: Probability-of-F-to-enter <= .050, 
Probability-of-F-to-remove >= .100). 
3 
9,10 anthraquinone . Stepwise (Criteria: Probability-of-F-to-enter <= .050, 
Probability-of-F-to-remove >= .100). 
4 
Anthracene . Stepwise (Criteria: Probability-of-F-to-enter <= .050, 
Probability-of-F-to-remove >= .100). 
a. Dependent Variable: 8-oxo-dG (nMol/M creatinine) 
Model Summary 
Model R R Square Adjusted R 
Square 
Std. Error of the Estimate 
4 .908d .825 .775 .20828
d. Predictors: (Constant), Benzo(a)pyrene, Age range, 9,10 anthraquinone, Anthracene 
 
 
The obtained coefficients (Table 79) were then validated by calculating the 8-oxo-dG 
values for the 25% of the data that was not included in the model, and the normalized mean 
bias (NMB) was calculated using the following equation (Harrison et al., 2009): 
Equation 3 
ܰܯܤሺ%ሻ ൌ ∑ ሺݕ௣௥௘ௗ௜௖௧௘ௗ െ ݕ௠௘௔௦௨௥௘ௗሻ
௡௜ୀଵ
∑ ሺݕ௠௘௔௦௨௥௘ௗሻ௡௜ୀଵ ൈ 100 
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Table 79: Summary of coefficients, standard error and significance (FIXAT project without 
occupationally exposed subjects). 
Coefficientsa 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 
B Std. Error Beta 
4 
(Constant) .748 .265  2.819 .014
Benzo(a)pyrene .140 .026 .604 5.305 .000
Age range .361 .110 .377 3.281 .005
9,10 anthraquinone -.651 .182 -.416 -3.579 .003
Anthracene 1.324 .519 .300 2.552 .023
a. Dependent Variable: 8-oxo-dG (nMol/M creatinine) 
 
The obtained equation is reported below.  
Equation 4: 
ࢅ ൌ ૙. ૚૝૙	ࢇ	 ൅ ૙. ૜૟૚	࢈ െ ૙. ૟૞૚	ࢉ	 ൅ ૚. ૜૛૝	ࢊ	 ൅ ૙. ૠ૝ૡ 
Where a was benzo(a)pyrene (µg/m³), b was the age range, c was the 9,10 anthraquinone 
(µg/m³), and d was anthracene (µg/m³). 
Unfortunately, due to the missing data for some of the measurements, the sample 
number had to be drastically reduced, and this excluded the occupationally exposed and the 
MATCH study subjects. The results suggested that the main contribution to the oxidative stress, 
for this subset of samples, is coming from airborne PAHs exposure, although 9, 10 
anthraquinone has a negative coefficient, suggesting a negative contribution of that compound.  
The validation of the model was performed by calculating the 8-oxo-dG concentration on the 
25% of the data that was randomly selected and excluded from the model calculation, using 
the obtained equation. The calculated values accuracy was then evaluated by NMB (Equation 
3). The obtained value for NMB was -33%, which suggests that our model, for this data set, 
tends to underpredict values. Although this value does not seem to be very far from the actual 
values, it is important to remember that 8-oxo-dG variations are often minimal. Therefore, 
although the model does provide an estimation of the oxidative stress generated by exposure 
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to certain compounds, the main conclusion that we can draw from the result, is that 
benzo(a)pyrene, anthracene, 9,10-anthraquinone, together with the age range, are the main 
contributors to oxidative stress in an heterogeneous general population. However, this data 
alone is not sufficient to build a reliable model for prediction of oxidative stress with the 
amount of data that we have available.  
In order to include all of the variables and to analyse the full data set, the missing values 
were substituted with the mean. The obtained model (Table 80) did not have a significant R² 
value (R²=0.101).  
 
Table 80: Overview of model obtained with the full data set (FIXAT + MATCH) and missing 
values substituted with the mean. 
Coefficientsa 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 
B Std. Error Beta 
2 
(Constant) 1.361 .051  14.631 .000
P.E. naphthalene (µg/m^3) -.019 .008 -.238 -2.327 .022
Urinary O-xylene (ng/L) .003 .002 .224 2.185 .032
a. Dependent Variable: 8-oxo-dG (nMol/M creatinine) 
Model Summary 
Model R R Square Adjusted R 
Square 
Std. Error of 
the Estimate 
2 .318 .101 .080 .41979
 
 
Another model was calculated, using the full data set, this time without substituting the 
missing data with the mean, the cases were excluded listwise, including in the analyses only 
the cases with a complete set of data. In order to maximise the amount of cases included in the 
analysis, we included only the variables that were measured in all of the groups. Therefore, the 
model was calculated using urinary VOCs and cotinine, and airborne benzene, toluene, and 
ethylbenzene, which were measured for all the subjects. Airborne PAHs were not included, as 
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they were not measured for the occupationally exposed subjects and that would cause the 
exclusion of a whole subgroup. The dependent value was again 8-oxo-dG.  
When the model was calculated, no variables were entered in the equation. The same result 
was obtained also using only the FIXAT samples. The outcome of these calculations shows 
that the variables that are available for all the subjects are not suitable to calculate a regression 
model for 8-oxo-dG. This finding is in accordance with the results presented in Table 78, where 
none of the urinary biomarkers was included in the model. The result is also in accordance to 
the weak relationship observed between 8-oxo-dG and most of the measured compounds, 
suggesting that although we can observe a relationship, between several compounds and 8-
oxo-dG, we do not have the statistical power to build a model for this population.  
The outcome of these calculations suggests that the main contributors to the oxidative 
stress, in this particular data set, are not VOCs. However, due to the relatively small sample 
set, it is also possible that a reliable model cannot be calculated. When the sample subset was 
integrated with MATCH samples, the data pool became very heterogeneous, due to the 
different levels of exposure and to the different sources. This inhomogeneity might have 
affected negatively the calculations. Moreover, the amount of missing data, in this sample pool, 
affects the results and the possibility of using all of the variables, since in some cases certain 
compounds were not measured. All of these factors did not allow to calculate a model with the 
complete variable set, however, when only the variables that had no missing data were 
included, the obtained model was not satisfactory, although we were able to obtain a model 
(Equation 4:). The obtained model suggested that benzo(a)pyrene, which is a known human 
carcinogen (IARC, 2012), age range, 9,10-anthraquinone, which is a possible human 
carcinogen (IARC, 2010), and anthracene, which is the most abundant compound of the PAH 
mixture, are predictors of the 8-oxo-dG concentration. The predictions obtained with that 
model, however, due to the normalized mean bias (-33%), could not predict the 8-oxo-dG 
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concentration accurately enough to be valuable, due to the typically low variations (20% in 
smokers) of the DNA damage biomarker (Evans et al., 2010). 
  
V. High PAH exposure and oxidative stress: a case study of Jeddah, Saudi 
Arabia 
This chapter details results from a sampling campaign at three locations in Jeddah. The 
objective was to assess the impact of high level exposure to PAHs on early biomarkers of effect 
in a population of school children living near an oil refinery and a heavy traffic ring road. 
The data discussed in this chapter was collected by Dr Magdy Shamy, King Abdulaziz 
University, Jeddah, Saudi Arabia.  
 
V.1 Introduction and study population 
Airborne PAH data was collected at three locations in Jeddah, Saudi Arabia. The 
locations were three schools, placed at different distances from an oil refinery.  
Location A (Pitrumin) is a school in the immediate neighbourhood (700m) of an oil refinery, 
location B (Qweiza) is a school located next to a heavy traffic ring road at a distance of 5 Km 
from the refinery. Location C (Obhur) is a school located in the north part of Jeddah, next to 
the red sea, far from the refinery and traffic, which is used as a rural/background site. The air 
sampling was performed using polyurethane foam (PUF) filters for the vapour phase and quartz 
filters for the particle phase (Trasande et al., 2015).  
Along with the air measurements of the PAHs, urine samples were collected the 
morning after the air measurement from the children attending each school. The urine samples 
were analysed for hydroxylated metabolites of phenanthrene (OH-phenanthrene) and pyrene 
(OH-pyrene) (1-, 2-/9-, 3-, 4-hydroxyphenanthrene, 1-hydroxypyrene) and creatinine. The 
creatinine concentration was used as a normalization factor. Along with the urine samples, 
dietary information, age, body mass index (BMI), physical information, pulmonary function 
and information on any disease were also collected through questionnaires. 
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The air and urine sampling were performed on the same day for locations A and B, 
while for location C the sampling was performed four weeks later.  
Several studies have been performed previously on the concentration of PAHs 
metabolites in urine, which were synthesized in the PhD dissertation from Li (2009) (Table 
81), where the readings show a decreasing trend during the years. The most influent works in 
terms of number and exposure levels are Heudorf & Angerer, (2001) and Li et al., (2008). 
Heudorf & Angerer studied high exposed subjects, for whom exposure arose from parquet glue 
containing high levels of PAHs, while Li et al. treated US general population.  
The concentrations of urinary OH-pyrene from Jeddah school children (Table 82) are generally 
much higher than the previously reported values, indicating a very high exposure of the 
population to PAHs. 
Table 81: Overview of urinary PAH metabolite 1-OH-pyrene in different populations over the 
years (Li 2009).  
Population - Country 
Age 
range 
N 
Median concentration 
(range) 
(ng/g creatinine) 
Reference 
Adults – Atlanta USA 31-62 
8 subjects  
(439 samples) 
67 (17-5839) Li 2009 
Adults – Atlanta USA 25-58 
8 subjects  
(427 samples) 
58 (7-1963) Li et al. 2010 
US population - USA ≥20 1625 subjects 41 (15-233) Li et al. 2008 
Adults - Germany ≥20 495 subjects 88 (LOD-1172) Heudorf & Angerer 
2001 
Non-smoking adults - 
Italy 
22-81 327 subjects 149 (52-654) Roggi et al. 1997 
General population 
and ETS exposed - 
UK 
18->66 
100 subjects 
(500 samples) 
Geom. Mean  
96 (19-656) 
Aquilina et al., 2010 
Present study 10-14 
167 subjects 
(501 samples) 
264 (15-2476)  
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Table 82: Summary of concentrations of 1-OH-pyrene and sum of OH-phenanthrene species 
in Jeddah school children. 
Species N 
Median concentration 
(ng/g creatinine) 
Range 
(ng/g creatinine) 
1-OH-Pyrene [Day 1] 167 267 15-1632 
1-OH-Pyrene [Day 2] 167 259 25-2476 
1-OH-Pyrene [Day 3] 167 267 30-1904 
Sum of OH-Phenanthrene [Day 1] 167 512 84-3499 
Sum of OH-Phenanthrene [Day 2] 167 492 112-2349 
Sum of OH-Phenanthrene [Day 3] 167 519 122-9591 
 
 
Li (2009) reported that the main source of urinary PAH metabolites is dietary ingestion 
of PAHs as for example burned or chargrilled food. However, in that study the levels of 
exposure were much lower than the ones from Jeddah school children. In our case, having only 
three days of urinary biomarkers for each site to compare with the air measurements makes it 
difficult to find a correlation between air concentration and urinary metabolites. Although there 
are major differences between the air measurements in the three sites (Figure 46 and Figure 
47), the differences between the urinary concentrations are not so remarkable, as shown in 
Figure 46 and Figure 49. Interestingly, the airborne concentrations measured in school site A 
and B (next to the oil refinery and to the ring road, respectively) are significantly higher than 
the concentrations measured in the MATCH study, which took place in UK before the smoking 
ban (Harrison et al., 2009). The reported airborne concentrations for pyrene and phenanthrene 
from MATCH study are in the order of 1 ng/m3, while in this case, site A and B show 
concentrations up to 10 times higher for pyrene and up to 30 times higher for phenanthrene.    
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Figure 46: Concentrations of airborne pyrene on the three days before each urine sampling, 
pyrene concentrations are sensibly different between the three sites. 
 
  
Figure 47: Concentrations of airborne phenanthrene on the three days before each urine 
sampling, phenanthrene concentrations are sensibly different between the three sites. 
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Air concentration of phenanthrene showed a different pattern when compared to 
airborne pyrene, showing higher concentrations on the second day of sampling for site A and 
B. However, the urinary metabolite did not show a similar pattern as showed in Figure 49, and 
the measured levels did not show significant differences across the three locations in terms of 
day to day variation in each site. Similarly, urinary OH-pyrene did not show any significant 
changes nor any similarity with the pattern of the airborne measurements on a daily basis, as 
shown in Figure 48. However, for both urinary metabolites, it is possible to observe a lower 
concentration in the rural background site. 
 
 
Figure 48: Box plot of the urinary concentration of OH-pyrene, no remarkable difference 
between the three days can be identified, and the difference between the three sites is less 
evident. 
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Figure 49: Box plot of the urinary concentration of the sum of OH-phenanthrene, no 
remarkable difference between the three days can be identified. 
 
In this study, OH-pyrene was analysed together with the different species of OH-
phenanthrene. Due to the high level of correlation between the various OH-phenantrene 
species, the sum of the total OH-phenanthrene concentrations was used for the analyses. 
Samples were log transformed prior analysis, and then ANOVA test was performed with 
Bonferroni post hoc comparison within the subgroups created based on the school site. The 
ANOVA test showed a statistically significant difference between the site subgroups for the 
urinary OH-phenanthrene measured in all of the samples on each day (p=0.009 for day 1; 
p=0.06 for day 2; p=0.009 for day 3). OH-pyrene levels also compared with ANOVA test, and 
it showed statistically significant differences in all of the sampling days (p=0.003 for day 1; 
p=0.001 for day 2; p=0.002 for day 3). Further information was obtained with the Bonferroni 
post hoc comparison, which showed a statistically significant difference between the samples 
from the rural background (location C) and the location next to the ring road (location B) for 
all the three days for both metabolites. However, there was no statistically significant difference 
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between the samples taken from the school next to the refinery (location A) and location B on 
any day. Interestingly, no statistically significant difference was observed between location A 
and location C on any day. The whole three-day data was then pooled together and the three 
groups were again compared with the ANOVA test with Bonferroni post hoc comparison. In 
this case, the differences were more relevant. The three groups showed statistically significant 
difference for both metabolites (p<0.001 for OH-phenanthrenes and p<0.001 for OH-pyrene). 
The Bonferroni post hoc comparison showed a difference between the location C and the others 
for OH-phenanthrene (p<0.001 C-B; p<0.001 C-A) and for OH-pyrene (p<0.001 C-A and C-
B). The data was then analysed on a boxplot for both metabolites (Figure 50 and Figure 51) 
and although the difference is not evident, it is possible to observe a lower concentration for 
both metabolites in the samples from site C. 
189 
 
 
Figure 50: Boxplot showing the pooled data for urinary OH-phenanthrenes divided by the 
school site. 
 
 
 
Figure 51: Boxplot showing the pooled data for urinary OH-pyrene divided by the school site. 
 
In light of the findings for urinary 1-hydroxypyrene and airborne pyrene we could 
conclude that although the dietary exposure plays a primary role in the contribution to the 
urinary metabolites, the chronic exposure of the subjects of this study is so high that the 
contribution from the diet, although present, does not invalidate the evaluation of airborne 
exposure to PAHs of this particular set of subjects.  
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V.2 8-oxo-dG analysis 
Urinary 8-oxo-dG was analysed as a DNA damage biomarker in order to study a 
possible correlation between the exposure level and the level of DNA damage. No correlation 
was found between 8-oxo-dG and the OH-pyrene (p=0.237) or the sum of OH-phenanthrenes 
(p=0.255). 
The population was divided in different subgroups based on the school site, and the 
level of 8-oxo-dG were compared. Unfortunately, the available samples only included one 
sampling event (day 2) of subjects living next to the oil refinery and next to the ring road. The 
ANOVA test showed a statistically significant difference between the two available groups 
(p=0.001), that were then plotted on a boxplot graphic (Figure 52). As a control reference, 
FIXAT + MATCH project’s geometric mean (red) ± geometric standard deviation (black) 
reference lines were added to the graphic, showing significantly higher values for the Saudi 
samples. The median concentrations and the ranges are reported in Table 83. However, due to 
the large differences in the populations, the FIXAT + MATCH samples could not be included 
in the statistical analyses. 
 
Table 83: Comparison of the median concentrations and ranges of urinary 8-oxo-dG between 
the UK and Saudi subjects. 
Group name 
Median 8-oxo-dG 
concentration 
(ng/g creatinine) 
Range 
(ng/g creatinine) 
Jeddah schoolchildren 
School next to ring road 
1.70 0.87-4.12 
Jeddah schoolchildren 
School next to oil refinery 
1.48 0.67-3.40 
FIXAT 
subjects 
1.14 0.51-2.36 
MATCH high level exposed 
subjects 
1.28 0.72-2.41 
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 Interestingly, the subjects at the school next to the ring road showed the higher 
concentration between the two groups. Another important factor to take in account is the health 
status of the subjects, therefore the population was divided in groups based on the diseases that 
they declared in the questionnaires as showed in Table 84, and the 8-oxo-dG levels of each 
group were compared. The ANOVA test showed a statistically significant difference between 
the groups, but the Bonferroni post hoc comparison could not be performed due to the small 
number of cases in some of the groups. The data was then plotted on a boxplot for visualization 
(Figure 53). It is clear from the figure that certain health conditions are likely to affect the 
amount of 8-oxo-dG excreted in the urine. Digestive tract issues appear to be an important 
factor, together with urinary tract problems and interestingly blood diseases. The digestive tract 
subgroup contains only one subject that is affected of favism, while the others all declared to 
suffer from diarrhoea. For the blood diseases, only one subject suffered from rheumatic hearth 
condition, which could be a source of inflammation, while the other subjects all suffered of 
anaemia-related problems. Interestingly, subjects suffering of pulmonary diseases did not show 
a significantly higher level of 8-oxo-dG, while the subjects with urinary tract problems, 
predictably showed a significantly higher level. 
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Table 84: Groups based on the declared diseases. 
No disease declared (N=154) N/A 
Neurological (N=8) 
Nervous 
Dizziness, adenoids and headache 
Low visual activity 
Headache 
Hydrocephalus 
Nocturnal enuresis 
Digestive tract (N=3) 
Diarrhoea  
Favism 
Blood (N=5) 
Rheumatic heart 
Sickle cell anaemia 
Anaemia 
Sickle cell anaemia carrier 
Allergy and bone pain (N=6) 
Allergy 
Bone pains 
Pulmonary (N=21) 
Bronchial asthma 
Cough 
Urinary tract (N=2) 
Burning micturition 
Urinary tract stone 
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Figure 52: Boxplot showing the urinary concentration of 8-oxo-dG of the subjects from sites A 
and B. Dotted line represents the geometric mean of FIXAT+MATCH project ± standard 
deviation (red). 
 
 
Figure 53: Boxplot showing the urinary concentration of 8-oxo-dG of the subjects divided by 
the declared disease group. 
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Another relevant factor to analyse was the relationship between the district where each 
subject lives and the urinary 8-oxo-dG, which would give further information on the 
contribution of the exposure at home versus the exposure at the school. In this case, the subjects 
living next to the oil refinery (Pitrumin, 700m away from the refinery) showed a higher 
concentration of 8-oxo-dG compared to the subjects living in the other districts. Unfortunately, 
the subjects that indicated “other” in the questionnaires, did not provide further information on 
the residence location. The subjects living in Qweiza area, were the subjects living next to the 
ring road, 6Km away from the oil refinery, while the urine samples from Obhur area were not 
made available.  
The same analyses with the same groups were carried out also for the PAHs urinary metabolites 
to investigate if the pattern seen with the 8-oxo-dG was consistent with the other data. If 
compared with the urinary concentrations of PAH metabolites, the available data for 8-oxo-dG 
seems to have a similar pattern, especially for OH-pyrene (Figure 55, Figure 56). 
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Figure 54: 8-oxo-dG concentrations divided by the living district. 
 
 
Figure 55: OH-phenanthrene concentrations divided by the living district. 
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Figure 56: OH-pyrene concentrations divided by the living district. 
 
When analysed for OH-pyrene and OH-phenanthrene, the health condition subgroups did not 
show significant differences (Figure 57 and Figure 58), although higher concentrations of 
urinary OH-pyrene were observed in the digestive tract disease subgroup.  
 
Figure 57: Boxplot of urinary concentration of OH-phenanthrene divided by the declared 
disease. 
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Figure 58: Boxplot of urinary concentration of OH-pyrene divided by the declared disease. 
 
These findings underline the importance of choosing healthy subjects for DNA damage 
biomonitoring, as any illness or disease can affect the results. It is impossible to determine if 
the exposure can cause any of the diseases, although it would be possible to hypothesize that 
lung-related diseases and even allergies could be correlated to the chronic exposure to 
pollutants, as it has been previously suggested for both PAHs and VOCs (Sørensen et al., 
2003a; Rossner et al., 2008; Röder-Stolinski et al., 2008). No significant differences were 
observed in the urinary concentration of the metabolites for each disease group, except for the 
urinary tract diseases (Figure 57), and digestive tract diseases (Figure 58). In the case of urinary 
tract diseases, the number of subjects with that problem is very small (N=2), as well as for the 
digestive tract diseases (N=3), and the difference in the concentration is not big enough to be 
related to the disease. Although the main contribution to 8-oxo-dG is likely to be generated 
from the health condition of the subjects, a difference was observed when the 8-oxo-dG levels 
were compared based on the living district (Figure 54). This could indicate that the location of 
the house is also a factor that can influence the levels of oxidative stress of the subjects.  
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V.3 Correlation and statistical analysis 
The way the experiment was performed is limiting in terms of possible analyses of the 
database that go beyond the correlation between the variables and comparison between 
different subgroups, since the urine samples were collected only on three days in two schools 
and on three different days in the school in the background site. Although the air sampling 
campaign lasted for a month, the airborne concentration data that can be used for the 
correlations with the urinary metabolites is limited to the days where the urine was sampled. 
The sampling of the urine has been performed only on three days instead of spreading it 
throughout the month.  
Pearson correlation analysis was conducted for all of the variables to highlight the 
correlations between the variables. To select possible relevant grouping variables, each group 
was associated with a score, corresponding to the expected level of exposure (e.g. 1 for the 
background site, 2 for the ring road site, and 3 for the site near the oil refinery). Pearson 
correlation with the data was then analysed to investigate if there was an increasing pattern for 
any of the biomarkers that was coherent with the score assigned.  
The first correlation that is found is between the income, the school location and the 
airborne concentration. The same high correlation level is found also between the cooking 
appliance and the airborne concentration. This can be explained by the fact that the volunteers 
are living in the various districts based on their income and therefore the different districts have 
different cooking appliances (some areas might have more gas cookers than others) as well as 
different levels of exposure. As shown in Table 85, a trend between the geographical 
distribution is evident, with the subjects living next to the oil refinery belonging to the lowest 
income interval, in opposition to the majority of the subjects in the highest income interval 
living in the rural background site. This observation would suggest an environmental 
inequality, where the cheaper houses are located closer to pollution sources. This inequality is 
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reflected also in the air quality of the premises of each group, and the consequent health effects, 
especially as this trend was found also in the urinary PAHs metabolites and 8-oxo-dG, as shown 
in Figure 59, Figure 60 and Figure 54. Unfortunately, it is not possible to determine if the levels 
of the PAHs metabolites are influenced by the airborne exposure or from the different cooking 
appliance effect on food cooking (different temperatures could cause the food to burn more 
easily).  
 
Table 85: Overview of subjects’ distribution based on cooking appliance, district and income. 
 District 
Pitrumin Qweiza Obhur Other 
Count Count Count Count 
Cooking appliance type 
Not answered 2 2 0 0 
Gas 55 60 34 5 
Electric 6 5 16 0 
Gas and Electric 3 1 10 0 
 Income 
Not answered <3000 SR 3000-9000 SR >9000 SR 
Count Count Count Count 
District 
Pitrumin 2 36 24 4 
Qweiza 3 19 36 10 
Obhur 2 1 21 36 
Other 0 2 3 0 
 
Table 85 shows also the distribution of the population in the different districts. Pitrumin 
and Qweiza district showed a similar distribution of cooking appliances, mainly being gas 
cookers, a slight different distribution was observed for Obhur district, which had a higher 
number of electric cooking appliances. As mentioned, a significant difference in the 
distribution was also observed for the residence district of the population divided by the income 
intervals. A chi-square test was performed to evaluate the differences between the groups, and 
in both cases the difference in the distribution was statistically significant (p<0.001 in both 
cases). This difference in the distribution among the cooking appliance type could be partly 
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responsible for the variations observed in the urinary metabolites (Figure 59 and Figure 60). 
However, the subjects not living in any of those districts, showed the lowest concentrations of 
urinary OH-PAHs, suggesting that the geographical placement might have a role in the 
exposure to PAHs (Figure 55 and Figure 56).  However, this pattern is not followed by the 8-
oxo-dG concentrations, which were found to be higher in the subjects with gas + electric 
appliances (Figure 61).  
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Figure 59: Levels of OH-phenanthrene grouped by cooking appliances type. 
 
 
 
Figure 60: Levels of OH-pyrene grouped by cooking appliances type. 
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Figure 61: Levels of 8-oxo-dG for each cooking appliance group. 
 
A similar strong correlation was found between the airborne PAH concentration and 
the distance between the school and the house, confirming the dominance of geographical 
positioning for the correlation with airborne PAHs levels. All of these correlations highlight a 
population that is divided mostly by the geographical position and the three groups are not 
homogeneous between them. Even if this grouping is not helpful to identify characterizing 
variables from the database, it can be used to identify the three groups by level of exposure 
since all the variables that are correlated to the geographical distribution can be included in the 
single variable of the volunteer’s house location.  
Although marginally significant correlations were found between the cooking 
appliances and various PAH metabolites, the observed differences between the subgroups are 
more likely to be related to the district of provenience of the subjects (Table 85). In fact, the 
correlations were more consistent and significant between the urinary PAH metabolites and the 
airborne PAH concentrations. Therefore, although a different cooking appliance can affect the 
way food is cooked, the variable could be represented from the district, due to the strong 
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correlation with airborne PAHs and the distribution of the cooking appliances in the different 
districts.  
Surprisingly no significant correlations were found between the urinary PAH 
metabolites and the use of incense, smokers in the house and the habit of kitchen fan use. 
The main source of urinary PAH metabolites reported in the literature is suggested to 
be the diet, specifically from burnt or charbroiled food (Strickland et al., 1996; Harrison et al., 
2009; Aquilina et al., 2010; Roggi et al., 1997b). However, when analysed in the current study 
with an ANOVA test, the PAH metabolites, did not show statistically significant differences 
(p=0.475 for OH-phenanthrenes and p=0.082 for OH-pyrenes) between the different subgroups 
(Figure 62 and Figure 63). 
 
 
Figure 62: Boxplot showing the sum of OH-phenanthrenes urinary concentrations, divided by 
charbroiled food consumption. 
 
 
  
204 
 
 
Figure 63: Boxplot showing the OH-pyrene urinary concentrations, divided by charbroiled 
food consumption. 
 
 
In Table 86 are summarized the frequencies of each disease group divided by the school 
site. Since the number of declared disease cases is small, it is not possible to determine a 
correlation between the geographical area (and therefore the level of exposure) and a 
predominance of a certain kind of disease. Furthermore, the diseases seem to be evenly 
distributed between the three groups. The only uneven groups are the allergy/bone pain and 
blood diseases, which are more frequent in site B (school next to ring road). 
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Table 86: Frequency table of disease groups divided by school site. 
 Count 
Disease 
group 
No disease 
mentioned 
Rural/Urban background (School next to 
Red Sea) 
45 
School next to ring road 47 
School close to oil refinery 62 
Neurological 
Rural/Urban background (School next to 
Red Sea) 
4 
School next to ring road 2 
School close to oil refinery 2 
Digestive tract 
Rural/Urban background (School next to 
Red Sea) 
1 
School next to ring road 1 
School close to oil refinery 1 
Blood 
Rural/Urban background (School next to 
Red Sea) 
0 
School next to ring road 5 
School close to oil refinery 0 
Allergy/bone pain 
Rural/Urban background (School next to 
Red Sea) 
0 
School next to ring road 5 
School close to oil refinery 1 
Pulmonary 
Rural/Urban background (School next to 
Red Sea) 
9 
School next to ring road 9 
School close to oil refinery 3 
Urinary tract 
Rural/Urban background (School next to 
Red Sea) 
1 
School next to ring road 1 
School close to oil refinery 0 
 
Interestingly the lung capacity (measured by spirometry) does not seem to be affected 
by the PAH exposure. In fact no relevant correlation between lung function and airborne or 
urinary PAH concentration and no significant difference in the subgroups was observed with 
other tests. 
No significant correlation was observed between the urinary PAH metabolites and the 
corresponding airborne PAH between the three sites in the single day exposure for day 1, while 
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for day 2 a marginally significant correlation (p=0.05) was observed between airborne 
phenanthrene (filter + PUF) and OH-phenanthrene. Interestingly the airborne phenanthrene 
was correlated with the OH-pyrene (p=0.09), which was not correlated with airborne pyrene.  
For day 3, airborne phenanthrene was found to be highly correlated with the urinary 
OH-phenanthrenes (p=0.003) and OH-pyrene (p=0.001). Airborne pyrene was found to be 
highly correlated with the urinary OH-pyrene (p=0.002) and marginally correlated with OH-
phenanthrenes (p=0.011). However, due to the correlations being calculated only over one day, 
it is not possible to draw conclusions on this set of analyses. 
When the three day data was analysed for correlations, a statistically significant 
correlation was found between OH-phenanthrenes and the airborne phenanthrene (p<0.001) 
and between OH-pyrene and airborne pyrene (p<0.001).  
However, when the whole 3-day data was analysed for correlations, the urinary OH-
pyrene and OH-phenanthrenes showed statistically significant correlation (p≤0.001) with all of 
the airborne PAHs, with R values ranging from a minimum of 0.142 (benzo(a)pyrene / OH-
phenanthrenes) to a maximum of 0.269 (phenanthrene / OH-pyrene). 
It is important to underline that these correlations have been calculated with only three 
time points for the airborne pollutants, as the urine sampling was performed only on three days 
for each school, so the results might be debatable. The correlation observed, reflects mainly 
the difference evidenced when the population was divided by school site where, on average, 
the urinary concentrations showed a pattern that was similar to the airborne concentration. 
As mentioned previously, PAH metabolites do not enter the urine by passive diffusion 
like the unmetabolized VOCs, as they are excreted as glucuronide conjugates (Jongeneelen et 
al., 1987; Jongeneelen, 2001), in this case we obtained better results using the measurement 
normalized against creatinine.  
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These results suggest that in this particular population, there is a correlation between 
the single event exposure (although the sampling period is very limited) and the urinary 
metabolites. Although it has been previously reported that the main source of urinary PAH 
metabolites is the dietary intake of the compounds (Strickland and Kang, 1999; Harrison et al., 
2009; Aquilina et al., 2010), in this particular case, the exposure levels are so high that the 
exposure is influencing the amount of urinary metabolites.  
When the subgroups were compared with the ANOVA test, both urinary metabolites 
concentrations showed statistically significant difference between the site C (rural background) 
and the sites A and B, but it was not possible to determine any significant difference between 
the site A and B (next to the oil refinery and next to the ring road). It is important to consider 
that the two sites are only 5 Km away from each other and the ring road is downwind to the 
refinery, even though in Figure 46 and Figure 47 is showed that the airborne concentrations are 
significantly different. Perhaps this result further underlines the influence of food preparation 
and cooking appliances as PAH sources more than airborne concentration of the pollutants. 
Another interesting observation is the difference between the geographical location of the 
residence, which was strongly correlated with the income. This suggests that the population is 
divided in different areas based on the income, likely because of the housing prices. The 
population with lower income was concentrated mainly in the vicinity of the oil refinery, while 
the population in the median range of income was split between the vicinity of the oil refinery 
and the ring road, with a majority of subjects in the latter. There was a distinct separation in 
the population with highest income, which were prevalently located in the rural background 
site. Possibly the vicinity to the oil refinery affects the housing prices, or the area prevalently 
contains cheaper accommodation, however, this separation generates also a difference in the 
exposure, as showed in Figure 55 and Figure 56. These differences suggest a social difference 
that affects the exposure, and potentially the health condition of the subjects. The 8-oxo-dG 
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data did not provide meaningful data regarding the correlation with the exposure, the urinary 
8-oxo-dG concentration was not correlated with any of the PAH metabolites, and it did not 
show significant differences between the sites, although a difference could be observed (Figure 
52). A major problem with the 8-oxo-dG analysis was that no control samples (from site C) 
were provided, making it difficult to understand if there is a difference between subjects with 
different levels of exposure at school. When the 8-oxo-dG concentration was compared 
between the groups created on the base of the district of residence, the subjects living in the 
“other” districts (not the refinery or ring road district) showed a significantly lower level of 8-
oxo-dG, but the sample pool was too small to draw any solid conclusion (N=5). The result, 
however, is promising and suggests a significant difference based on the location of the house 
and therefore the vicinity to the pollution sources. Another important finding was the level of 
8-oxo-dG in the various disease group, showing a significant difference in people suffering of 
digestive tract and blood disease, which underlines the importance of recruiting only healthy 
subjects to avoid misinterpretation of the data. In this specific case, it is likely that the digestive 
tract disease could have caused higher readings of 8-oxo-dG, in particular diarrhoea. Diarrhoea, 
as a symptom, could be linked to the inflammatory bowel disease, which is known to be related 
to oxidative stress and inflammation (Goyal et al., 2014). 
 
A proposal for future studies would be to analyse the urine for other metabolites that are less 
prone to diet contaminations like unmetabolized VOCs or VOC metabolites together with the 
analysis of 8-oxo-dG of the whole sample set. 
 
It has not been possible to draw further conclusions or try a regression model, because although 
the metabolites show a correlation with the exposure, the usable airborne data is limited to only 
3 days. Furthermore, 8-oxo-dG in our case did not show any correlation with the PAH 
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metabolites, while it showed a correlation with 1-OH-pyrene in previous studies (Al-Saleh et 
al., 2013). Our results could be affected by the lack of data for the control site, which does not 
allow us to have a low exposed control group. 
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VI. Benzene effects on DNA damage and oxidative stress upon A549 lung 
epithelium cells using a novel exposure system 
This chapter discusses the design and test of a novel lung model using A549 lung epithelium 
cells by analyzing the early effects of exposure to low benzene concentrations.  
This study was completed in collaboration with Dr. Nikolas Hodges, School of Biosciences, 
University of Birmingham. 
 
This chapter is based on the following accepted manuscript:  
Mascelloni M., Hodges, N., Harrison R. M., Delgado-Saborit J. M. V. Benzene effects on 
DNA damage and oxidative stress upon A549 lung epithelium cells using a novel exposure 
system. Toxicology Letters, 2015. http://dx.doi.org/10.1016/j.toxlet.2015.05.015 . 
 
VI.1 Introduction  
People spend much of their time indoors where they are continuously exposed to low 
concentrations of a wide variety of chemicals including volatile organic compounds (VOCs). 
It has been demonstrated that building materials, furniture and consumer products are a source 
of low level VOC exposure contributing together with the outdoor air to the exposure of general 
population (Delgado-Saborit et al., 2011; Wolkoff, 2012). Indoor exposure to VOCs has been 
reported to cause a number of symptoms ranging from irritation of the respiratory system to 
sick building syndrome (Brinke et al., 2004; Wang et al., 2013). In addition, VOCs are also 
reported to contribute to oxidative stress induction via production of reactive metabolites and 
hence have the potential to damage DNA (Knaapen et al., 2006; Lu et al., 2007; Saint-Georges 
et al., 2008; Snyder and Hedli, 1996; Sørensen et al., 2003a; Wang et al., 2013). Exposure to 
VOCs such as styrene can also lead to an inflammatory response in the lungs that can then 
result in oxidative stress (Bönisch et al., 2012; Röder-Stolinski et al., 2008; Fubini and 
Hubbard, 2003; van Berlo et al., 2010). It has been suggested that other compounds such as 
benzene and toluene can trigger an inflammatory response, but DNA damage caused by such 
response has not been supported by solid evidence (Pariselli et al., 2009; Wang et al., 2013). 
The relationship between exposure to benzene and DNA damage has been extensively studied, 
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especially for occupational exposures, demonstrating that benzene is involved in DNA damage 
through reactive metabolic intermediates (Snyder and Hedli, 1996; Hartwig, 2010) and 
generation of reactive  oxygen species (ROS) (Barreto et al., 2009). Because of the detailed 
knowledge of its metabolism, benzene serves as an ideal positive control test compound for the 
development of new toxicological assays and tests. Furthermore, in several studies of human 
exposure to benzene at medium and low concentrations (0.001 ppm – 0.03 ppm), a correlation 
was found between levels of urinary benzene, benzene metabolites and urinary 8-oxo-2’-
deoxyguanosine (8-oxo-dG) a biomarker that is widely considered to be associated with ROS 
related DNA damage and repair (Andreoli et al., 2012; Manini et al., 2010; Bagryantseva et 
al., 2010).  
A recent review (Hartwig, 2010) summarised the possible mechanisms through which benzene 
and its metabolites can cause DNA damage.  In vivo, after absorption, benzene is metabolized 
by cytochrome P450 2E1 (CYP2E1) in the liver to produce metabolites including: phenol, 
catechol, hydroquinone and 1,2,4-trihydroxybenzene. These closed ring metabolites then 
undergo further metabolism in the bone marrow to form o- and p-benzoquinone. p-
Benzoquinone is thought to be the toxic metabolite responsible for myelotoxicity due to its 
high reactivity and is known to form adducts with proteins and DNA (Rappaport et al., 2005; 
Linhart et al., 2011). Bone marrow, due to the high rate of cell mitosis and lower DNA repair 
capacity (Buschfort-Papewalis et al., 2002) is a sensitive tissue for DNA instability, resulting 
in possible health effects sooner than other tissues.  
 
All of the phenolic benzene metabolites are chemically active in cells, increasing the oxidative 
DNA damage, directly or through further metabolism. Therefore, although the main target 
tissues and the metabolism of benzene have been studied and understood, it is important to 
develop models to assess the toxicity caused by VOC exposure of other metabolically 
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competent tissues including the lung epithelium, which is a principal route of exposure to 
benzene and other VOCs. Such models could also be useful to study other VOCs, as currently 
there is little evidence of any linkage between exposure and DNA damage for other VOC 
species, even if it has been suggested from studies in animal models and in vitro studies (Sarma 
et al., 2011; Singh et al., 2009). 
 
Currently there are only few detailed studies on the development of in vitro models to examine 
the effects of such pollutants on the lung. Pariselli et al. (2009) developed a method to expose 
lung cells to various concentrations of benzene and toluene, evaluating some of the effects 
caused by the pollutants on lung cells growing on permeable supports that allow exposure of 
cells to gas mixtures, modelling a real life situation of exposure.  
 
Although Pariselli et al. (2009) reported interesting results on inflammatory response triggered 
by VOC exposure and cell viability, no further studies on DNA damage or ROS production 
were reported deriving from lung epithelium models. We therefore aimed to progress by 
exploring the feasibility of an air-liquid interface (ALI) in vitro model using lung epithelial 
cells grown on a permeable membrane. The main focus of this study was on the short-term 
effects of exposure of lung cells to VOCs with two main endpoints: oxidative stress and DNA 
damage. 
VI.2 Methodologies 
The experiments and analyses were conducted following the methodologies described 
in sections III.15 - III.19 (Methodologies)  
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VI.3 RESULTS 
Visual analysis of the cells before and after the exposure demonstrated little mechanical stress 
and slight drying sustained by the cells due to the airflow, but this did not result in overt cell 
toxicity as assessed by light microscopy (data not shown).  
 
 
VI.4 Induction of Oxidative Stress 
Cells were analysed for levels of ROS before and after the exposure together with a control 
that was exposed only to synthetic air and a set of incubator controls both with and without 
apical medium. The results presented in Figure 64 clearly indicate that cells exposed to 0.3 
ppm benzene had elevated levels of intracellular ROS compared to controls as assessed by the 
fluorescein oxidation assay. The presented results are based on two independent replicates 
(each including three technical replicates) for 0.03 ppm and 0.3 ppm benzene, and a single 
measurement of three technical replicates for 0.1 ppm benzene. Incubator control results are 
based on 5 independent replicates. The means were compared using ANOVA with Bonferroni 
post-hoc comparisons. The only statistically significant difference between the pre and post 
exposure was observed for the 0.3 ppm benzene exposed cells (p<0.001).  
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Figure 64: Summary of the DCF fluorescence measurements before and after exposure. Error 
bars represent standard deviation. (***) indicates a statistically significant difference between 
the pre and the post exposure.  
 
A generalized increase of fluorescence was observed in all the treatments, including the 
incubator controls, suggesting a baseline production of ROS in normal cell metabolism. 
Unfortunately, in the case of 0.1ppm benzene exposure, the pre-exposure condition showed a 
high reading, most likely due to media background fluorescence. These findings are 
comparable with previously published data (Pariselli et al., 2009). Although further tests need 
to be performed, treatment with benzene shows an oxidative effect in the cells, which could be 
related to either an inflammatory response to benzene itself, or more probably to oxidising 
metabolites such as benzoquinones (Snyder and Hedli, 1996).  
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VI.5 Induction of DNA Strand Breaks 
Following exposure of cells to air (Controls), low (0.03 ppm) and medium (0.1 ppm) benzene 
concentrations, the incidence of highly damaged “hedgehog” cells was below 15% of the total 
number of cells counted. In contrast the number of not quantifiable nuclei was increased at 
higher benzene concentrations (23–60% of unquantifiable nuclei, N=300). The high frequency 
of “hedgehogs” at the highest concentration of benzene exposure tested (0.3 ppm) made DNA 
damage quantification difficult and is probably indicative of direct benzene cytotoxicity to cells 
at this concentration of benzene exposure. 
 
Table 87: Descriptive statistics of the Comet assay data (% tail intensity). 
 N 
(Cells) 
Mean Median Standard 
Deviation 
Variance H 
(Variance/
Mean) 
Incubator Controls (Media) 1550 4.52 0.74 9.40 70.98 20.61 
Incubator Controls (Dry) 1376 6.73 3.40 11.80 135.26 18.98 
Controls 1028 7.40 3.15 11.60 147.82 20.77 
0.03 ppm benzene 314 11.49 3.21 15.58 243.83 21.26 
0.1 ppm benzene 318 16.02* 5.53* 21.28 456.49 28.37 
0.3 ppm benzene 375 12.27* 5.13* 16.90 303.75 23.29 
 
The % tail intensity was used as a metric to quantify DNA damage in the cells. Experimental 
data were pooled from 5 controls and one of the independent replicates of each exposure, which 
consisted of 3 technical replicates for each exposure, and the findings are summarised in Table 
87 and Figure 65 and Figure 66. Each exposure event was compared with the relative control. 
The reported data refers to a single exposure experiment and the relative controls. Two other 
independent replicates were performed for the 0.03 ppm and 0.3 ppm exposure, obtaining 
similar results (Table 87, appendix X.9). Differences were observed between the absolute 
values of the tail intensities, however the ratios between the exposed and the control cells were 
found to be similar between the replicates.  The ratios were compared by a Kruskal-Wallis 
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independent samples test, which retained the null hypothesis of the samples having the same 
distribution (p=0.102). An independent samples median test also retained the null hypothesis, 
suggesting that the medians of the ratios are similar (p=0.354). The observed differences of the 
absolute values between the independent replicates are likely due to different starting 
conditions of the cells. Tail intensities of each exposed sample were compared with its relative 
air exposed control using Friedman’s 2-way ANOVA by ranks. The only statistically 
significant differences were observed between the samples exposed to 0.1 ppm and 0.3 ppm 
benzene and their relative controls. No statistically significant difference was observed 
between air exposed controls and incubator controls under any condition. 
A clear concentration-dependent induction of DNA strand breaks following the exposure to 
benzene (0.03–0.3 ppm) was observed as assessed by the exposed/control ratio of mean tail 
intensity (Figure 67). In general, due to the large numbers of “hedgehogs”, the cells exposed 
to 0.3 ppm benzene, showed a decreased amount of DNA damage compared to the cells 
exposed to 0.1 ppm benzene. Linear regression analysis showed a significant correlation 
between the level of benzene exposure and the extent of DNA damage when the value was 
normalized against the relative controls (R2=0.718). An increase of DNA damage was observed 
in all the exposures, however a statistically significant difference with the control was observed 
only for 0.1 ppm and 0.3 ppm benzene concentrations (Figure 65). Figure 66 represents the 
pooled data of each exposure experiment in a scatter plot. Data was plotted to evaluate the 
increase of dispersion of the readings with higher benzene exposure, indicating a generalized 
increase in DNA damage related to the concentration of airborne benzene. Importantly, we 
observed a statistically significant increase in levels of DNA-strand breaks in cells exposed to 
0.1 ppm benzene were there was no evidence of direct cytotoxicity to the cells. 
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Figure 65: Mean tail intensity (%) of the control and exposed cells. Error bars represent the 
standard deviation of the means. (***) indicates a statistically significant difference between 
the exposed sample and their relative controls. The figure includes 3 independent replicates 
for the controls, and a single independent replicate for the exposed cells. Each independent 
replicate consisted of 3 technical replicates.   
 
 
The coefficient of dispersion (H) (Tice et al., 2000), expressed as the ratio of variance/mean, 
was also calculated to further evaluate the data (Table 87). H is an accepted parameter used to 
express the dispersion of the Comet data and is sensitive to a large DNA damage response in a 
small proportion of cells and is also less affected by inter-experimental variability. All of these 
parameters were consistent with a concentration-dependent increase in DNA strand breaks 
following exposure of cells to benzene. 
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Figure 66: Graphical representation of the % tail intensities measured in the Comet assay as 
a function of benzene concentration. The figure includes 5 independent replicates for the 
controls, 2 independent replicates for 0.03 and 0.3ppm benzene, and a single independent 
replicate for 0.1ppm benzene. 
 
To minimise the effects of inter-experiment variability, the ratio of mean % tail intensity 
between the treated cells and the controls of the same exposure experiment were compared. 
This enhanced the difference between the low level exposure (2h 0.03 ppm) and the higher 
levels. The reported ratios (Figure 67) are obtained by averaging the ratio of exposed/control 
mean tail intensity (%) of each independent replicate. Interestingly, the difference between the 
ratios of the two higher conditions was smaller than the difference in the ratios observed 
between the 0.03 ppm and 0.1 ppm benzene, as shown in Figure 67. Moreover, the higher 
concentration showed a lower ratio than 0.1 ppm exposed cells, with a higher variability. This 
is likely due to the higher amount of unquantifiable cells in the highest benzene concentration, 
which made the quantification difficult. 
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Figure 67: Average ratio between mean % tail intensities of treated cells and each of the 
relative controls of 3 independent replicates for 0.03 ppm and 0.3ppm and of 2 independent 
replicates for 0.1 ppm. Error bars represent standard deviation between the ratios of each 
replicate. 
 
VI.6 DISCUSSION 
The aim of this pilot study was to develop an in vitro system to study the short-term effects of 
airborne exposure of lung cells to toxic chemicals in a physiologically relevant model. 
Although carcinoma cells were used instead of primary cells, A549 cells are commonly used 
as a toxicological model for lung tissue. Moreover, they represent a relevant model as they 
express CYP2E1, which is required for the metabolic activation of benzene which, in-vivo has 
a multi-organ toxicity (Snyder and Hedli, 1996; Hartwig, 2010; Bois et al., 1996). Benzene 
was chosen as a test pollutant due to its known genotoxic effects.  The benzene concentrations 
used in this work lie between typical ambient air and occupational exposure levels.  Delgado-
Saborit et al. (2009; 2011) report personal exposure concentrations measured in the UK of 
0.15-30.2 µg m-3 (0.05-9.3 ppb) while in Saudi Arabia, ambient air benzene concentrations 
ranged from 0.09-1.1 ppb (Alghamdi et al., 2014) and in 43 Chinese cities varied between 0.7-
10.4 ppb (Barletta et al., 2005).  These compare with concentrations in this study of 0.03-0.3 
ppm (30-300 ppb), and the European Union ambient air quality standard of 5 µg m-3 (1.5 ppb).  
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On the other hand, the occupational exposure limit for benzene recommended by both NIOSH 
(US) and HSE (UK) is 1 ppm time-weighted average over an 8-hour shift. 
 
As previously reported, a limitation of many in vitro cellular models of lung toxicity is that 
cells are exposed to test chemicals dissolved in cell culture media (Pariselli et al., 2009). This 
is physiologically unrealistic, and furthermore the media itself can have a matrix effect, and 
the uptake and the interaction of the pollutants with the cells does not model a real life situation 
(Ritter et al., 2001). The exposure vessel custom designed and used in this study proved to be 
a useful and reliable tool to evaluate the effect of benzene on cultured lung A549 cells. It also 
represents a more physiologically relevant model than exposure of cells to benzene dissolved 
in cell culture media. Development of permeable cell culture inserts has allowed the 
development of models whereby lung epithelial cells can be grown in a monolayer and the 
apical medium can be removed during the exposure to airborne chemicals, thus better 
modelling a lung epithelium and allowing exposure of cells to controlled atmospheres. This 
method of exposure is much closer to the in vivo situation, providing a more realistic model for 
exposure studies. For logistical reasons, the gas flow rate was higher than previously reported 
in the literature (10 ml/min vs. 2 ml/min). However, this variable did not affect the performance 
of the exposure vessel or the cells negatively, as shown by the comparisons between incubator 
controls and synthetic air exposed controls (Figure 64 and Figure 65). However, some 
mechanical stress was observed in the cells at the centre of the airflow by optical microscopy 
analyses, which can be solved in future experiments by reducing the flow rate as suggested by 
Pariselli et al. (2006). A longer exposure (4h) of cells to synthetic air was also tested, but the 
majority of the cells did not survive during the experiment.  Overall, our findings confirmed 
the feasibility of the experiments and the reliability of the model. 
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Measurement of ROS levels using the DCF assay showed a significant increase of oxidised 
fluorescein in cells exposed to 0.3 ppm benzene for 2 hours. This finding is in accordance to 
previously reported data that has linked benzene exposure with inflammation and ROS 
production (Pariselli et al., 2009; Wang et al., 2013; Barreto et al., 2009; Mögel et al., 2011; 
Sørensen et al., 2003a). Furthermore, this data is consistent with a previous report by Mögel et 
al. (2011) that A459 cells express CYP2E1, that is involved in the benzene metabolism and 
ROS production. Intracellular ROS production could be related to the production of oxidising 
metabolites of benzene such as benzoquinone as suggested by Hartwig (2010).  
 
Metabolism of benzene has also been linked to DNA damage due to reactive benzene 
metabolites and ROS generation, which was confirmed in the current study by the results of 
the Comet assay. Figure 66 shows the direct correlation between the benzene concentration 
and DNA damage, and importantly there is evidence of DNA strand breaks at concentrations 
that were not directly toxic to the cells. One of the possible mechanisms of action could be 
through the known reactive benzene metabolite p-benzoquinone. One of its cellular targets is 
topoisomerase-II, which is inhibited, generating DNA double strand breaks (DSB) which are 
then repaired by homologous recombination (HR) or non-homologous end-joining (NHEJ). 
NHEJ is thought to be more error prone than HR, however DSB damage can lead to DNA 
aberrations by base deletions or translocations. Furthermore, the metabolism of benzene 
through redox cycling and generation of ROS is proposed as another main source of DNA 
damage. When hydroquinone or catechol are oxidised in the presence of oxygen, superoxide 
(O2-) is formed, which is then transformed into H2O2 by superoxide dismutase. H2O2 is not 
responsible for DNA damage directly, but it increases the oxidative potential of the cell, and in 
the presence of transition metals ions, hydroxyl radical (OH) is formed, which reacts with 
lipids, proteins and DNA. OH is responsible for the formation of 8-oxo-dG and other 
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nucleobase alterations due to oxidation (Halliwell and Aruoma, 1991). H2O2 production is also 
linked to an inflammatory response of which, as stated above, VOC exposure has been reported 
to be a trigger.  
 
In addition to non-toxic concentrations, relatively high concentrations of benzene (compared 
to the concentrations that can be found in everyday life), which have been reported to have 
cytotoxic effects as well as genotoxic effects, were also studied. In the current study, we saw 
evidence of benzene cytotoxicity following exposure of cells for 2h at a concentration of 0.3 
ppm as indicated by the fact that a large number of cells nuclei were not quantifiable by the 
Comet assay, but appeared instead as “hedgehogs”. Further evidence of that effect is 
represented by the tail intensity data normalised against the controls (Figure 67) and the H 
value decreasing at the higher concentration. In the 0.3 ppm exposure a significant fraction of 
nuclei in the Comet assay appeared as “hedgehogs” and were classified as unquantifiable (23-
60% of unquantifiable nuclei, N=300 per slide), while at lower levels of benzene, the number 
of “hedgehogs” was negligible. Although the significance of hedgehog nuclei in the Comet 
assay is not entirely clear, they may represent nuclei derived from either apoptotic or necrotic 
cells, although other studies have shown that cells sustaining extensive DNA damage can 
survive and repair the damage taken (Collins, 2004). These results could provide a further 
insight on the interpretation of the data reported by Pariselli et al. (2009). In that study, the tests 
were performed after incubating the cells in complete medium for 24h after the exposure, 
allowing the cells to respond to the pollutants and their effects. It is known that large amount 
of DNA damage and bulky adducts can trigger apoptotic response (Roos and Kaina, 2006), and 
furthermore benzene has been shown to be capable of inducing apoptosis by production of 
ROS and DNA damage in leukaemia cells (Sarma et al., 2011). In our study, cells were 
analysed immediately after 2h exposure, not allowing sufficient time for the apoptotic response 
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to happen, therefore there is the possibility that most of the “hedgehogs” we observed in the 
higher benzene exposure could eventually undergo apoptosis.  
 
The Comet assay data confirmed the genotoxic activity of benzene not only in its widely 
acknowledged target organs (bone marrow), but also in metabolically competent cells derived 
from lung epithelial cells. Although the mechanism of action was not fully elucidated, 
generation of ROS arising from benzene exposure was observed, as well as an association 
between exposure to benzene and DNA damage.  
 
In conclusion, with this pilot study we have confirmed that A549 cell line represents a valid 
model to test exposure and DNA damage arising from airborne exposure to benzene. Although 
the metabolism of benzene in vivo is more complex and involves different tissues, A549 cells 
appear to produce a response that is comparable to the one found in the target organs of those 
compounds in vivo. Further metabolomic and proteomic studies would be needed to confirm 
the theory, and further studies with different endpoints will be needed in order to have a better 
understanding of benzene metabolism and its correlation with DNA damage. Furthermore, the 
results obtained by studying a well known carcinogen confirmed the validity of this model for 
analysing not only the effects of exposure of lung cells to benzene, but also opens the way for 
analysing other common VOC with the same procedure, to assess the potential DNA damage 
caused by exposure. 
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VII. Conclusions 
 
VII.1 Assessment of VOC and PAH exposure in different population groups in 
Birmingham, UK 
The main outcome of this study was that although a correlation between exposure to 
VOCs and variations in the level of oxidative stress can be observed for general population, a 
prediction model could not be calculated due to the limited amount of samples that affected the 
precision of the model. The precision of the prediction model was of crucial importance to be 
a valuable tool, since the changes in 8-oxo-dG concentration are generally very small. Different 
categories of general population, although being exposed to similar concentrations of 
pollutants, have proven to be very variable in terms of lifestyle. These heterogeneous 
categories, together with the limited amount of subjects proved that there are also differences 
in lifestyle that can affect oxidative stress, which in some cases are not directly related to 
exposure. General population is often referred at as a control group for occupational exposure 
studies, however, we observed a variance which should be taken in consideration especially 
when the group is used as a comparison factor.  
  
We observed significant correlations between urinary VOCs and urinary cotinine even 
in subjects that were categorized as “non-ETS exposed”. These findings would suggest a role 
of ETS as a contributor to VOC exposure even at concentrations that are not categorized as 
second hand smoking but can still be detected by urinary cotinine measurement. This finding 
would also suggest the contribution of third hand smoke towards the exposure, however, 
although aged smoke has been reported as a source of PAHs and nicotine (Winickoff et al., 
2009; Matt et al., 2008; Hoh et al., 2012), long term persistency of VOCs due to aged smoke 
has not been proved (Sleiman et al., 2014). Another possible route of exposure to third hand 
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tobacco smoke could be from visited places. Interestingly, the ETS exposure levels (although 
urinary cotinine was still detected) in the subjects living/working in new or recently refurbished 
buildings were generally lower. Taking in account that by definition, the control group should 
not have any new furniture or carpets, we could speculate that in some cases the house or 
furniture were exposed to tobacco smoke and are still releasing persistent pollutants such as 
PAHs and nicotine (Matt et al., 2008). The hypothesis of third hand tobacco smoke exposure 
would be in accordance with the observed correlation between airborne PAHs and cotinine 
(Fleming et al., 2012). Third hand tobacco smoke, however, does not fully explain the 
correlation observed between urinary cotinine and VOCs in the non-ETS exposed subjects. 
Although it has been proved that certain cloths can off gas VOCs after being exposed to tobacco 
smoke (Chien et al., 2011), this explanation would be applicable only to relatively fresh 
exposures (i.e. presence in a room of a person who smoked outside). VOCs, due to their 
characteristics of volatility, would not be likely to remain in an ambient or off gas from clothing 
after long periods.  
A slight difference was observed for 8-oxo-dG between the different subgroups of 
FIXAT project, although this difference was not found to be statistically significant. This 
underlines a shortcoming of this study, which lies mostly in the number of participants. The 
variations in the levels of oxidative stress are generally reported to be minimal between groups 
with significantly different levels of exposure (e.g. non-smokers vs smokers which differ on 
average by ~20% (Evans et al., 2010) ), while the sample pool of this study was mostly general 
population. Even the occupationally exposed subjects were not exposed to significantly higher 
levels of VOCs compared to the control subjects.  
Significant differences in urinary VOCs, however, were observed between the FIXAT and 
MATCH project subjects. MATCH subjects were exposed mainly to high levels of ETS, and 
the samples included in this study were chosen within the higher exposed subjects.  
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Although differences were observed within the markers of exposure, no significant 
difference was observed in 8-oxo-dG within the groups. This lack of observable results could 
be sourced back to the general homogeneity of the exposure levels, as within our sampling 
groups we did not have levels of exposure that stood out, except for MATCH. Moreover, the 
sample number was too small to observe statistically significant differences on the levels of a 
metabolite that is known to have small variations. In addition, the spot sampling of different 
subjects, accounted for more variability in the oxidative stress measurements. Different 
subjects with different lifestyle, had different levels of oxidative stress. In a relatively small 
sample pool, it is not an easy task to determine the causes and the effects of the oxidative stress.  
Although we observed that exposure to low levels of benzene does have an effect on 
cells that are metabolically competent towards the compound (chapter VI), we failed to observe 
those effect on the FIXAT or MATCH population. This is likely due to the different activities 
and other substances that the subjects are exposed to, that generate a baseline level of oxidative 
stress that cannot be related only to VOC exposure. Statistically significant correlations 
between urinary VOCs and 8-oxo-dG were observed in the ETS exposed subjects (Table 64). 
Interestingly, in this case, the correlations were observed between the various combinations of 
sums of urinary BTEX + naphthalene and 8-oxo-dG and between toluene, ethylbenzene, 
xylenes and 8-oxo-dG. Another significant correlation was observed between urinary 
naphthalene and 8-oxo-dG but in this case the coefficient was negative. Still in Table 64, the 
non-ETS exposed subjects showed statistically significant correlations between the 
combinations of sums of urinary BTEX + naphthalene and urinary cotinine. The same 
subgroups of samples showed correlations between urinary cotinine and urinary toluene and o-
xylene. These findings suggest that even at extremely low ETS exposures, in our sample pool, 
the main contributors to the urinary VOCs are probably ETS and third hand tobacco smoke. It 
is important to remember that the subjects that participated in this study belong to the general 
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population, and they spent most of their time indoors. Moreover, more than 47% of the non-
ETS exposed subjects had an indoors job (either office work or not), which would reduce the 
chances of ETS exposure. The measured levels of cotinine for this subset are extremely low, 
however, a statistically significant correlation is observed. The coefficients of correlation are 
low (R=0.347, urinary BTEX + naphthalene and cotinine), suggesting that the correlation 
between urinary BTEX and cotinine is weak but, however, statistically significant (p=0.004). 
The observed variability suggests that ETS is not the only contributor towards the urinary 
VOCs, but the observations suggest that it is one of the main ones.  
Furthermore, a threshold of effect was observed for VOC exposure upon oxidative 
stress (Figure 38, Figure 39 and Figure 40). We observed that above the ETS exposed threshold 
(urinary cotinine >1µg/L) a relationship between urinary BTEX + naphthalene and 8-oxo-dG 
could be found. Under that threshold, no kind of relationship between urinary VOCs and 8-
oxo-dG was detected. However, when the relationship between urinary cotinine and urinary 
BTEX + naphthalene was considered (Figure 39) a correlation between urinary cotinine and 
urinary BTEX + naphthalene was observed for non-ETS exposed subjects, while in the ETS 
exposed subjects, the correlation was observed between urinary cotinine and 8-oxo-dG, and 
more importantly, between urinary BTEX + naphthalene and 8-oxo-dG (Table 64). From these 
results, it is possible to conclude that for our sample pool, the point of discrimination between 
non-ETS exposed subjects and ETS exposed subjects, also represents a threshold of effect for 
VOC exposure. Under that threshold, 8-oxo-dG is not correlated to the urinary concentration 
of VOCs, while above the threshold, the correlation becomes more evident. The observed 
threshold coincides with the point of intersection between the regression line of the 
cotinine/urinary BTEX + naphthalene plot, and the discriminant urinary cotinine concentration 
between ETS exposed and non-ETS exposed subjects. In terms of urinary concentration of total 
VOCs the threshold was identified at 550 ng/L of BTEX + naphthalene. The proportions of the 
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single compounds are variable in each sample, however, subjects with higher total urinary 
VOCs concentrations showed higher 8-oxo-dG concentrations (Figure 40).  
In conclusion, the definition “threshold of effect” is due to the difference observed 
above and under the reference. Above the threshold of effect, it is possible to see a relationship 
between the urinary BTEX + naphthalene and 8-oxo-dG, under the threshold, the variance of 
the 8-oxo-dG is not related to the urinary BTEX and it might be caused from other sources or 
activities. The threshold of effect represents the data reported in Table 64.  
 In addition, in section IV.9 we observed a statistically significant correlation between 
airborne phenanthrene and 8-oxo-dG. This finding suggests that for the concentrations 
observed in FIXAT and MATCH project, phenanthrene exposure has an effect on oxidative 
stress or it represents the effect of the PAH mixture, as it is one of the most abundant of the 
compounds (Aquilina et al., 2010). Furthermore, the lack of correlation observed between 
airborne phenanthrene and urinary cotinine, suggests that tobacco smoke is not the main source 
of phenanthrene in our study. Unfortunately, we were not able to measure the urinary 
metabolites of the PAHs with our instruments in the FIXAT samples. Although the urinary 
PAH metabolites measurements were available for MATCH project, no correlation was found 
between any of the urinary PAH metabolites and 8-oxo-dG. Similar results were obtained with 
the samples from Jeddah schoolchildren, where no correlation between urinary PAH 
metabolites and 8-oxo-dG was observed (V.3).  
No significant differences in the urinary levels of VOCs or 8-oxo-dG were observed in 
subjects living or working in new or recently refurbished buildings after 1 year (IV.2). An 
important factor to consider is that the number of samples was relatively small, and we could 
only perform a spot sampling, so it is possible that the measured 8-oxo-dG values could be 
affected by other factors. However, the significance of the t-test was not far from being 
statistically significant (p=0.087). This result could suggest that with a bigger sample size, it 
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might be possible to find a statistically significant difference, by reducing the inter-sample 
variation. Marginally significant differences were observed in the urinary VOC concentrations 
of the occupationally exposed subjects at the end of the working week and after the weekend, 
for ethylbenzene (p=0.023) and m+p-xylene (p=0.017), suggesting a work-related source of 
these two compounds. However, also in this case, the lifestyle of some volunteers (smoking 
and ETS exposure) could be a confounding factor. In particular, in this case the commitment 
factor played a key role, as together with positively committed subjects, there were subjects 
that declared to be non-smokers, which was in contrast with the measurement of urinary 
cotinine. Also in this case, the sample number was relatively small, and the sampling was 
performed only in two events for each subject. Although the two urine sampling events were 
close to each other (Saturday morning at the end of the working week and Monday morning at 
the beginning of the working week), and the variations in the subjects’ lifestyle was minimal, 
we could not identify statistically significant differences in 8-oxo-dG concentration between 
the two days.  
PCA analyses (IV.10) evidenced a difference between urinary and airborne VOC data, 
where generally the urinary VOC measurements had a higher significance in explaining the 
variance of the data set. However, the differences in some of the airborne samplings 
(occupationally exposed group) could possibly have influenced the results due to the limited 
amount of compound measured. Moreover, when all the variables were included in the analyses 
for the full data set, too many factors were extracted, underlining the need of a higher number 
of samples for successful extractions. Within the urinary biomarkers, xylenes, ethylbenzene 
and toluene were found to be the main contributors to the variance. 8-oxo-dG although present 
within the principal components, was not one of the main contributors towards the variance. 
Another variable that was always present within the principal components, was the urinary 
cotinine, which proved to be another important marker to take in account even for subjects that 
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are classified as non-ETS exposed. PCA also confirmed the utility and feasibility of sampling 
campaigns based on general population and low exposed individuals. Moreover, when only the 
urinary biomarkers were analysed we were able to identify three principal components which 
allowed to interpret as lifestyle related VOC exposure, ETS and oxidative stress caused by 
exposure (Table 75). 
The results obtained by the calculation of a linear model for 8-oxo-dG underlined some 
of the shortcomings of this study. Although we obtained significant predictors for 8-oxo-dG 
(benzo(a)pyrene, age range, 9,10-anthraquinone, anthracene), we were not able to obtain a 
good prediction for 8-oxo-dG on the validation subset. This is likely due to the limited amount 
of samples available to build the model, and to the high inter-individual variance of 8-oxo-dG, 
which, together with the generally small span of the variation in the concentration, make the 
calculation of an accurate model difficult.  
Another important factor that must be taken in account and that can affect the results 
dramatically is the volunteers’ commitment. Although in this study all the subjects voluntarily 
applied for the monitoring, not everyone was committed and interested in the study. Many 
subjects volunteered within the university, and had a scientific background, or however had a 
basic understanding of a personal sampling experiment. This subset was generally very open 
in providing information about the sampling day. This allowed us to collect good data and 
information about the sampling events. However, in some cases the subjects tended to provide 
extremely detailed information, or even overestimate some of the questions. A fitting example 
is given by some of the subjects that answered positively to the question regarding ETS (both 
at home and in the workplace), however, according to the cotinine analyses, the exposure they 
were subjected to was not relevant and the subjects were not categorized as ETS exposed. Upon 
investigations, the subjects explained that they considered to be exposed to ETS because of 
occasional exposures happening outside of the workplace (ETS in the workplace) or because 
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their smoker partners smoked outside of the house (ETS at home). This information alone, 
without urinary cotinine measurement, would have been misleading in the analyses.  
On the other hand, subjects that did not have a scientific background, tended to provide 
the more honest and “correct” answers to the questionnaires. However, in some cases they were 
reluctant to provide details about their day. This was evident in some of the occupationally 
exposed subjects: some subjects were interested in the study and very collaborative, mainly 
driven by curiosity. Other subjects were reluctant to provide information and in some cases, 
did not provide true information to some of the questions (some subjects declared to be non-
smokers, which was in contrast with the measured amount of urinary cotinine).  
The “commitment” factor is often underestimated or not mentioned in the studies, and 
especially if a significant amount of data is gathered from questionnaires, it should be taken in 
great consideration. It is important to have a committed population, and in some cases it is 
preferable that the volunteers are not overcommitted, in order to avoid false positives or 
incongruent data. In conclusion, the commitment factor should be taken in account especially 
for information that cannot be double assessed with a measurement (i.e. ETS exposure), in 
order to avoid bias in the collected information. 
In conclusion, with this project, we demonstrated the possible application of headspace 
microextraction for biomonitoring of low exposed subjects, together with personal exposure 
sampling. Furthermore, the measurement of oxidative stress biomarkers showed the influence 
of exposure to different pollutants (ETS, VOCs, PAHs) towards the oxidative stress. We were 
able to link exposure to some of the pollutants to early effects biomarkers (8-oxo-dG), which 
suggests that indoor and outdoor exposures to low levels of pollutants can have an effect on 
the oxidative stress. We managed to identify a threshold of effect for urinary VOCs, as a pivotal 
point between exposure and early effect (measured as oxidative stress). This threshold of effect 
defines the point where the exposure level leads to an observable effect on the oxidative stress. 
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Under that threshold, although it is possible to find a correlation between urinary cotinine and 
urinary VOCs, it is not possible to observe an effect. 
This study can be considered a pilot for further projects based on general population, 
and the difficulties encountered in this project can be used to enhance future studies.  
The crucial aspects to be considered would be:  
-Sample number 
-Subjects commitment 
-Number of measurements per subject 
-Timing of the biological samplings 
 
VII.2 PAH and oxidative stress biomonitoring in Jeddah school children 
The analyses of the data obtained from Saudi Arabia, showed the contribution of 
outdoor pollution sources towards the urinary PAHs metabolites. Although in previous works 
it has been suggested that the main contribution towards urinary OH-PAHs arises from dietary 
intake (Harrison et al., 2009), we observed differences in the urinary PAH metabolites 
concentration between populations living in different districts and being exposed to different 
levels of pollution.  
Similar differences in the urinary concentration of the PAH metabolites were observed 
between subjects using different cooking appliances, which however were also related to 
different areas, which might have a stronger effect on the PAH exposure. Moreover, no 
difference was observed between subjects eating charbroiled food and subjects eating non-
charbroiled food. Charbroiled food is a known source of urinary PAHs, as dietary intake is 
generally suggested to be one of the main sources of exposure (Strickland and Kang, 1999; 
Strickland et al., 1996). Our findings suggest that in this case dietary exposure could be not the 
only source of exposure, as airborne PAHs showed to have an effect on the urinary 
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concentration of their metabolites when the subjects were divided based on the residence area. 
This difference suggests an inequality based on the wealth of the population, since the subjects 
with lower income were mostly residing in the vicinity of the oil refinery, while the majority 
of subjects in the higher income were residing in the rural background site. The residence area 
is likely to be affected by the income and this results in a difference in the air quality and higher 
exposure to pollutants of the subjects with lower income.  
Differences were observed in the urinary 8-oxo-dG levels between subjects living in 
different areas. Unfortunately, due to the limited availability of samples and sampling events, 
it was not possible to investigate in depth the correlations between 8-oxo-dG and the measured 
PAHs. However, the lack of correlation between urinary PAH metabolites and the oxidative 
stress biomarker observed in this case, would suggest other sources of oxidative stress, which 
have not yet been analysed, although significantly higher concentrations of 8-oxo-dG were 
observed in relation to some disease conditions. Due to the sampling sites location (next to an 
oil refinery and a heavy-traffic ring road) it is possible that VOCs play a major role in the 
contribution to the oxidative stress, instead of PAHs.  
The results suggest possible further developments with a set of analyses similar to the 
ones performed for FIXAT project. This would allow to explore a broader spectrum of 
metabolites and biomarkers, in order to identify possible contributors to the oxidative stress in 
this particular population.  
 
VII.3 In-vitro test of exposure to controlled benzene concentration on metabolically 
competent cells 
With this pilot experiment, we tested the feasibility of an in-vitro test to study the early 
effects of exposure to pollutants. We used benzene as it is a known carcinogen and its metabolic 
pathway has been extensively studied. We designed a custom exposure vessel in order to 
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expose cells to controlled atmospheres. With this project we intended to test the feasibility of 
the methodology, in order to open the way to more detailed future studies. Moreover, we aimed 
to create a system to expose the cells in a physiologically relevant way, creating a toxicological 
model that is closer to the real life situation than the classical model. We managed to have 
successful exposures of cells to air and to benzene at three key concentrations. We were able 
to observe early effects of exposure on DNA, with a dose-effect relationship.  
These findings suggested that both the design of the exposure vessel and the A549 cells, 
are a valid toxicological model to study the exposure to VOCs. The designed model could be 
used for future projects, in order to evaluate the effects of exposure to various pollutants, or to 
study the metabolic pathways of different compounds.  
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VII.4 Shortcomings of the studies 
Each project showed a number of weaknesses and shortcomings that, however, 
provided useful information for future projects and development.  
 
FIXAT project 
With FIXAT project, we encountered difficulties in developing the method for 
measurement of quinones in urine (benzoquinone, hydroquinone and PAH quinones), due to 
the low concentrations of the metabolites we were analysing. The main problem is represented 
by confounding factors, as it is possible that some biomarkers can be also related to normal 
metabolism, such as hippuric acid, which is a metabolite of toluene, but can also be a result of 
catabolism of proteins or metabolism of naturally occurring benzoic acid (Fustinoni et al., 
2000). Confounding factors and specificity are generally not a major issue, since most of the 
studies are performed either on occupationally exposed subjects or on populations that have a 
high baseline exposure (e.g. highly polluted cities/areas, smokers). The importance of the 
specificity of the biomarkers is inversely proportional to the exposure level. When analysing 
general population, the confounding factors can provide a significant contribution towards 
certain biomarkers, affecting the significance of the analyses. In our study, we noticed an 
important contribution of ETS, even in cases that were classified as non ETS exposed. This 
suggests that the exposure that does not arise from ETS is so small that cigarette smoke, even 
at extremely low concentration, can affect the biomarkers. A possible solution for this issue, 
would be the search for new biomarkers. However, this task is not easy, as urine is a complex 
matrix and there are significant variations induced by variables such as diet, genetic 
polymorphisms, and many more. This variability makes the typical biomarker discovery 
approaches (e.g. metabolomics) difficult, as it is hard to isolate metabolites and biomarkers that 
are only related to exposure to pollutants.  
236 
 
We could not see statistically significant differences between our groups when urinary 
8-oxo-dG concentrations were compared, which might be caused by the relatively small 
number of subjects in each group and the small variability of 8-oxo-dG concentrations. 
Probably, with larger study populations, it would be possible to detect statistically significant 
differences within different groups of general population.  
 
PAH and oxidative stress biomonitoring in Jeddah schoolchildren 
The analyses performed on the samples obtained from Saudi Arabia did not show the 
same correlations observed between PAHs (airborne and urinary) and oxidative stress. 
Although the 8-oxo-dG levels were higher than the ones measured in FIXAT and MATCH 
projects (Figure 52, section V.2), the comparison would not be significant, as the two subsets 
are coming from different populations with different age ranges, lifestyles and genetic subsets. 
The main shortcomings of this study were the sampling campaign, which only provided 
samples from three days, with the control samples not collected at the same time as the exposed 
subjects. Furthermore, the control urine samples, and the urine samples of day 1 and 3 of the 
campaign were not made available for 8-oxo-dG measurement. This made it difficult to draw 
conclusions based on the oxidative stress only. In this study, no personal exposure data was 
collected, and all the correlations were calculated using fixed site data, which provided only 
three data points, and only for urinary metabolites. Although the sample size was large, the 
sampling time span was limited and it was not possible to assess correlations between airborne 
concentrations of PAHs and their urinary metabolites or 8-oxo-dG. Further measurements of 
urinary VOCs were not included in this campaign, making it difficult to make comparisons 
with FIXAT and MATCH results, since the only overlapping measurements were the ones of 
8-oxo-dG for FIXAT and 1-OH-pyrene and 8-oxo-dG for part of the samples from MATCH.  
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Benzene effects on DNA damage using a novel in-vitro exposure device 
The study on DNA damage caused by exposure to low concentrations of benzene using 
A549 cells provided good results. However, since it was a pilot study in quest of observable 
effects in order to proceed with further studies, few replicates were performed. DCF assay was 
performed only on one of the concentrations, in order to evaluate if there was production of 
ROS arising from exposure to benzene. The study was aimed to assess if it was possible to 
observe an effect that was caused by the exposure, and the result was positive.  
However, this in-vitro system lacks one of the other main contributors towards 
oxidative stress, which is the immune system. Often, exposure is related to oxidative stress 
damage that is caused from the immune system reaction to the exposure (Klebanoff, 2005; van 
Berlo et al., 2010; Knaapen et al., 2006; Schottenfeld and Beebe-Dimmer, 2006; Wang et al., 
2013). In our case, it would not be possible to observe such secondary effects. However, it 
would be possible to measure inflammation biomarkers (e.g. interleukin-8) which are strongly 
correlated to inflammatory response and neutrophils chemotaxis.  
 
VIII. Future directions 
The results obtained from these studies underlined a need of new biomarkers of 
exposure for general population. 
It was not possible to determine a “fingerprint of exposure” due to the high variability of the 
samples, although the population could be considered homogeneous. One of the main 
directions that would be worth following is to identify metabolomic profiles of different groups 
of subjects, using a large sample base. Similar studies are undergoing (Smolders et al., 2014), 
however they mainly focus on biomonitoring. A metabolomic approach on a large cohort of 
subjects could add useful information on exposure and allow to identify a fingerprint of 
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exposure on a complex matrix such as urine. This would not be possible in small scale 
experiments, due to the high variability of the samples and the analysed matrix.  
 Another interesting field of study would be to develop further our cell exposure vessel, 
creating a hybrid, more complex system, with different tissues that would serve as a more 
complete model for exposure and toxicological studies. Recent developments on 3D cell 
cultures and organ-on-a-chip systems could be implemented and improved for specific 
exposure experiments (Huh et al., 2012; Bhatia and Ingber, 2014).  
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X. Annex  
 
X.1 Synthetic urine 
Method development for extractions and testing was performed using synthetic urine, prepared 
according to Putnam (1971). The synthetic urine composition was: 
Albumin 0.1 g/L 
Ammonium sulphate 1 g/L 
Ascorbic acid 0.02 g/L 
Bilirubin 0.005 g/L 
Citric acid 0.5 g/L 
Creatine 0.5 g/L 
Creatinine 1.5 g/L 
L-cystine 0.1 g/L 
D-glucuronic acid 0.5 g/L 
Hippuric acid 1 g/L 
L-hystidine 0.5 g/L 
Magnesium sulphate 1 g/L 
Phenol 0.5 g/L (only added in first batch as it generated interference) 
Urea 15 g/L 
Uric acid 0.5 g/L 
Glycine 0.5 g/L 
Synthetic urine was used as a matrix for method development to ensure reliability within 
different methodologies of extraction and analysis.  
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X.2 Baseline-screening questionnaire sample  
FIXAT- Project 
PARTICIPANTS BASELINE QUESTIONNAIRE 
 
Volunteers ID:      Date: 
 
 
PART A: GENERAL INFORMATION ABOUT YOUR HOUSE 
 
A.1 DESCRIBE THE LOCATION OF THE HOME.    Please tick one box 
 
Rural area 
Suburb 
City centre 
 
A.2 DESCRIBE THE TYPE OF DWELLING.    Please tick one box 
 
Flat 
Centre terrace house 
End terrace house 
Semi-detached house 
Detached house 
 
A) IF YOU DO NOT LIVE IN A FLAT, PLEASE GO TO QUESTION A.6 
 
A.3 ON WHICH FLOOR IS THE FLAT LOCATED? 
 
 (Please specify, e.g. 1, 2, 3 or Basement =B, Ground Floor = F) 
 
A.4 WHAT IS IMMEDIATELY BELOW THE FLOOR OF YOUR FLAT? 
 Please tick one box 
The ground 
Another flat 
Garage 
Other (please describe below) 
 
 
A.5 WHAT IS IMMEDIATELY ABOVE YOUR FLAT? 
 Please tick one box 
The roof – is it a top floor flat 
Another flat 
Other (please describe below) 
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A.6 APPROXIMATELY WHEN WAS YOUR HOUSE BUILT?    Please tick one box 
 
Less 3 months ago 
more than 3 months - 1 
year 

1- 5 years 
More than 5 year 
 
 
 
A.7 HAVE YOU DONE EXTENSIONS OR REDECORATIONS TO YOUR HOME?   
Less 3 months ago 
 3 months - 1 year 
More than 1 year 
N/A 

 
   
A.8 FOR EACH ROOM IN THE TABLE BELOW, PLEASE WRITE HOW MANY 
MONTHS AGO       YOU DID EACH OF THE FOLLOWING 
If more than 12 months write X 
 Wallpapering  Carpeting 
/ Lino 
Sanding / 
Stripping 
Painting New 
furniture 
Kitchen   
Living rooms       
Bedrooms       
Other rooms       
  
IF NO NEW CARPET/LINO HAS BEEN LAID PLEASE GO TO A.12 
 
A.9 WAS RUBBER-BACKED NYLON CARPET LAID?  Please tick one box 
 
Yes  
No 
Don’t 
know 

 
A.10 WAS THE CARPET/LINO GLUE TO THE FLOOR? Please tick one box 
 
Yes  
No 
Don’t 
know 

A.11 HAS ANY SEALANT BEEN USED IN THE LAST 12 MONTHS? 
 This question is about sealants used for waterproofing around baths, pipes 
etc.  Please tick one box 
Yes  
No 
Don’t 
know 

 
A.12 DO YOU HAVE A GARAGE? 
Yes 
No 
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If no, please go to A.17 
A.13 IS THE GARAGE PART OF YOUR HOME (OR DIRECTLY ATTACHED TO 
 THE UNDERNEATH OR SIDE OF YOUR HOME) ? 
Yes 
No 
If no, please go to A.17 
 
A.14 (a) DO YOU KEEP A CAR IN THE GARAGE? 
Usually 
Sometime
s 

Never 
If never, please go to A.17 
 
A.15 (b) WHAT TYPE OF FUEL DOES THE CAR RUN ON?  
Unleaded petrol 
Diesel 
Don’t know 
 
 
A.16 WHICH ROOM HAS A DOOR TO THE GARAGE?  Please tick one box 
 
Hall 
Kitchen 
Utility room 
Living room 
None 
Other (Please 
describe below) 

 
 
 
A.17 IS ANY OF THE FOLLOWING ITEMS STORED/USED IN: 
 
            GARAGE    IN THE HOUSE 
 PETROL VEHICLE         
 DIESEL VEHICLE         
 PETROL LAWNMOWER        
 OPEN PAINTS          
CLOSED PAINTS         
SOLVENTS          
INKS/TONER          
PETROL          
DIESEL          
FERTILISER          
GLUES           
SPARE BUILDING MATERIAL        
SPARE CARPETS         
TUMBLE DRY          
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PART B: HEATING & COOKING 
 
B.1 HOW MANY ROOMS DO YOU USUALLY HEAT AT THIS TIME OF YEAR? 
 Write a number in each box 
  
Living rooms       (include studies, dining rooms etc. but not kitchen diners  
or living rooms with kitchen included) 
 
Living room or dining room which includes kitchen    
Kitchen  
Bedrooms  
Bathrooms  
Other rooms  
 
B.2 REGARDING  THE MAIN METHOD OF HEATING AT THIS TIME OF YEAR? 
WHAT FUEL DO YOU USE FOR YOUR MAIN HEATING? Please tick one box 
Natural gas 
Electricity 
Bottled gas 
Other (Please 
describe below) 
Not applicable 

 
 
 
 
 
WHAT TYPE OF HEATING SYSTEM DO YOU USE FOR YOUR MAIN HEATING?  Please tick 
one box 
Electric storage heaters 
Central heating with 
radiators 

Warm air central heating 
Individual heaters or fires in 
each heated room 

Other (Please describe 
below) 
No applicable 

 
 
 
B.3 WHERE IS YOUR BOILER LOCATED?  
Kitchen 
Hallway 
Under stairs 
Other (Please describe 
below) 

 
 
B.4 HAVE YOU USED ANY ADDITIONAL TYPE OF HEATING DURING THE 
SAMPLING DAY? 
Yes 
No 
If no, please go to B.6 
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B.5 WHAT TYPE OF ADDITIONAL HEATING DO YOU USE MOST? 
      WHAT FUEL DOES IT USE?  Please tick one box 
 Sampling 
day 
Sampling 
week 
Natural gas   
Electricity   
Bottled gas   
Coal /coke   
Wood   
Paraffin   
Other (Please 
describe below) 
  
 
 
 
  WHAT TYPE OF HEATING SYSTEM DO YOU USE FOR YOUR ADDITIONAL   
HEATING?   Please tick one box 
 Sampling 
day 
Sampling 
week 
Electric storage heaters   
Central heating with radiators   
Warm air central heating   
Individual heaters or fires in each 
heated room 
  
   
   
Other (Please describe below)   
 
 
 
 
B.6 DO YOU USE ANY FURTHER GAS OR SOLID FUEL WHICH YOU HAVE NOT 
INCLUDED IN YOUR MAIN OR ADDITIONAL HEATING  (NOT INCLUDING COOKING 
FUEL)? 
 Sampling 
day 
Sampling 
week 
Yes (please describe 
below) 
  
No   
If yes, please describe in box below 
 
 
 
B.7 AT WHAT HOURS WAS YOUR HOUSE HEATED? 
 Please mark off the boxes to show when you have heating on 
 
                        
1 2 3 4 5 6 7 8 9 1
0 
1
1 
1
2 
1
3 
1
4 
1
5 
1
6 
1
7 
1
8 
1
9 
2
0 
2
1 
2
2 
2
3 
2
4 
Midnight            Midday  
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B.8 WHAT MAIN COOKING FUEL DO YOU USE?  Please tick one box 
Natural gas 
Electricity 
Bottled gas 
Other (Please 
describe below) 

 
 
 
IF YOU DO NOT USE GAS FOR COOKING PLEASE GO TO PART B.11 
 
B.9 HOW MANY HOURS WAS YOUR GAS COOKER USED ON THE SAMPLING DAY? 
  
 
 
Hours 
 
 
B.10 DO YOU EVER USE THE GAS COOKER, WHEN YOU ARE NOT COOKING, TO 
HEAT THE KITCHEN (OR ANY OTHER PART OF THE HOME)?  Please tick one box 
Yes, regularly 
Yes, sometimes 
Yes, only 
occasionally 

No, never 
 
B.11 DO YOU HAVE A COOKER HOOD? 
Include cooker hoods which extract air to the outside, but NOT hoods which only 
filter air and return it to the kitchen. 
Yes  
No 
If no, please go to PART C 
 
B.12 HOW OFTEN IS THE COOKER HOOD USED?   Please tick one box 
 
Fan not used 
Fan sometimes used 
Fan normally used 
when room in use 

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PART C: WINDOWS & VENTILATION 
 
C.1 PLEASE INDICATES WHICH DIRECTION THE WINDOWS IN YOUR HOME 
FACES.    Please tick more than one box if applicable 
 
 Street Side Back Garden Side Street/Side 
Alley 
Other (please 
specify) 
Kitchen     
Bathroom   
Living room     
Your bedroom     
Other*     
Other*   
*Please specify (e.g. dining room, second bedroom, corridor, etc.) 
 
C.2 HOW OFTEN WAS THE WINDOWS OPEN DURING THE SAMPLING DAY?  
Please tick one box for each room type 
 
 All or 
most of 
the time 
Part of 
the day 
Only when 
needed 
Rarely or 
never 
No window Don’t 
know 
Kitchen    
Bathroom    
Living 
rooms 
      
Bedrooms       
Other 
rooms 
      
 
C.3 DID YOU LEAVE WINDOWS OPEN AT NIGHT DURING THE SAMPLING DAY? 
 Please tick one box for each room type 
 
 Yes How long? No Don’t know 
Kitchen   
Bathroom     
Living rooms     
Bedrooms     
Other rooms   
 
C.4 DO YOU HAVE DOUBLE GLAZING? 
Yes  
No 
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C.5 DO YOU HAVE ANY ELECTRIC EXTRACTOR FANS?    
  
This is a question about electric fans which extract air from the home to the outside. These 
fans are fitted in a window or wall, you may have one in a ceiling which blows air up a pipe 
and through the roof.  Do not include cooker hoods. Please tick one box.             
Yes  
No 
If no, please go to PART C.7 
 
C.6 PLEASE INDICATE WHETHER THERE IS A FAN IN THE ROOMS LISTED 
 IN THE TABLE BELOW, AND WHETHER IT IS USED, BY TICKING THE 
 APPROPRIATE BOXES 
 
 No fan Fan present, 
but not used 
Fan sometimes 
used 
Fan normally 
used when room 
in use 
Kitchen   
Bathroom     
Other 
rooms 
    
 
C.7 WOULD YOU SAY THAT WINDOWS AND/OR VENTILATORS IN YOUR HOME 
PROVIDE ADEQUATE FRESH AIR?  Please tick one box 
Usually  
Sometime
s 

Never 
 
PART D:   THINGS THAT AFFECT THE AIR IN YOUR HOME 
 
D.1 DO YOU SMOKE INDOORS AT HOME? 
Yes  
No 
 
D.2 DOES ANYONE ELSE IN YOUR HOUSEHOLD SMOKE INDOORS AT HOME? 
Yes  
No 
 
D.3 DOES ANYONE ELSE REGULARLY SMOKE INDOORS AT HOME? 
Yes  
No 
 
IF NOBODY SMOKES PLEASE GO TO D.5 
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D.4 FOR EACH PERSON WHO SMOKES INSIDE YOUR HOME PLEASE ESTIMATE 
THE AMOUNT SMOKED PER WEEK INSIDE YOUR HOME. 
 
PERSON 1 2 3 4 5 6 
Cigarettes (number)   
Pipe tobacco (oz)       
Small cigars 
(number) 
      
Large cigars 
(number) 
      
 
D.5 HAVE YOU NOTICED ANY PATCHES OF MOULD ON THE WALLS OR CEILINGS 
OF YOUR HOME AT ANY TIME IN THE LAST 12 MONTHS? 
 
Yes  
No 
If yes, please indicate in which room(s) in the box below 
 
 
 
D.6 DO YOU OWN ANY PETS (WHICH ENTER THE HOUSE) ? 
Yes  
No 
If no, please go to D.8 
If yes, please indicate in which room(s) in the box below 
 
 
 
D.7  WHICH ROOMS ARE YOUR PET ALLOWED IN? 
Kitchen  
Living rooms 
Bedrooms 
Other rooms 
D.8 HAVE YOU USED ANY GERMICIDE, PESTICIDE, OR PARASITE KILLER ON: 
 Sampling 
day 
Sampling 
week 
Yes (please describe below)   
No   
 
 
D.9 DID YOU DO ANY DIY? 
Sampling day Sampling week Sampling month   
           
           
 
If yes, please specify any recent DIY in the box below, including approximately when it was 
done. 
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D.10 PLEASE TICK TO INDICATE HOW OFTEN DO YOU DO THE FOLLOWING 
 
 Most days or 
every day 
About once a 
week 
Less often Rarely / never 
Hoover     
Dust     
 
D.11 PLEASE TICK TO INDICATE HOW OFTEN YOU USE THE FOLLOWING 
 
 Most days or  
every day 
About once a 
week 
Less often Rarely / 
never 
Aerosol insect 
killer 
    
Aerosol air 
freshener 
    
Other aerosol     
 
 
 
D.12  Can you provide us with your approximated weight? 
in kg. or  lbs. 
 
--------------------------------------------------- 
 
X.3 Activity diary sample 
FIXAT Project- ACTIVITY DIARY 
           
Volunteer ID        Date:     
           
Time  Where are you? 
What are 
you doing? 
Are there 
any 
windows or 
doors 
open? Y/N 
Anyone 
smoking?  
Y/N 
Location number 
for   Level of exercise 
Places 
visited  Travelling  Rest  Low  Med  High 
0000-
0030                              
0030-
0100                              
0100-
0130                              
… ... ... ... ... ... ... ... ... ... ...
2230-
2300                              
2300-
2330                              
2330-
2400                              
NOW PLEASE COMPLETE A LOCATION SHEET FOR EACH PLACE VISITED AND EACH TIME YOU 
TRAVELLED 
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X.4 High VOC/PAH exposure activity questionnaire sample 
 
  
Volunteer ID Measurement Date
Activities Specify the activity you 
are doing
For how 
long?
What products are 
you using?
What is your location?
FIXAT Project- Sampling Questionnaire
Is there any 
ventilation?  
Level of exercisePlease 
Tick used 
day week Yes No
R
e
st
Lo
w
M
ed H
ig
h
Cleaning  
Dusting                         
(e.g. furniture polish)
 
Vacuuming  
Aerosol and perfume 
use  (including plug-in 
air fresheners)
 
Cosmetics (e.g. Nail 
polish, nail remover or 
glue)
 
Solvent use                   
(e.g. fertiliser, de-icer, 
insect spray)
 
Dry cleaning  
Candle burning  
Use of a photocopier  
Use of fireplace  
Use of any other fossil 
fuels (e.g. petrol lawn 
mower)
 
Visit to petrol 
station/refuelling car
 
DIY - Painting  
DIY - Wallpapering  
DIY – Gluing  
DIY – Other                   
(please specify)
 
Gardening                     
(e.g. lawn mowing)
 
Not Applicable - non of 
above activities done.
 
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X.5 Food preparation, self-medication or prescribed drugs and caffeinated drinks 
questionnaire sample 
Sampling Date:      Sampling ID:    
         
Please list here where your meals were prepared:         
  
Where? Plastic container? 
Other, 
please 
specify: Restaurant 
Home 
(prepared 
from 
scratch) 
Fast food or 
Take away 
Ready 
made 
food 
Re-heated 
in Kept in N/A 
Breakfast                 
Snack                 
Lunch       
Dinner                 
Other snack                 
                  
        
IN THE LAST 3 DAYS DID YOU CONSUMED ANY: 
    
Average amount per day (average cup of 250-
300ml) 
Tea     _______   Cups N/A   
Coffee    _______   Cups N/A     
Prescribed drugs or self-medication products: Amount per day:   
Amount 
per 
dose:
__________________________ _________       ____________ 
                  
Vitamines or 
supplements (if any, 
please list):     Amount per day:  
Amount 
per 
dose: 
__________________________ _________       ____________ 
__________________________ _________       ____________ 
Soft drinks (1 can = 330ml):        
Cola           _______ ml  N/A
Sport drinks (e.g. Gatorade) _______ ml  N/A
Energy drinks (e.g. Red bull)       _______ ml  N/A
Other drinks please list:        
__________________________ _______ ml  N/A
__________________________ _______ ml  N/A
__________________________   _______ ml  N/A
__________________________   _______ ml  N/A
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X.6 Dietary questionnaire sample 
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X.7 ETS exposure questionnaire sample 
 
 
 
 
TIME OF EXPOSURE: e.g. 3pm – 4pm ______________________________________________________ 
 
WHEN YOU ARE EXPOSED TO PEOPLE SMOKING PLEASE COMPLETE ONE OF THESE FORMS 
 
1) PLEASE COMPLETE THE FOLLOWING TABLE: 
 
How far was the smoker 
from you? 
How many people were 
smoking? 
Approx how many 
cigarettes were smoked? 
How long were you exposed 
to the smoke for? 
Less than 2 metres    
More than 2 metres    
 
2) WHO WAS THE SMOKER?  
 A FRIEND OR RELATIVE IN MY COMPANY 
 A PERSON WHO WAS NOT IN MY COMPANY 
 A PASSER BY 
 
3) WHERE WERE YOU EXPOSED TO THE SMOKE?  
 OUTSIDE, IN AN OPEN SPACE 
 INSIDE, IN AN ENCLOSED SPACE 
 OTHER, PLEASE DESCRIBE 
________________________________________________________________________ 
FOR OPEN SPACES: 
 
4) IF YOU WERE IN AN OPEN SPACE PLEASE DESCRIBE IT: 
 PRIVATE GARDEN 
 PARK 
 PLAYGROUND 
 STREET 
 BUS STOP 
 OTHER, PLEASE DESCRIBE 
________________________________________________________________________ 
 
5) HOW LONG WERE YOU IN THE OPEN SPACE?  
(e.g. 3pm – 4pm) 
 
FOR ENCLOSED SPACES: 
 
6) IF YOU WERE IN AN ENCLOSED SPACE  
PLEASE SAY WHERE YOU WERE: 
 
7) HOW SMOKY IS THE ROOM? 
 NOT SMOKY AT ALL 
 SLIGHTLY SMOKY, PEOPLE ARE SMOKING OCCASSIONALLY 
 SMOKY, PEOPLE ARE FREQUENTLY SMOKING 
 VERY SMOKY, THERE ARE PEOPLE CONSTANTLY SMOKING 
 
8) HOW VENTILATED IS THE ROOM? 
 IT IS WELL VENTILATED 
 THERE IS SOME VENTILATION 
 IT IS NOT VENTILATED 
 I DON’T KNOW 
9) ARE THERE ANY SOURCES OF VENTILATION IN THE ROOM? 
 OPEN WINDOWS 
 OPEN DOORS 
 FAN 
 CEILING FAN 
 AIR EXTRACTORS 
 AIR CONDITIONING 
 PASSIVE VENTILATION 
 DON’T KNOW 
10) HEN YOU WERE EXPOSED TO THE SMOKE WERE ANY HEATING SOURCES ON? 
 YES 
 NO 
 DON’T KNOW 
  
VOLUNTEERS ID:   MEASUREMENT                     DATE  
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X.8 Travelling questionnaire sample 
 
 
Volunteers ID Measurement Date
Location number 1 2 3 4 5
Length of time travelling? (e.g. 30mins)
Start time of travelling?
If return journey along same route, what 
time is return?
Where are you travelling from?
Where are you travelling to?
How are you travelling?
Car/Taxi     
Motorbike     
Bus     
Electric Train     
Diesel Train     
Metro/Underground     
Cycling     
Walking     
How busy are the roads?
Not busy (very few cars around)     
Busy at times (busy on some roads)     
Busy (constant moving traffic)     
Very busy (congested/stationary traffic)     
Not Applicable (travelling by train/metro)     
Is anyone smoking?
No (not smoky at all)     
Occasionally (slightly smoky)     
Frequently (smoky)     
Constantly (very smoky)     
Location number                                         
(continued from previous page)
1 2 3 4 5
Are you:
Driving     
Passenger     
Do you own the car/motorbike?
Yes     
No     
Make of car/motorbike?
Model of car/motorbike?
Fuel type:
Petrol     
Diesel     
Engine size
Year of manufacture
Is the air conditioning used?
Yes     
No     
Is the fan/heater used?
Yes     
No     
Where was the briefcase kept?
In the seating area of the car     
In the boot of the car     
In the travel case of the bike     
Other     
LOCATION SHEET FOR TRAVELLING - Information About your Journey
Any other information you would like to 
tell us about:
Please name the areas travelled through 
or the bus or train route taken:                
(e.g. Harborne-Edgbaston-City Centre, Bus 
Number 22, Train Route - Cross City Line - 
New Street to Erdington, e.t.c.)
If you are travelling by car, taxi or motobike please complete the following questions:
Please name the roads travelled along:    
(e.g. Hagley Road-Broad Street-Queensway-
A38M-A38 Tyburn Road  e.t.c.)
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X.9 Supplementary information on Comet assay 
 Mean Tail 
Intensity (%) 
Median Tail 
Intensity (%) 
Exposed/Control 
Ratios 
Replicate 1  
Ctrl 0.03 11.85 5.35 0.97
Benzene 0.03 11.49 3.21
Ctrl 0.1 5.29 1.04 3.03
Benzene 0.1 16.02 5.53
Ctrl 0.3 2.94 0.27 4.18
Benzene 0.3 12.27 5.13
Replicate 2       
Ctrl 0.03 16.61 5.38 0.63
Benzene 0.03 10.52 1.96
Ctrl 0.1 N/A N/A  
Benzene 0.1 N/A N/A  
Ctrl 0.3 9.54 5.93 1.70
Benzene 0.3 16.19 2.63
Replicate 3       
Ctrl 0.03 11.39 3.76 0.69
Benzene 0.03 7.84 3.64
Ctrl 0.1 3.62 0.16 2.31
Benzene 0.1 8.36 1.40
Ctrl 0.3 7.01 4.01 1.59
Benzene 0.3 11.15 4.08
 
Supplementary table: Overview of the mean and median tail intensities of each of the 
independent replicates, including their relative air exposed controls. The reported data 
consists of the average of 3 technical replicates for each concentration. 
In replicate 1 it was possible to perform a better measurement of the tail intensities for the 0.3 
ppm benzene concentration, however, on average the exposed/control ratio was lower in the 
cells exposed to 0.3 ppm than in the cells exposed to 0.1 ppm. 
